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ABSTRACT
MOLECULAR ANALYSES OF CHANGES INDUCED IN THE MICROBIAL
POPULATIONS OF MURINE COLON AFTER As (III) EXPOSURE

By
Rishu Dheer
August, 2011

Dissertation supervised by Dr. John F. Stolz
The gut microbiota is essential for mammalian health and metabolism.
Thus identifying factors that influence the host microbiota is key to understanding the
dynamic interplay between the host and its microbiota. Recent studies have shown the
effect of chronic exposures of trivalent arsenic [As(III)] in environmentally relevant
concentrations on host physiology, however, little is known of how it impacts the gut
microbiota.
This study examined the hypothesis that environmentally relevant concentrations
of As(III) in drinking water will directly affect the murine colon microbial composition
and physiology. The colon microbial communities from 10 and 250 ppb of As(III)
exposed mice were compared to the control mice after 2, 5 and 10 weeks of As(III)
exposure. Molecular analysis based on 16S rRNA gene and 16S- 23S intergenic region
indicated a time and dose dependent shift in microbial community composition. Analysis
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of 16S rDNA clone libraries demonstrated an increase in Bacteroidetes and
proportionally fewer Firmicutes in colon microbiota in response to As(III) exposure.
Microbes have developed mechanisms to tolerate arsenic present in the
environment. This study is the first to show that the gut microbes express arsenic resistant
genes (arsA and arsB) in the colon. However, exposure to ppb concentrations of As(III)
did not induce the expression of these genes in colon microbes. These data suggest that
the selective effect of As(III) on colon microbiota was not due to direct exposure of colon
microbes to As(III), but rather a response to changes in the host physiology.
Since arsenic affects the NO levels in human cell lines, it was hypothesized that
As(III) will affect the pathways that are linked to NO levels in human body. Many
microbes present in human body have nitrogen metabolizing genes (nrfA) that contribute
to NO levels, thus the expression levels of nrfA gene in colon microbes was examined.
Real time RT-qPCR studies showed a time and dose dependent increase in nrfA
expression in response to As(III) exposure. Together, the results presented in this study
demonstrated an indirect effect of As(III) on the composition and physiology of murine
colon microbiota that may further impact the host health.
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Chapter 1 : INTRODUCTION
1.1 Arsenic Background
Arsenic (Atomic number 33 and mass 74.92) is the 20th most abundant element in
the earth’s crust with a concentration of 3.4 parts per million. Arsenic in combination
with elements such as iron, copper, nickel, cobalt etc. forms more than 245 minerals
including realgar (As4S4), arsenopyrite (FeAsS), nickel arsenide (NiAs), cobaltite
(CoAsS) and scorodite (FeAsO4) (Wedepohl, 1991; Nriagu, 2002). Used since antiquity,
arsenic was first discovered by Albert Magnus in 1250. Being colorless, odorless and
tasteless in nature, arsenic in the form of As2O3 is considered as the perfect poisoning
agent (NRC, 1997). Along with some famous cases of homicidal death due to arsenic
poisoning, many cases of accidental arsenic poisoning have been reported throughout
history (Nriagu, 2002). Despite its toxicity, arsenic has a long history for its use as a
curative for diseases such as psoriasis, syphilis and trypanosomiasis (Leonard, 1991). In
1905, Paul Ehrlich received the Nobel Prize in medicine for the discovery of salvarsan to
combat syphilis (Azcue & Nriagu, 1994). Arsenic in the form of arsenic trioxide is used
till today for the treatment of patients with acute promyleocytic leukemia due to its ability
to induce apoptosis in cancer cells (Antman, 2001). Both inorganic and organic forms of
arsenic have been used at a large scale in the manufacture of chemical warfare agent,
semiconductors, glass manufacturing, paints, dyes, wood preservation, feed additives,
pesticides and herbicides (Nriagu, 2002; Azcue & Nriagu, 1994). Due to concerns about
the risk posed by arsenic on human health, use of arsenic in certain household
applications has been completely banned (ATSDR, 2007). Even though the production of
1

arsenic in United States has been ceased since 1985, it is still the largest consumer of
arsenic. Most of the imported arsenic is used for commercial purposes such as
manufacturing glass and semiconductor devices. It is also used in metal and agricultural
industry sectors (ATSDR, 2007).
1.2 Arsenic in the environment
In the environment, inorganic arsenic occurs in sedimentary rocks, fossil fuel
deposits and minerals while organic arsenic in the form of arsenobetaine and
arsenocholine is found in marine animals and algae (Friberg et al, 1986; Lau et al, 1987).
In nature, arsenic exists in four different oxidation states: +5, +3, 0 and -3. Of these,
elemental arsenic [As(0)] is rare whereas arsine [As(-III)] is found at very low levels in
gases from oxygen deficient environments (Cullen & Reimer, 1989). As(III) and As(V)
are the most toxic and abundant forms of inorganic and organic arsenic, primarily
existing as oxyanions in the environment. Depending upon pH and oxygen, arsenate
usually exists as arsenic acid in 4 different states (H3AsO4, H2AsO4−, HAsO32− and
AsO43−) whereas arsenite forms arsenous acid species (H3AsO3, H2AsO3− and HAsO32−)
under reducing conditions (Ni & Sadler, 1991). Compared to arsenite, arsenate is the less
toxic and more oxidized form of arsenic, occurring mainly in aqueous aerobic
environments whereas arsenite is prevalent in anaerobic environments (Cullen & Reimer,
1989). Arsenate due to its ability to adsorb readily to minerals such as ferrihydrite, iron
oxide and alumina, is less soluble and relatively immobile as opposed to mobile arsenite
(Smedley & Kinniburgh, 2002). Changes in pH, oxidation-reduction potential, ion
concentration of iron, nitrate or sulfide and composition of microbiota in the surrounding
environment influences the release of arsenic from rocks or sediments (Smedley &
2

Kinniburgh, 2002; Oremland & Stolz, 2005). Arsenic species can be transformed from
one form to another but cannot be removed from the environment. Arsenic is released
into the environment from natural as well as anthropogenic sources. Natural sources of
arsenic release include volcanic disruption, dissolution from rocks, leaching from soil and
minerals into ground water whereas anthropogenic sources include mining, fossil fuel
combustion, waste incineration, wood treatment and irrigation runoff after pesticide and
herbicide application (Pacyna, 1987; Welch et al, 2000). In addition, aquatic and
terrestrial animals also introduce some methylated organoarsenicals in the environment as
excretory products (Andreae & Klumpp, 1979; Aposhian et al, 2000). Arsenic is one of
the most common health hazards in the environment and affects millions of people across
the world. Due to its toxicity and ease of exposure to humans, arsenic ranks first among
the hazardous elements on Superfund sites (HazDat, 2006).
1.3 Microbes mediated arsenic cycling
Arsenate enters into prokaryotic cells via phosphate transporters (Pst and Pit)
while arsenite enters through glycerol transporter (GlpF) (Rosen & Liu, 2009; Meng et al,
2004; Harold & Baarda, 1966). To deal with arsenic toxicity, a wide variety of
microorganisms have developed mechanism such as detoxification and methylation to
remove toxic arsenic species from the cell or to convert it into less toxic forms. In
addition, an increasing number of microorganisms are being discovered that can use
arsenic for energy and growth (Stolz & Oremland, 1999; Silver & Phung, 2005). Many
microorganisms have the ability to both oxidize and reduce arsenic and possess
machinery to perform a combination of the above mentioned processes (Richey et al,
2009; Saltikov et al, 2005; Macur et al, 2004). Such microbial properties have led to the
3

establishment of a rigorous microbe mediated arsenic biogeochemical cycle in certain
extreme arsenic rich environments like Mono Lake CA (Oremland et al, 2004). Recently
GFAJ-1 a γ proteobacteria isolated from this lake has been shown to replace phosphate
with arsenic in its genomic material and was able to grow actively after this substitution
(Wolfe-Simon et al, 2010). Figure 1.1 shows the various pathways adopted by
microorganism to combat arsenic toxicity.
Methylation
Microbe mediated methylation reaction is proposed to involve an alternating
sequence of reduction and oxidation of As(V) and As(III) respectively with methylation
(Bentley & Chasteen, 2002; Challenger, 1945), resulting in the production of volatile
methylated arsine gases and nonvolatile arsenic acids (McBride & Wolfe, 1971).
Methylation was originally considered as a detoxification method however recent
evidence suggests that some of these methylated compounds are more toxic then
inorganic arsenic species (Styblo et al, 2000; Petrick et al, 2001). In the case of Bacteria
and Archaea transfer of a methyl group from S-adenosylmethionine (SAM) to As (III) is
catalyzed by ArsM, a methyltransferase (Qin et al, 2006). Methyl cobalamin also serves
as a methyl donor in some bacterial species but the mechanism by which methyl group is
transferred to arsenic species is not clear yet (Gadd, 1993; Krautler, 1990).

4

Figure 1.1: Pathways adopted by microorganism to combat arsenic toxicity. (1) Entry of
arsenite and arsenate via glycerolporin and phosphate transporters. (2) As(V) reduction
followed by expulsion of As(III) (3) Detoxification of As(III) by sequestration (4)
arsenite oxidation (5) Dissimilatory As(V) respiration and (6) methylation of arsenic
species. Figure reproduced from Espino et al; 2009 with permission from the author.
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Arsenite oxidation
Arsenite oxidation by bacteria can be used either as a detoxification process or an
energy generation process (Tamaki & Frankenberger, 1992; Oremland & Stolz, 2003).
Bacteria from α, β and γ proteobacteria and other phyla representing more than 9 genera
have been reported to have arsenite oxidizing abilities (Santini et al, 2002; Salmassi et al,
2002; Gihring & Banfield, 2001). The detoxification reaction, mediated by heterotrophic
arsenite oxidizers (HAOs) involves oxidation of As (III) to As (V) by periplasmic
enzyme arsenite oxidase and no energy is generated in the process (Muller et al, 2003). In
Chemolithotrophic arsenite oxidizers (CAOs), oxidation of arsenite is an energy
generating process and the process is coupled to reduction of oxygen, nitrate or nitrite.
The energy generated in the process is used for fixing CO2 into organic material
(Oremland et al, 2002; Rhine et al, 2006). Arsenite oxidase belongs to the DMSO
reductase family and consists of aoxA and aoxB genes that encode, respectively, the large
90 KDa Mo containing and the small 14KDa Rieske (2Fe-2S) subunits of arsenite
oxidase (Ellis et al, 2001; Santini & vanden, 2004).
Arsenate reduction
Dissimilatory As(V)-respiring prokaryotes (DARPs) reduce As(V) to As(III) and
energy is generated in the process (Oremland & Stolz, 2005; Stolz & Oremland, 1999). In
DARPs, arsenate reduction is coupled to the oxidation of either organic or inorganic
compounds (Niggemyer et al, 2001; Hoeft et al, 2004; Liu et al, 2004; Takai et al, 2003).
The process was first discovered in Sulfurospirillum arsenophilum and has been
identified in many other bacterial species since then (Oremland & Stolz, 2005; Ahmann
et al, 1994). Arsenic requirement is not obligate for DARPs as they are capable of using
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other terminal electron acceptors such as nitrate, selenate, selenite, fumarate, and sulfur
compounds for energy generation (Oremland & Stolz, 2003). Respiratory arsenate
reductases belong to DMSO family of mononuclear molybdenum-containing enzymes
consisting of 87 and 29 kDa subunits. Both periplasmic and membrane bound respiratory
arsenate reductases have been found. The large catalytic subunit, ArrA, contains motifs
for binding an iron-sulfur cluster and Mo containing pyranopterin cofactor whereas ArrB,
the smaller electron transfer subunit, contains three [4Fe-4S] and one [3Fe-4S] iron-sulfur
clusters (Saltikov & Newman, 2003; Afkar et al, 2003).
Arsenate reduction via the ars operon is one of the most well studied systems for
arsenic detoxification and has been identified in wide variety of Bacteria, Archea and
yeast (Jackson & Dugas, 2003). In bacteria the genes for ars operon are located on
plasmids or chromosome. The genes that typically form an ars operon include: arsB,
arsC and arsR (Xu et al, 1998). arsA, arsD and arsH are some other genes that may
occur in the ars operon of some bacteria. The arrangement and configuration of genes
involved in arsenic tolerance vary from species to species (Figure 1.2).

7

Figure 1.2: Arrangement of ars operon in bacterial species. arsR (blue), arsB (green),
ACR3 (yellow), glutaredoxin coupled arsC (orange), thioredoxin coupled arsC (red),
arsH (purple) and other genes (white). Figure modified from Espino et al, 2009 with
permission from the author.
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ArsC, a 12- 16 KDa cytoplasmic arsenate reductase, reduces As(V) to As(III) (Ji
& Silver, 1992). As (III) is exported out of the cell via ArsB, an arsenite specific
transmembrane protein (Rosen, 1999). In some organisms the process of arsenite
expulsion is coupled to ATP hydrolysis to form an oxyanion- translocating complex and
the ATPase in these microbes is encoded by arsA (Dey et al, 1994). In bacteria where
ArsA is not present, the proton motive force across the cell membrane facilitates arsenite
expulsion (Figure 2A). ArsD is a 13KDa cytosolic metallochaperone that exists as
homodimer and facilitates the transfer of As(III) to ArsA thus helping in As(III)
expulsion (Lin et al, 2007). ArsR is a trans acting transcriptional repressor which in the
absence of As(III) represses the expression of ars operon by binding to the operator
region within the promoter of the operon (Xu et al, 1996). ArsH is a NADPH-flavin
mononucleotide oxidoreductase that is required for arsenic resistance in Yersinia
enterocolitica, Shigella flexneri and Sinorhizobium meliloti but its role in arsenic
detoxification is not clear yet (Vorontsov et al, 2007; Ye et al, 2007).
On the basis of structure, reducing power and the location of catalytic cysteine
residues the arsenate reductases are classified into 3 protein families: (i) E.coli plasmid
R773 type glutaredoxin coupled arsenate reductase (Gladysheva et al, 1994) (ii)
Staphylococcus aureus plasmid pI258 type thioredoxin coupled arsenate reductase (Ji et
al, 1994) (iii) Eukaryotic glutaredoxin coupled arsenate reductase from Saccharomyces
cerevisiae (Bobrowicz et al, 1997).
Similar to arsenate reductase, the As(III) membrane efflux protein is currently
divided into 2 distinct protein families (Rosen, 1999) (i) the typical ArsB protein type
found in Firmicutes and γ proteobacteria and (ii) ACR3 type present in Actinobacteria, α
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proteobacteria, Archaea and S. cerevisiae. The 2 protein types although similar in size,
differ in structure and specificity for metal transport (Wu et al, 1992; Wysocki et al,
1997). While ACR3 with 10 membrane spanning segments is specific for As(III) only,
ArsB with 12 membrane spanning segments can transport antimonite in addition to
arsenite (Ghosh et al, 1999).
The ars genes are transcribed from a single promoter to form a polycistronic
mRNA with a very short half-life of less than 4 minutes. ArsR is a 13 KDa protein that
belongs to winged-helix metalloregulatory proteins and forms a dimer (Busenlehner et al,
2003). In E.coli, arsenite binds to sulfur thiolates of 3 conserved Cys residues at position
32, 34 and 37 of the DNA binding domain of ArsR. The binding of As(III) or Sb(III) in
the DNA binding domain induces a conformational change in ArsR leading to disruption
of DNA-ArsR interaction. This disruption results in release of ArsR from the promoter
region, inducing the transcription of ars genes (Shi et al, 1996).
1.4 Routes of arsenic exposure
Water
Humans are exposed to inorganic forms of arsenic mainly through drinking water
and food and to a lesser extent via dermal absorption and by inhalation of dust (WHO,
2001). Natural level of arsenic in surface and ground water is 1-2 µg/L. However the
levels may reach upto 3400 µg/L in water bodies close to natural or anthropogenic
sources of arsenic (Matschullat, 2000). Approximately 100 million people across the
globe are exposed to high levels of inorganic arsenic mainly through drinking water
contaminated by natural mineral deposits. Besides natural sources, anthropogenic sources
including industrial waste, mining and agricultural manure release arsenic into the water
10

(Nriagu & Pacyna, 1988). Countries like Taiwan, Japan, Chile, China, Finland, Denmark,
Bangladesh and India have regions where arsenic concentration in water supplies have
reached ppm levels (WHO, 2001). In United States, approximately 13 million people
consume water from public supplies that have arsenic concentration >10 µg/L (Welch et
al, 2000). High concentrations of arsenic in the US are associated with mining,
geothermal activities and natural deposits. Due to its toxicity, EPA has reduced the
permissible exposure limits of As in drinking water supplies from 50 µg/L to 10 µg/L in
2006, to match that of WHO levels (EPA, 2001). According to the data collected by US
geological survey from 1973 − 2000 in 31,500 ground water supplies across the US,
various regions of US including New England, Maine, Nevada, Utah, New Mexico and
Arizona have arsenic concentrations above the recommended 10 ppb or 10 µg/L (USGS,
2007) (Figure 1.3).
Air
In the atmosphere arsenic is primarily released as arsenic trioxide or less
frequently as volatile arsine (Pacyna, 1987; Matschullat, 2000). Concentration of arsenic
in atmosphere ranges from 1-3 ng/m3 in remote locations but may reach upto 2000 ng/m3
in areas close to anthropogenic sources of arsenic. In the US about 355 tons of arsenic
compounds are released into the atmosphere every year (EPA, 2005). Exposure to higher
levels of arsenic via dust mainly occurs in people involved in production or use of arsenic
compounds such as workers at pesticide industry, glass production and metal smelters.
Also people living in vicinity of these industry inhale more arsenic as compared to people
living in clean environments (Pacyna, 1987).
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Figure 1.3: Arsenic concentrations in drinking water supplies across United States.
http://water.usgs.gov/nawqa/trace/pubs/geo_v46n11/fig2.html.

12

Food
The arsenic concentration in food ranges from 20 to 140 ppb. Rice, apple, grapes,
lettuce, tomatoes and potatoes may have arsenic concentrations in the ppm range (Schoof
et al, 1999). Also the food grown in arsenic contaminated soils may accumulate higher
levels of arsenic (Abedin et al, 2002; Carbonell-Barrachina et al, 1997). Exposure to
arsenic also occurs via poultry consumption because of widespread use of arsenic as a
feed additive in poultry industry (Lasky et al, 2003). Exposure to organoarsenicals
(arsenobetaine and arsenocholine) occurs by consuming seafood but is considered
nontoxic as organoarsenicals are excreted unchanged (Brown et al, 1990; Yamauchi et al,
1986). However, in vitro studies with intestinal microbes from humans have
demonstrated the transformation of arsenobetaine to DMA(V), TMAO and
dimethylarsinoylacetate under aerobic conditions (Harrington et al, 2008). It is estimated
that the average dietary intake of arsenic in US ranges from 0.31 – 1.14 μg/kg/day
(MacIntosh et al, 1997). According to Food and Agriculture Organization (FAO), the
maximum tolerable daily intake of total arsenic is 2-7 μg/kg body weight/day (WHO,
2010).
Soil and dermal absorption
Levels of arsenic in soil range from 1 to 40 mg/kg but may reach higher levels in
areas associated with arsenic use such as golf fields, agricultural lands, mining areas and
waste disposal sites (Mandal & Suzuki, 2002). Arsenic from such sites leaches into the
sub-surface aquifers and may enter into drinking water supplies. Although dermal
absorption of arsenic from soils is negligible, it occurs more commonly due to
occupational exposures (Lowney et al, 2007). In vitro studies with human skin have
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shown 1.9% absorption of inorganic arsenic over a period of 24 hours (Wester et al,
1993).
1.5 Fate of arsenic in humans
Absorption of As(III)
Ingested inorganic arsenic is readily absorbed in the GI tract (Vahter & Norin,
1980) wherein it binds to proteins and other low molecular weight compounds present in
the blood and is transported to other organs in the body (NRC, 1999). The amount of
arsenic absorbed by GI tract, its retention and distribution to other body parts is
dependent on the type of arsenic species, oxidation state and dose level; with As(III)
being more efficiently retained and transported (Thomas et al, 2001). Arsenic is also
absorbed via lungs after inhalation and this inhaled arsenic can subsequently be absorbed
in the GI tract after clearance from the respiratory tract (Vahter et al, 1986; Yamauchi et
al, 1989). Like microbes, As(III) is transported in the mammalian cells via
aquaglycoporins (APQ7 and APQ9) (Liu et al, 2002) whereas As(V) is transported by
phosphate transporters (Huang & Lee, 1996).
Arsenic metabolism
After absorption, inorganic arsenic is transformed in the human body by
reduction, oxidation, conjugation and methylation reactions (Carter et al, 2003). The liver
is considered as the main organ where methylation of inorganic As(III) occurs but the
role of other organs or tissues such as kidneys, lungs, skin and RBCs in arsenic
metabolism has also been reported (Buchet et al, 1984; Cohen et al, 2006). Two models
have been proposed for the biotransformation of arsenic in mammalian systems (i)
Generally accepted pathway suggested by Challenger (Challenger, 1945) (ii) alternate
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pathway proposed by Hayakawa (Hayakawa et al, 2005). The first step is common to
both the pathways wherein As(V) is reduced to As(III) in the blood with thiols working
as electron donors. Glutathione-S-transferase omega (GSTO1) is the arsenate reductase
enzyme that has been identified to play a role in this transformation (Zakharyan et al,
2001). In addition several other enzymes including purine nucleoside phosphorylase
(Radabaugh et al, 2002), glycogen phosphorylase (Gregus & Németi, 2007),
glyceraldehyde dehydrogenase (Gregus & Németi, 2005) that can reduce arsenate in
mammalian cells have been reported but their physiological role has not been established
so far. More recently the catalytic domains of human Cdc25B and Cdc25C phosphatases
have been proposed to play a role in arsenate reduction. These enzymes are structurally
similar to ArsC found in yeast (Bhattacharjee et al, 2010). In the generally accepted
pathway suggested by Challenger, arsenic undergoes alternate oxidation and reduction
along with methylation to produce methylated arsenic species in a specific order with +5
oxidation state of an arsenic species generated before the +3 state of the same arsenic
species (Figure 1.4). Both As3MT (arsenic methyltransferase) and CYT19 have been
proposed to methylate arsenic species (Zakharyan et al, 1999; Lin et al, 2002). According
to the Hayakawa pathway, As(V) is reduced to As(III) followed by formation of arsenic
triglutathione (ATG) in the presence of glutathione. ATG is further converted into
monomethyl arsenic diglutathione (MADG) and dimethyl arsinic glutathione (DMAG)
by transfer of methyl group from S-adenosyl methionine As3MT. Both MADG and
DMAG form equilibrium with MMA(III) and DMA(III) respectively. MMA and DMA
are readily converted to their pentavalent forms by oxidation (Figure 1.5).
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Figure 1.4: Arsenic biotransformation pathway suggested by Challenger. Figure
reproduced from Hayakawa et al, 2005 with permission from the author.
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Figure 1.5: Arsenic biotransformation pathway proposed by Hayakawa. Figure
reproduced from Hayakawa et al, 2005 with permission from the author.
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Arsenic excretion
From liver inorganic arsenic and its methylated metabolites are distributed to
other organs of the body. The retention time for inorganic arsenic is longer in skin, hair,
upper GI tract, skeleton and lens of the eye (Lindgren et al, 1982; Yamauchi &
Yamamura, 1985). The main products of methylation of inorganic As in humans are
monomethylarsonic acid [MMA(V)], monomethylarsonous acid [MMA(III)],
dimethylarsinic acid [DMA(V)] and dimethylarsinous acid [DMA(V)] ((Vahter, 2002; Le
et al, 2000). Of these, MMA(III) and DMA(III) are the most toxic and reactive forms but
are formed as intermediates only (Styblo et al, 2000; Petrick et al, 2001). MMA(V) and
DMA(V) are less toxic forms of arsenic and do not react readily with tissues. These
forms are readily excreted in the urine along with untransformed inorganic arsenic
(Vahter, 2002). In addition, relatively nontoxic trimethylarsine oxide (TMAO) and highly
toxic sulfur containing monomethylmonothioarsonic acid [MMMTA(V)] and
dimethylmonothioarsinic acid [DMMTA(V)] have also been observed in human urine
(Yoshida et al, 1998; Naranmandura et al, 2007). Elimination of arsenic from the human
body occurs in three phases: (i) 66% removal within two days (ii) 30% elimination in ten
days and (iii) 4% removed in 38 days (Mealey et al, 1959; Marafante et al, 1985). In
humans typically 10-30% of the arsenic is removed in its inorganic form, 10-20% as
MMA and 55-75% as DMA. However these values may differ in individuals depending
on genotype, sex, exposure dose and route of exposure (Loffredo et al, 2003). Although
the majority of absorbed arsenic is removed from the body via urine (80%), a small
amount of it is also removed via stool and sweat (10%). A small percentage of ingested
arsenic accumulates in the hair, nails, bones and muscles (ATSDR, 2007). Multi-drug
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resistance proteins (MRP1 and MRP2) have been documented to be involved in the
expulsion of As(III) and possibly arsenic glutathione from mammalian cells (Leslie et al,
2004).
Arsenic transformation by gut microbes
In vivo studies with intravenous injection of sodium arsenate in rats demonstrated
rapid formation of methylated arsenicals in a pattern similar to those found after oral
administration suggesting that intestinal microbes do not play any significant role in
methylation of arsenic under in vivo conditions (Rowland & Davies, 1982). However
studies have shown that metabolism of arsenic in rats differ significantly from human and
mice (Vahter, 1994). In all mammals, the rate of absorption of arsenic after oral
consumption via the GI tract depends not only on the oxidation state and speciation but
also on the bioavailability of the ingested arsenic species (Laparra et al, 2006; Juhasz et
al, 2006). The reentry of arsenic or its metabolites into the gut via enterohepatic
circulation also exposes the intestinal microbiota to this toxin (Csanaky & Gregus, 2002).
An in vivo study with rats showed toxic effects of arsenic (1mg/L) on the total bacterial
count in stool along with reduced levels of arsenic in the stool samples (Choudhry et al,
2010). In vitro studies have shown that the gut microflora of arsenic exposed individuals
can also play a significant role in detoxification and elimination of arsenic from the body.
Rat and mice cecal microbiota were shown to biotransform As(V) to As(III) with the
formation of MMA and DMA (Rowland & Davies, 1981; Hall et al, 1997). In addition to
As(V) reduction, dissimilatory arsenate reduction was observed in hamster fecal samples
after being fed with 100 mg/L of As(V) via drinking water (Herbel et al, 2002). More
recently it was demonstrated that the in vitro human intestinal microbial community has
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the ability for presystemic arsenic metabolism resulting in the formation of MMMTA
along with MMA and DMA (Van de Wiele et al, 2010). Moreover, formation of thiolated
methylarsenicals is observed in the presence of intestinal microbiota (Kuroda et al, 2004).
Together these studies indicate that arsenic transformation by intestinal microbes is
common at least at high doses of arsenic exposure.
1.6 Mechanism of arsenic toxicity and human health
Twenty four years ago, arsenic was classified as group I carcinogen by
International Agency for Research on Cancer (IARC, 1987). An acute exposure to arsenic
(1-3 mg/kg body weight/day) leads to immediate effects such as vomiting, diarrhea, GI
hemorrhage, multiple organ damage and death. The symptoms may appear within few
minutes to hours after ingestion (Levin-Scherz et al, 1987; Armstrong et al, 1984).
Regardless of the route of exposure, chronic exposure to arsenic in the range of 0.01–0.04
mg/kg/day results in arsenicosis/arseniasis, skin lesions, skin, lung, liver, kidney, prostate
and bladder cancer in humans (Wu et al, 1989). Additionally various epidemiological
studies have linked chronic arsenic exposure to reproductive defects, developmental
defects, neurological defects, respiratory effects, type II diabetes, weight loss and several
cardiovascular diseases including atherosclerosis, portal cirrhosis and blackfoot disease
(WHO, 2001). Transplacental studies have shown that arsenic crosses the placenta and
acts as a carcinogen inducing tumors at various sites in the progeny (Waalkes et al,
2004). Recently a number of studies have shown that drinking water containing
environmentally relevant concentrations of As(III) in parts per billion range have
significant effect on various organs of mammalian model systems (Table 1.1).
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Dose

Exposure
time

Organ
studied

50 ppb

5&8
weeks

Lung and
heart

50 ppb

4 weeks

Lungs

10, 50,
200 ppb

9 weeks

Lungs

50 ppb*

8 weeks

Liver

50 ppb

16 weeks

Brain

10 &50
ppb

3 weeks

Kidney

Effect
Disruptive Extra Cellular
Matrix
Altered protein expression
(RAGE, GST omega 1,
enolase 1, peroxyredoxin 6)
Increased growth of
implanted tumors
Increased glutathione and
early hepatocyte
degeneration
Spontaneous locomotor
activity, decreased
dopamine and antidoxidants
Increased hexokinase II
Altered expression of genes
involved in cell adhesion,
migration
Reduced immunity to
Influenza virus
Differential expression of
angiogenic and tissue
remodeling genes

100 ppb

5 weeks

Lung

100 ppb

5 weeks

Immune
system

50, 250,
500 ppb

5, 10, 20
weeks

Heart

10&250
ppb

2&5
weeks

Liver

Angiogenesis and vascular
remodeling

50, 100,
300 ppb*

~6 weeks

Brain

Increased glutathione

Reference
Hays et al, 2008
Lantz et al, 2007
Kamat et al, 2005
Bashir et al, 2006
Bardullas et al, 2009
Pysher et al, 2007
Kozul et al, 2009b
Kozul et al, 2009a
Soucy et al, 2003
Straub et al, 2007b;
Straub et al, 2007a;
Straub et al, 2008
Chaudhuri et al,
1999

Table 1.1: Changes induced in different organs of mammalian biological model sytems
in response to As(III) exposure.* indicates studies done in rats. All other studies were
done in mice.
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The understanding of the molecular mechanisms behind the etiology of these
diseases and organ dysfunction is very limited. However, various mechanisms for arsenic
toxicity have been proposed including protein binding of arsenic, chromosome
abnormalities, altered DNA repair, mitochondrial damage, DNA hypo and hyper
methylation, oxidative stress and altered signal transduction pathways that lead to cell
proliferation and tumorogenesis (Kitchin & Wallace, 2008; Liu et al, 2005; Hughes,
2002).
Arsenate exhibits structural similarity to phosphate and enters into the cell via phosphate
transporters. Within the cell arsenate interferes with phosphate uptake and affects the
processes that involve phosphate such as oxidative phosphorylation (Tamaki &
Frankenberger, 1992). Arsenite is neutral and structurally similar to non-ionized glycerol
at a pH less than 9.2. Arsenite can enter into the cell either by diffusion or through
glyceroporin membrane channels (Ramírez-Solís et al, 2004; Mukhopadhyay et al, 2002).
AQP9, a mammalian aquaglycerporin, has been shown to transport arsenite into the cells
((Liu et al, 2002). Arsenite has the ability to bind to the sulfhydryl and thiol groups of
amino acids and disrupt protein structure and function (NRC, 1999). It is estimated that
arsenic affects more than 200 enzymes just by binding to them (Abernathy et al, 1999).
Studies with vascular endothelial cells have shown that arsenite interacts
extracellularly with sphingosine-1-phosphate (S1P1), a G protein coupled receptor and
affects Rac1 GTPase activity (Straub et al, 2009). Rac1 GTPase is involved the in cell
survival signal transduction pathway (Sun et al, 2006). At sublethal doses, arsenite alters
the expression of stress response transcription factors (NFkB, Nrf2 and AP 1) and
mitogen activated protein kinases. These proteins play an important role in cell cycle
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control but the mechanism by which arsenite affect these pathways is not clear (Druwe &
Vaillancourt, 2010).
Altered DNA methylation has been associated with reduced levels of SAM due to
its use in biomethylation of arsenic in the body. Change in the expression of enzymes
involved in DNA methylation is considered as another factor involved in altered DNA
methylation (Ren et al, 2010). Aberrant chromosomes occur due to arsenic induced
deletion mutations, altered DNA repair enzymes, endoreduplication, aneuploidy and
micronuclei formation (Moore et al, 1997; Zhang et al, 2007).
Arsenite exposure at low levels has been shown to be associated with reactive
oxygen species (ROS) and OH- free radical production by various mechanisms, resulting
in oxidative damage and inactivation of proteins (Samikkannu et al, 2003; Shi et al,
2004). In human vascular smooth muscle cells, arsenite has been shown to activate
NADPH oxidase which reduces O2 to superoxide anion (Lynn et al, 2000). ROS alters the
redox potential of the cell by affecting GSH reductase and thioredoxin reductase thus
reducing the levels of thiols in the cell (Lin et al, 1999). ROS can directly damage DNA
or can alter signal transduction pathways (Hwang & Kim, 2007).
Arsenite has been reported to exhibit its toxicity via regulation of eNOS
(endothelial NO synthase) and iNOS (inducible NO synthase), thus directly affecting the
production of nitric oxide (NO) (de et al, 1996; Souza et al, 2001). Depending upon the
cell type and dose, the effect of arsenite on NO levels can vary from increased to
decreased or have no effect on NO production (Gurr et al, 2003). In addition, arsenite has
been demonstrated to have an indirect effect on cellular NO levels. In vascular
endothelial cells arsenite induces the expression of NOX, a superoxide generating
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enzyme (Smith et al, 2001). The superoxide anion generated in the process combines with
NO generated from the eNOS thus reducing the availability of NO for its normal
physiological functions (Pryor & Squadrito, 1995). NO causes DNA damage either by
directly binding to the amino groups of DNA, by forming N-nitroso compounds that
alkylate DNA or by forming reactive oxidative species such as peroxynitrite which causes
oxidative DNA damage (Tamir & Tannenbaum, 1996).
1.7 Mammalian GI tract microbiome
The GI tract of mammals hosts a variety of microorganisms including bacteria,
archaea, viruses, fungi, yeast and protozoa. Of these, bacteria are the predominant forms
with the number of bacterial cells in the GI tract far exceeding the number of eukaryotic
cells in human body (Savage, 1977). The GI tract of the neonate is usually sterile but
bacterial colonization starts during birth with intestinal microbiota of infants showing
similarity to their mothers (Palmer et al, 2007; Turnbaugh et al, 2009). The microbial
profile of infants delivered vaginally differed significantly from those delivered by
cesarean section and is also affected by infant diet, hygiene and medication (Penders et
al, 2006). Bacterial profiling by molecular techniques showed that infant microflora is in
constant flux but becomes more stable and resembles to adult towards the end of infancy
(Palmer et al, 2007). Throughout life, a number of factors have been shown to influence
the microbiota of the host including age, diet, antibiotic use and genotype (Mariat et al,
2009; Turnbaugh et al, 2008; Dethlefsen et al, 2008; Zoetendal, 2001). Beside these
external and genetic factors, environmental factors within the gut such as oxygen, pH,
nutrient availability, redox potential and presence of other microbes also play a key role
in determining the microflora of the gut (Hill, 1995). A large number of commensal,
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symbiotic and opportunistic bacteria inhabit the GI tract of mammals, with density of
bacteria increasing from stomach to large intestine (O'Hara & Shanahan, 2006). The
diversity and type of bacteria differs not only longitudinally from stomach to the distal
portion of the large intestine but also radially from mucosa to luminal (fecal) regions
(Frank et al, 2007; Zoetendal et al, 2002). Culture independent high throughput 16S
rRNA gene sequencing of human and mice intestinal microbiota have shown that gram
negative Bacteroidetes and low GC gram positive Firmicutes are the major phyla in the
GI tract, together constituting about 90% of the total sequenced population. Within
Firmicutes, genera belonging to clusters XIVa and IV of the clostridial group
predominate. Proteobacteria, Verrucomicrobia, Deferribacteres, Actinobacteria,
Fusobacteria and other gram negative bacteria are also found in the GI tract but in very
low abundance (Nava et al, 2011; Eckburg et al, 2005). Although the number of bacterial
phyla in mammalian gut is very low, there are approximately 1800 different genera found
in the gut with the number of species reaching close to 15,000. Out of these only about
2000 different phylotypes are harbored by any particular individual at any point (Frank et
al, 2007; Frank & Pace, 2008). The predominating bacterial genera found in the
mammalian gut include Clostridium, Bacteroides, Ruminococcus, Lactobacillus,
Acinetobacter, Enterobacter, Bifidobacterium with more anaerobes as compared to
aerobes (Eckburg et al, 2005; Gordon & Dubos, 1970). The bacterial composition is
generally conserved at the phylum level; it is the genera and species that vary greatly
from individual to individual. Molecular 16S rRNA gene based studies of gut microbiota
have shown sequences that do not show identity to the previously described microbes
indicating the uniqueness of gut microbiota for each individual (Nava et al, 2011;
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Eckburg et al, 2005; Frank & Pace, 2008). In addition, the proportion of different bacteria
can vary from individual to individual at all levels of bacterial taxonomy. A recent
metagenomic study has shown that although the bacterial populations differ widely
between individuals the overall metabolic pathways encoded by these microbes tend to
remain the same (Qin et al, 2010). A reciprocal gut microbiota transplant study done by
using germ free mice and zebrafish showed that the gut of a given host can be colonized
by the microbiota of another host but eventually the recipient host modulates the
colonized microbiota such that it resembles to its own natural microbiota (Rawls et al,
2006). These emergent properties of the intestinal microbiota while providing valuable
information regarding evolutionary history of gut residing microbes also helps in
discerning the mechanistic aspect of differential patterns of microbial localization within
the gut in response to various factors.
1.8 Role of intestinal microbiota in health and disease
In a healthy adult the host bacterial interaction is primarily a symbiotic
relationship. Intestinal bacteria play a variety of protective, structural and metabolic
functions that provide benefits to the host (McCracken & Lorenz, 2001). The protective
function of intestinal bacteria helps in immunity development, GI tract homeostasis and
prevention against pathogen colonization (Hand & Belkaid, 2010; Rakoff-Nahoum et al,
2004; Medellin-Pena & Griffiths, 2009). The metabolic function of microbes helps in
release of key nutrients and energy from the diet, which is used by host and microbes for
growth and sustenance (Hooper et al, 2002). However information about the role of
individual bacterial species in host related physiological function is limited due to the
difficulty in culturing these strict anaerobes in laboratory environments (Duncan et al,
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2007). Section 1.9 discusses the general properties of a few bacterial genera that have
been characterized and are commonly found in the mammalian colon.
Within the gut environment the metabolic function of microbes produce short
chain fatty acids (acetate, butyrate, propionate), CO2, H2 and CH4. In addition to
generating energy from complex dietary sources, intestinal microbes also account for
uptake and storage of this energy (Hooper et al, 2002; Bäckhed et al, 2004). Intestinal
microbes such as B. thetaiotamicron have been shown to adapt their metabolism
according to nutritional availability (Bjursell et al, 2006). The metabolic characters of
different bacterial groups differ significantly with some species being more efficient in
one pathway of energy generation than others (Mahowald et al, 2009). Studies have
shown that obesity is related to the relative distribution of Bacteroidetes and Firmicutes
in the gut, with obese mice and humans having less Bacteroidetes and more Firmicutes
(Ley et al, 2005; Ley et al, 2006). Within the Firmicutes, mollicutes were found in
increased proportions in high fat/ high sugar diet related obese mice. In these mice the
diet induced the selection of microbes that were more efficient in metabolizing the
readily available carbon source (Turnbaugh et al, 2008). The intestinal microbiota has
also been found to be involved in detoxification and biotransformation of toxic metals,
modulation of host metabolic phenotypes, metabolism of otherwise indigestible dietary
compounds and metabolism of xenobiotics that can have profound effect on host health
(Diaz-Bone & Van de Wiele, 2010a; Li et al, 2008; Sidhu et al, 2001; Nicholson et al,
2005). Until recently, a number of diseases were found to be associated with a single type
of microorganism such as C. difficile caused antibiotic associated diarrhea and H. pylori
induced gastric carcinoma (McFarland, 2008; Correa & Houghton, 2007). However some
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of the recent studies on human and mice GI tract have shown a link between changes in
multiple microbial populations of the host and diseases such as autism, inflammatory
bowel diseases, type I diabetes and atopy (Table 1.2). In most of these diseases the
patient shows altered microbial composition and diversity of the gut microbiota when
compared to healthy individuals. However it is not known whether this dysbiosis (change
in microbiota) is responsible for the disease, plays a role in the progression of the disease,
or is merely a result of the disease. The GI microbiota is known to be resilient but
bacterial profiling after antibiotic treatment has shown that certain species may take
anywhere from few weeks or months to years to reappear at normal levels (Dethlefsen et
al, 2008; De La Cochetiere et al, 2005; Jernberg et al, 0000). Additionally comparative
studies between germ free and pathogen free animals have shown that gut microbes
contribute to the development and maintenance of other organ systems in the host by
releasing metabolites that influence gene regulation (Wikoff et al, 2009). These studies
have linked gut microbiota with cardiac output, immune system development, appetite
control, development of nervous system, host response to stress and mood disorders
(Gordan et al, 1963; Macpherson & Harris, 2004; Fetissov et al, 2008; Rhee et al, 2009;
Sudo, 2006; Forsythe et al, 2010).
Manipulation of host microflora by using pro and prebiotics is rapidly increasing
as a treatment of diseases such as atopic eczema, neurological defects and various
gastrointestinal diseases (Kalliomäki et al, 2003; Forsythe & Bienenstock, 2008; Preidis
& Versalovic, 2009). However a complete understanding of the mechanisms lying behind
host microbe interaction is needed for the development of individual based treatment
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strategies. Nevertheless, the microbial community residing in the GI tract contributes to
host health and disease and can be a useful tool in the prognosis of the diseased state.

Host

Disease

Part of GI
tract
studied

Mice

Obesity

Caecum

Human

Obesity

Stool

Children
(0-7yrs)@

Obesity

Stool

Children
(2-13 yrs)

Autism

feces

Human*

Liver
Cirrhosis

feces

IL-10
deficient
129 Sv/Ev
mice $

Colitis

Large
intestine

Human

Crohn’s
disease and
Ulcerative
Colitis

colon

Human

Colorectal
cancer

Colorectal
Mucosal
biopsies

Children

Type I
diabetes

Stool

Type of bacteria
affected
Bacteroidetes(↓)
Firmicutes(↑)
Bacteroidetes(↓)
Firmicutes(↑)
Bifidobacteria(↓)
Staphylococcus
aureus(↑)
Bacteroidetes(↑)
Firmicutes(↓)
Actinobacteria(↓)
Proteobacteria(↑)
Overall diversity(↑)
Bifidobacterium(↓)
Enterobacter(↑)
Enterococcus(↑)
Clostridia(↑)
Bacteroides(↑)
Bifidobacterium(↑)
Clostridium(↑)
Eubacterium(↓)
Acidophilus(↓)
Bacteroidetes(↓)
Lachnospiraceae(↓)
Proteobacteria(↑)
Bacillus(↑)
Bacteroides(↓)
Proteobacteria(↑)
Dorea(↑)
Faecalibacterium(↑)
Coprococcus(↓)
Bacteroides(↑)
Overall diversity(↑)
Bacteroidetes(↑)
Firmicutes(↓)
Ruminococceae (↓)
Lachnospiraceae(↓)
Eubacteriaceae(↓)
Veillonellaceae(↑)
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Reference
Ley et al, 2005
Ley et al, 2006
Kalliomäki et al,
2008
Finegold et al,
2010

Zhao et al, 2004

Bibiloni et al,
2005

Frank et al, 2007

Shen et al, 2010

Giongo et al,
2011

Infants^
Infants*

Atopic
eczema
Wheezing/
Allergy

Bacteroideaceae(↑)
Porphyromonadaceae(↓)
Rikenellaceae(↓)
E.coli(↑)
C.difficile(↑)
Bifidobacterium(↓)
Clostridium(↑)
Bacteroidetes(↑)
Firmicutes(↓)
Proteobacteria(↑)
Bacteroidia(↑)
Prevotella(↑)
Clostridia(↓)
Roseburia(↓)
Bacilli(↑)
Bacteroides(↓)
Firmicutes(↓)
Fusobacteria(↓)
Proteobacteria(↑)
Overall diversity(↓)

Feces
Feces

Human

Type II
diabetes

Stool

Preterm
Infants

Nectrotizing
enterocolitis

Stool

Penders et al,
2007
Verhulst et al,
2008

Larsen et al,
2010

Wang et al,
2009

Table 1.2: Changes in the composition of gut microbiota associated with various
diseases. * indicates culture dependent studies, $ represents DGGE analysis, @ indicates
results based on RT-qPCR and FISH, ^ represents RT-qPCR based study whereas all
other studies were based on clone library. (↑) indicates increase in population and (↓)
represents decrease in microbial population.

30

1.9 Predominant microbes in mammalian colon
Bacteroidetes
The phylum Bacteroidetes includes gram negative bacteria found in aqueous
environments, soil, sediments and the intestines of animals. The phylum consists of three
classes Bacteroidia, Flavobacteria and Sphingobacteria (Krieg et al, 2010). Of these,
Bacteroidia is the predominant class found in the mammalian GI tract (Frank et al, 2007).
Within class Bacteroidia, members of Bacteroidaceae, Porphyromonadaceae and
Prevotellaceae are routinely found in the mammals (Nava et al, 2011).
Bacteroides
Members of the genus Bacteroides are rod shaped non-motile, gram-negative
cells with rounded ends that occur singly or in pairs. The % mole GC of DNA varies
from 39 to 49%. These strict anaerobes form smooth, white to gray colonies that are 1-3
mm in diameter and are nonhemolytic. These bacteria are characterized by their ability to
grow on media containing 20% bile. Most of the species are chemoorganotrophic and
saccharolytic but weakly proteolytic (Song et al, 2010). Bacteroides are notorious for
antibiotic resistance and have an ability to transfer antibiotic resistant genes via
transposons and plasmids. Members of this genus can utilize a wide variety of complex
polysaccharides as energy sources (Xu et al, 2003). The main members of this genus are
B. thetaiotamicron, B. vulgaris, B. intestinalis, B. distasonis, B. ovatus and B. fragilis.
Porphyromonas
Members of the Porphyromonas are sensitive to bile, asaccharolytic and
pigmented. The % mole GC of DNA is 40−55. The species belonging to this genus are
short, non-motile, non-spore forming rods or coccobacilli. Most species yield n-butyric
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acid, acetic acid, propionic acid and other organic acids upon fermentation (Summanen &
Finegold, 2010).
Prevotella
Members of the Prevotella are sensitive to bile, moderately saccharolytic and may
have pigmented or non-pigmented species. The % mole GC of DNA is 39.2. The species
from this genus are short, non-motile, non-spore forming anaerobes that are rod shaped
(Shah et al, 2010).
Firmicutes
The phylum Firmicutes includes both low and high GC gram positive bacteria.
Members of this phylum vary in shape ranging from cocci to straight, helical or curved
rods. Most of the members are chemoorganotrophic, form endospores and may be motile
or non-motile. The % mole GC ratio is generally < 50%. Some members can grow under
thermophilic and halophilic conditions (Schleifer, 2009). The phylum consists of 26
families and 223 genera. Bacilli, Clostridia and Erysipelotrichia are the three classes that
are classified under Firmicutes. Class Bacilli includes two orders: Bacillales and
Lactobacillales. Class Clostridia consists of three orders: Clostridiales, Halanaerobiales
and Thermoanerobacterales. Within each order there are several families however only
one family has been assigned to Erysipelotrichia (Ludwig et al, 2009). The important
genera that are found in the colon of mammalian hosts from this phylum include
Lactobacillus, Ruminococcus, Coprococcus, Clostridium, Dorea, and Roseburia.
Lactobacillus
Lactobacillus is taxonomically classified under the order Lactobacillales and
family Lactobacillaceae. Most of the species belonging to this genus are non-motile, non-
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spore forming, obligate saccharoclastic and facultative anaerobes with a % mole GC
content ranging from 32−55%. Optimal growth conditions are 30-40oC with pH ranging
from 5.5-6.2. Members of this genus cannot reduce nitrate but have the ability to use
nitrite as final electron acceptor during lactate oxidation. Cells vary in shape and may
exist in chains and form convex, smooth, non-pigmented opaque colonies that are 2-5
mm in diameter. These bacteria metabolize carbohydrates via Embden Meyerhof
pathway and phosphogluconate pathway. Both homo and hetero fermentative species are
found in this genus (Hammes & Hertel, 2009).
Ruminococcus
Member of the Ruminococcus are gram positive, strict anaerobes isolated from the
GI tract of animals and classified under order Clostridiales and family Ruminococceae.
Cells are coccids that exist in pairs or chains and are motile with 1−3 flagella. Most
species are chemoorganotrophic and yield small chain fatty acids (SCFA) such as acetate,
formate, lactate, succinate and ethanol upon carbohydrate fermentation. The % mole GC
content of the DNA is 39-47%. Species from this genus do not have the ability to ferment
amino acids or peptides (Tayayuki, 2009a).
Coprococcus
The Coprococcus genus is assigned to the order Clostridiales and family
Lachnospiraceae. Coprococcus species are gram positive, non-motile, cocci that may
occur in pairs or chains and are obligate anaerobes with 39-42% mole GC content in the
DNA. Members are chemoorganotrophic and yield butyric, acetic, formic and propionic
acid on fermentation (Tayayuki, 2009b).
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Clostridia
Classified under order Clostridiales and family Clostridiaceae, Clostridia consists
of 168 species assigned to ten clusters. With 22−53% mole GC content in DNA, these
gram positive, endospore forming rods are either motile or non-motile. Most members are
obligate anaerobes and chemoorganotrophs, however, some species are aerotolerant and
chemoautotrophic or chemolithotrophic. The species vary in their metabolic properties
from being saccharolytic to proteolytic or neither or both (Rainey et al, 2009).
Roseburia
The Roseburia genus is taxonomically assigned under order Clostridiales and
family Lachnospiraceae. Roseburia species including are gram negative, anaerobic,
chemoorganotrophic, motile, curved rod shaped cells that occur singly or in pairs. The %
mole GC content of DNA varies from 29−42%. Members of this genus can hydrolyze
and ferment starch and can use oligosaccharides such as maltose and xylose as energy
and carbon source (Stanton et al, 2009).
Dorea
Members of the Dorea genus are gram positive, non-spore former, non-motile,
obligate anaerobes that belong to order Clostridiales and family Lachnospiraceae. Cells
are rod shaped that occur singly or in pairs (0.5-1.0 x 1.0-4.5 µm). Species from this
genus cannot hydrolyze complex polysaccharides such as starch and cellulose. Ethanol,
formate, acetate, H2 and O2 are produced after fermentation but no butyrate production
occurs. The % mole GC content of the DNA is 40-45.6% (Blaut et al, 2009).
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1.10 Role of gut microbes in nitric oxide (NO) generation
NO is a key signaling molecule that plays an important role in numerous
physiological processes such as neurotransmission, vasodilation, signaling, respiration
and immunity (Moncada, 1999). Within blood NO is rapidly oxidised to nitrite or nitrate
by heamoglobin (Hb) (Doyle & Hoekstra, 1981). Due to a very short half life, NO mainly
acts as a paracrine signaling molecule and affects the sites or cells in its close proximity
(Lundberg & Weitzberg, 2005). Classically it was assumed that in humans NO is
generated by eukaryotic oxygen dependent NO synthases (NOS) wherein L-arginine
combines with O2 to produce NO and citrulline (Palmer et al, 1988). However in the past
decade or so, evidence for the role of host commensal bacteria as a source of NO has
emerged.
In humans, diet is the major source of nitrate mainly derived from green leafy
vegetables (Ysart et al, 1999). Nitrate present in the diet is reduced to nitrite by bacteria
residing in the oral cavity (Lundberg & Govoni, 2004). The enzymes involved in
reducing nitrate to nitrite are cytoplasmic Nas, periplasmic Nap and membrane associated
Nar (Potter et al, 1999; Stolz & Basu, 2002). No mammalian homologues of these
enzymes are found indicating the process is exclusive to bacteria residing in the host.
Following ingestion of a nitrate rich meal the levels of nitrite in saliva increase about
10−20 fold from 50−150 µm to 1−2 mM range (Spiegelhalder et al, 1976). Nitrite
obtained from any source (diet, oxidized product of NO or reduced product of nitrate)
under acidic conditions of the stomach is non-enzymatically protonated to form nitrous
acid (Benjamin et al, 1994). The nitrous acid thus formed is converted to various
compounds including NO. In addition, xanthine oxidase (XO), aldehyde oxidase and
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deoxygenated Hb have been shown to convert nitrite to NO in various cells and tissues
under hypoxic conditions (Zhang et al, 1997; Zweier et al, 2010; Huang et al, 2005). In
the stomach NO has been demonstrated to have a gastroprotective effect and plays a role
in mucosal blood flow, mucus production and host defense against pathogen (Bjoerne et
al, 2004; Petersson et al, 2007). Typical concentrations of NO in stomach lumen is 20400 ppm but is found in very low levels in the lower GI tract (Benjamin et al, 1994;
Lundberg et al, 1994).
Recent studies with human feces showed generation of NO in the presence of
nitrate or nitrite at pH equivalent to those found in the lower GI tract under anaerobic
conditions (Sobko et al, 2005). In vivo studies with germ free and conventional animals
showed increased NO levels in the latter indicating that bacteria in the lower GI tract play
a role in NO generation (Sobko et al, 2004). In the lower GI tract besides eukaryotic NO
generation, gut microbes can produce substantial amounts of NO by any of the 3
processes: bacterial NOS, denitrification or dissimilatory nitrate reduction to ammonia
(DNRA). Bacterial NOS have been identified in many organisms and show similarity to
eukaryotic NOS (Choi et al, 1997; Yarullina et al, 2006; Gusarov et al, 2008). Species of
Streptomyces, Bacillus and Deinococcus have been shown to generate NO from arginine
under in vivo conditions. (Johnson et al, 2008a; Adak et al, 2002a; Adak et al, 2002b) A
variety of environmental bacteria have been shown to possess either the copper
containing NirK or the cytochrome cd nitrite reductase NirS in the periplasm and convert
nitrite to NO during denitrification (Berks et al, 1995; Potter et al, 2001). Another set of
bacteria possess nitrite reductase (pentaheme NrfA or siro heme NirBD) that converts
nitrite to ammonia but are known to produce enzyme bound NO as an intermediate (Cole
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& Brown, 1980; Einsle et al, 2002). In vitro study with E.coli has demonstrated that NrfA
can reduce exogenously supplied NO to ammonia, an important mechanism for cellular
detoxification (Poock et al, 2002). Studies to date have showed that most of the
commensal bacteria reduce nitrate mainly via the DNRA pathway under conditions
similar to those found in GI tract (Allison & Macfarlane, 1988; Parham & Gibson, 2000).
At low concentrations of nitrate and nitrite, similar to those found in human body the
periplasmic enzymes for nitrate (Nap) and nitrite reduction (Nrf) are activated. At high
concentrations of nitrate and nitrite the cytoplasmic enzymes (Nar and NirBD) are
expressed (Potter et al, 1999). In vitro studies involving N15 tracer experiments with
human fecal microbiota showed that the most plausible explanation for the formation of
NO by gut bacteria is enzymatic reduction of nitrate to ammonia wherein NO is produced
along the pathway (Joan Vermeiren et al, 2009). Despite an increasing amount of
evidence showing a role of gut microbes in NO generation, the significance of this
alternate pathway of microbes mediated NO generation in lower GI tract is not well
understood.
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1.11 Overview of specific aims and hypothesis
Chronic exposure to arsenic via drinking water is a global health problem (NRC,
2001). Although, the effect of environmentally relevant chronic exposures to arsenic via
drinking water on various organs has been well established, its effect on the microbiota of
the GI tract is not well studied. There is evidence that suggests arsenic exposure via
drinking water may affect the host microbiota either by being toxic or by affecting
physiology. An in vivo study with rats has showed toxic effects of arsenic (1 mg/L) on
the total bacterial count in stool samples (Choudhry et al, 2010). A wide variety of
microorganisms have developed detoxification mechanism to deal with As toxicity and
arsenate respiring bacteria have been isolated from the stools of Syrian Hampsters
exposed to As(V) (Oremland & Stolz, 2003; Herbel et al, 2002). In vitro studies have
shown that the gut microflora of the arsenic exposed individual can play a role in
detoxification and elimination of the arsenic from the host body (Diaz-Bone & Van de
Wiele, 2010). Thus the purpose of this work was to investigate the in vivo effect of
chronic ingestion of environmentally relevant concentrations of arsenic via drinking
water on the composition and physiology of the microbial community of the lower GI
tract by molecular techniques. To accomplish this aim, microbial community composition
and gene expression (arsA, arsB and nrfA) in colon samples from 10 and 250 ppb of
As(III) exposed mice were compared to the control mice after 2, 5 and 10 weeks of
As(III) exposure via drinking water. Four specific aims were proposed to test the
following hypotheses:
Hypothesis 1: As(III) exposure will change the microbial community profile of mouse
colon in dose and time dependent manner.
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Specific Aim 1: Compare the microbial community profile of mice colon exposed to 10
and 250 ppb of As(III) for a period of 2, 5 and 10 weeks to that of control mice by RISA
and ARISA.
Hypothesis 2: As exposure will promote the selection of arsenic metabolizing microbes.
Specific Aim 2: Determine the microbial community structure and composition of control
and As(III) exposed mice using molecular techniques (DGGE and 16S rRNA gene based
clone libraries) and perform statistical methods to determine the populations that are
significantly affected by As(III) exposure.
Hypothesis 3: As (III) associated microbiota will have more widespread distribution of
ars operon and arsenic resistant genes (arsA and arsB) will be induced in time and dose
dependent manner in the presence of As(III).
Specific Aim 3: Bioinformatically determine the distribution of ars operon in colon
microbes and design species specific primers and perform comparative Ct to compare the
expression levels of arsA and arsB gene.
Hypothesis 4: Increased Nitric oxide production in endothelial cells is one of the many
pathways that play a role in arsenite induced toxicity. As(III) induced altered NO level in
the host may affect the physiology of colon microbes by altering the transcription of
genes such as nrfA that are involved in NO generation or are regulated by NO levels.
Thus it was hypothesized that As(III) exposure will change the physiology of colon
microbes.
Specific Aim 4: To design species specific primers and perform comparative Ct for
determining the expression levels of nrfA.

39

Chapter 2 : MATERIALS AND METHODS
2.1 Mice exposure
Sodium arsenite at a concentration of 0, 10 and 250 ppb was added to the drinking
water and was fed for a period of 2, 5 and 10 weeks to groups of five C57BL/6NTac male
mice that weighed approximately 20 g and aged 6-8 weeks. However, only four mice
were exposed to As(III) for 2 week 0 ppb group to obtain colon samples. The 0 ppb group
for each time point was considered as the control group. Sodium arsenite solution was
prepared using the regular tap water supplied by the Municipality of Pittsburgh, PA. The
mice from each group were euthanized by IP injection of sodium pentobarbital and their
colons were removed. All mouse exposure experiments were done at the University of
Pittsburgh by members of Dr. Aaron Barchowsky’s group in accordance to the
institution’s guidelines for animal safety. Freshly removed colon samples were flash
frozen in liquid nitrogen and stored at −80oC until used. The microbial composition and
structure of these mice was characterized using molecular approaches and compared to
those of control mice (0 ppb group). These exposure experiments were performed twice
on two different sets of mice (study 1 and 2). Due to the fewer number of mice and
absence of 10 ppb As(III) exposed mice, the results of study 1 are described in appendix
1. From here on things relevant to study 2 are mentioned.
2.2 DNA extraction
Microbial community DNA was isolated from 2, 5 and 10 week mouse colon
samples (control and As(III) exposed) using the QIAamp DNA stool mini kit according
to the manufacturer’s instructions (Qiagen Inc., Valencia, CA, USA). Flash frozen
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samples were thawed on ice and about 40 mg of each colon sample was homogenized in
a 2.0 ml eppendorf tube using a pipette tip followed by addition of 1.4 ml of buffer ASL
(provided with the kit) for cell lysis. The samples were vortexed for 1 min to obtain
uniform suspension followed by heating at 80oC for 5 minutes. The tubes were
centrifuged at 10,000 x g for 2 minutes. The supernatant was transferred to a new
eppendorf tube and 1 inhibit EX tablet was added to remove PCR inhibitors from the
colon samples. The tubes were vortexed for 1 minute, incubated at room temperature for
one minute and centrifuged at 10,000 x g for 6 minutes. The supernatant was transferred
to a fresh tube and 30 µl of proteinase K and buffer AL (equal to the volume of
supernatant) was added. After vortexing the tubes for few seconds the samples were
incubated at 70oC for 10 minutes. DNA was precipitated from the above lysate by adding
equal volumes of 100% ethanol. DNA was purified from the above lysate by passing the
lysate through a QIAamp spin column and spinning the column at 10,000 x g for 1 min.
The column was washed twice with 500 µl of buffer AW1 and once with 500 µl of buffer
AW2. Each washing was followed by centrifugation at 10,000 x g for the removal of
filtrate. After all the washings, DNA was eluted into a 1.5 ml eppendorf tube with 200 µl
of buffer AE by centrifuging the column at 10,000 x g for 1 minute. The quantity of
nucleic acid was estimated by using Perkin Elmer UV/Vis spectrophotometer lambda 2S
(260/280 nm, 50 µg DNA = O.D. of 1). A 0.8% agarose gel was used to check for high
MW genomic DNA. The extracted DNA was then used for the downstream processes.
2.3 Ribosomal intergenic spacer analysis (RISA)
Bacterial community estimation by RISA and ARISA technique were based on
the principle that the length of the spacer region between 16S and 23S rRNA gene varies
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from species to species (Borneman, J. and Triplett, E. W., 1997). However RISA and
ARISA estimation of bacterial community in a sample can differ from the actual
estimation as the same bacterial species can have a different spacer length or different
bacterial species can have same spacer length (Kovacs et al, 2010). For this study
differences in RISA and ARISA profiles were assumed to reflect the differences in
bacterial community of the samples and were used for comparison of samples and
bacterial diversity estimations. Although both RISA and ARISA are based on the same
principle, the output of the results differs between the two techniques. RISA results are
interpreted from a polyacrylamide gel whereas ARISA results are obtained from a genetic
analyzer. In this study different primer pairs were used for the two techniques.
The spacer region between the 16S and 23S rRNA gene was amplified from the
microbial community DNA of each of the colon sample using ITSF (binds to 3’ end of
16S rRNA gene) and ITSReub primer pairs (specific for 23S rRNA gene) (Table 2.1)
(Cardinale et al, 2004). The reaction mixture consisted of 150 ng of genomic DNA, 10 μl
of 5X buffer, 35 pmol each of forward and reverse primers, 1 μl dNTPs from a 200 μM
stock, 1.25U of GoTaq DNA polymerase (Promega, Madison, WI, USA) and sterile
water to a final volume of 50 μl. The touchdown program was used for amplification to
increase the diversity of microbial estimation (Hecker & Roux, 1996). The reaction was
performed on Techgene thermal cycler (Techne incorporated, Princeton, NJ, USA) with
initial denaturation at 94oC for 5 minutes followed by 20 cycles of denaturation at 94oC
for 1 minute, annealing temperature decreasing from 60 oC to 50oC at a rate of 0.5oC
decrease/cycle for 1 minute, extension at 72oC for 1 minute then 15 cycles of denaturing
(1 min), annealing (1 min) and extension (3 min) at 94oC, 50oC and 72oC and a final
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extension of 7 minutes at 72oC. The absence of contaminants in the reagents was
confirmed by using no template (water) as a negative control. After PCR the products
were checked for amplification by visualizing on a 1.8% agarose gel after ethidium
bromide staining.
Amplified products of the 16S-23S intergenic region from 2, 5 and 10 weeks
mouse colon samples were loaded separately on a 5% polyacrylamide gel (Appendix 2).
The gel was run at 70V for 105 minutes in 1X TBE buffer on a Mini-PROTEAN gel
system (Biorad, Hercules, CA, USA) and the products were separated on the basis of
their length. The resulting gels were stained in ethidium bromide solution (0.5 µg/ml
EtBr in DI water) and were photographed using a Kodak gel documentation and analysis
system 120.
2.4 Dendrogram analysis
The digital images of RISA and DGGE gels from 2, 5 and 10 weeks were loaded
into the Quantity one software (Biorad, Hercules, CA, USA). The background was
subtracted from the images, bands were detected automatically as well as manually and
matching of bands between the lanes was done with 1% matching tolerance. Similarity
values for the community was obtained with the Quantity one software using a similarity
matrix calculated using the Dice coefficient based on the presence and absence of bands.
Dendrograms were constructed by the unweighted pair group method (UPGMA) using
similarity matrix. The dice coefficient is a similarity coefficient calculated by the
following formula:
Dsc = [2j / (a+b)],

------------------------------------------------------ (2.4.1)

Where a = number of DGGE bands in lane 1,
43

b = number of DGGE bands in lane 2, and
j = number of DGGE bands that are common in lane 1 and lane 2.
A Dsc value of 1 indicates that the DGGE profiles are identical (Dice, 1945).
UPGMA is a hierarchical clustering method in which the two most similar lanes are
grouped together based on the highest similarity index to form a composite group and
sequentially more such groups are determined until only two groups are left that are then
joined to form a rooted dendrogram (Sokal, R. and Michener, C., 1958).
2.5 Automated ribosomal intergenic spacer analysis (ARISA)
PCR for ARISA was done following the protocol used by Fisher and Triplett
(1999). The reaction mixture consisted of 150 ng of genomic DNA, 5 μl of 5X buffer, 2.5
mM MgCl2, 0.5ug of BSA per µl, 12.5 pmol each of forward and reverse primers, 0.5 μl
dNTPs from a 200 μM stock, 1.25U of GoTaq DNA polymerase (Promega, Madison, WI,
USA) and sterile water to a total volume of 25 μl. The primers used were 1406F and
23Sr, with 1406F being labeled at the 5’end with the phosphoramidite dye 5-FAM (Table
2.1). The reaction mixture was denatured at 94oC for 2 minutes, followed by 30 cycles of
denaturation at 94oC for 15 sec, annealing at 55oC for 15 sec, extension at 72oC for 45 sec
and a final extension at 72oC for 2 min. Water was used as negative control to check for
the absence of contamination in the reagents.
Equal amounts of PCR product along with 0.75 μl of the internal size standard
LIZ-1200 (Applied Biosystems, Foster City, CA, USA) and 8 ul of DI formamide were
added to final volume of 10 μl and the reaction mixture was denatured at 95 oC for 5
minutes followed by cooling on ice. LIZ-1200 is a size standard containing 68 LIZ dye
labeled single stranded DNA fragments that range in size from 20 to 1200 base pairs. The
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fragments were separated using a 3100-Avant Genetic Analyzer under gene scan mode
and the results were analyzed by using the peak scanner software (Applied Biosystems,
Foster City, CA, USA). An electropherogram with a series of peaks was obtained for
each sample wherein each peak represents a different operational taxonomic unit (OTU).
The program provides the sizes of these peaks based on the fragment sizes of the internal
standard along with the fluorescence of each peak in the form of peak height and peak
area. In order to remove the background noise, ARISA peaks exceeding the peak height
of 50 fluorescence units were considered for analyses. All the experiments were done in
triplicates and the peaks for individual sample replicates were averaged for relative peak
height and relative peak area using TREX software (Culman et al, 2009). The heat maps
for the relative peak height dataset were generated using permut matrix software (Caraux
& Pinloche, 2005). The matrices obtained for presence/absence of peaks, relative peak
height and area were used for Principle Component Analysis (PCA) using Ade 4 software
package (Chessel et al, 2004). PCA is an ordination method that determines two major
principle components from multivariate datasets under the constraint that these principle
components are linear combination of all variables and account for most of the variation
observed in the variables (Pearson K., 1901). In the present study different OTUs
(presence/absence matrix) and their abundance (peak height and area matrix) were
considered as variables.
2.6 Denaturing gradient gel electrophoresis (DGGE)
DGGE is one the most widely used molecular technique to determine the
microbial community of environmental samples. This technique is based on the principle
that under denaturing conditions DNA fragments of equal sizes denature differently on
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the basis of their % mole GC content. Such fragments when run on a denaturing gel will
move differently. The high % mole GC fragments, due to less denaturation, migrate
towards the bottom of the gel whereas the low % mole GC fragments stay towards the top
of the gel due to high denaturation (Fischer & Lerman, 1983). In order to protect the two
strands of DNA fragments from falling apart, a GC clamp (stretch of about 40 GC rich
nucleotides) is added to one of the primers used during amplification. In this study,
similar sized PCR products amplified from same region of the 16S rRNA gene were used
for comparison of microbial community among colon samples. Since GC content of the
same 16S rRNA region varies from species to species the profile obtained from DGGE is
an indicator of microbial diversity. However like RISA and ARISA, DGGE estimation of
bacterial community in a sample can differ from the actual estimation as the same
bacterial species can have multiple 16S rRNA genes and each gene within a species can
have a different GC content or different bacterial species can have the same GC content
(Muyzer & Smalla, 1998).
DGGE was performed according to protocol followed by Muyzer et al (Muyzer et
al, 1993) with some modifications. Variable region 3 (V3) of the 16S rRNA gene was
amplified from the colon bacteria using HDA1-GC and HDA2 primers (Table 1) (Walter
et al, 2001). The reaction mixture consisted of 150 ng of genomic DNA, 10 μl of 5X
buffer, 25 pmol each of forward and reverse primers, 1 μl dNTPs from a 200 μM stock,
1.25U of GoTaq DNA polymerase (Promega, Madison, WI, USA) and sterile water to a
total volume of 50 μl. The touchdown program was used for amplification with annealing
temperature decreasing from 60oC to 50oC at a rate of 0.5oC decrease/cycle. Absence of
contamination in reagents was confirmed by using sterile water as negative control. After
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PCR, the amplification was confirmed by visualizing the products on a 1.8% agarose gel
after EtBr staining.
Amplified products of 16S rRNA gene from 2, 5 and 10 weeks mouse colon
samples were loaded separately on a 10% acrylamide-bis acrylamide denaturing gel
containing 40% - 60% Urea- formamide gradient (Appendix 3). A non denaturing 10%
acrylamide spacer gel was applied on top of the denaturing gel and was allowed to
polymerize for 2 hours. The gel was run at 70V for 990 minutes at 60oC in 1X TAE
buffer using a DCode universal mutation detection system (Biorad, Hercules, CA, USA).
The resulting gels were stained in a 1: 10,000 dilution of SYBR green in 1X TAE buffer
and were photographed using Kodak gel documentation and analysis system 120.
2.7 Clone library Construction
Near full length 16S rRNA genes were amplified from the microbial community
DNA isolated from each of the 2, 5 and 10 week colon sample using universal primers 8F
(Edwards et al, 1989) and 1492R (Stackebrandt & Liesack, 1993). The reaction mixture
consisted of 50 ng of genomic DNA, 4 μl of 5X buffer, 10 pmol each of forward and
reverse primers, 0.4 μl dNTPs from a 200 μM stock, 0.5U of GoTaq DNA polymerase
(Promega, Madison, WI, USA) and sterile water to a total volume of 20 μl. The
touchdown program was used for amplification with annealing temperature decreasing
from 60oC to 50oC at a rate of 0.5oC decrease/cycle. The PCR products obtained from
each of the sample were ligated into the pCR2.1®-TOPO vector. The ligation reaction
mixture consisting of 4 µl of PCR product, 1 µl of salt solution and 1 µl of TOPO vector
provided with the kit was incubated for 15 minutes at room temperature and was used
immediately or stored at −20oC until transformation was done.
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Transformation
Ligation reaction (2 µl) described above was added to a tube of OneShot top10
chemically competent E.coli cells provided with the kit. The reaction was incubated for
15 to 30 minutes on ice, and then heat shocked in a water-bath at 42oC for 30 seconds.
To the transformed cells, 250 µl of SOC media (provided with the kit) was added and the
tube was incubated horizontally on a shaker at 37oC and 200 rpm for one hour.
Transformed cells (50 µl) were then spread on prewarmed ampicillin selective, X-gal
spread LB plates and 50 µl of untransformed cells were spread on an LB plate to verify
cell viability (Appendix 4). The plates were incubated at 37 oC overnight. Approximately
24 positive clones were picked randomly from each sample and transferred with a sterile
toothpick to a fresh ampicillin selective plate and 5 ml of LB broth containing ampicillin
at a concentration of 100 µl/ml. The plates and the LB broth inoculated with single
colony were then incubated at 37oC overnight.
Plasmid extraction
Plasmid extraction was performed using the Promega Wizard SV DNA column
purification kit (Promega, Madison, WI, USA). The culture obtained from overnight
grown colonies in LB-amp media was spun down at 7,000 rpm for 5 minutes. The pellet
was then resuspended in 250 µl of cell resuspension buffer and the cells were lysed with
250 µl of cell lysis buffer. The mixture was incubated for 3-5 minutes at room
temperature and 10 µl of alkaline protease was added, followed by 5 minute incubation.
Neutralization solution (350 µl) was then added, and the tubes were spun at 12,000 rpm
for 15 minutes. The supernatant was removed to a fresh tube and spun a second time
under the same conditions. The supernatant from the second spin was added to the
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column. The column was washed twice with wash buffer, and the plasmid was eluted
with 100 µl nuclease free water and stored at −20oC.
Sequencing from plasmid DNA
The purified plasmid DNA was sequenced using M13 forward and reverse
primers at the Genomics and Proteomics Core Laboratory, University of Pittsburgh, PA
using ABI 3730 sequencer (Applied Biosystems, Foster City, CA, USA).
2.8 Sequence analysis
Sequences obtained from the clone libraries were analyzed in Chromas version
2.01 (http://www.technelysium.com.au/chromas_lite.html). Sequences obtained from the
reverse primer were converted into forward reading sequence and were aligned to the
forward complementary strand using CLUSTAL W (Larkin et al, 2007). Low quality
sequences with ambiguous bases (N) were not analyzed further. The consensus sequences
were edited to exclude the primer binding sites and were compared to those in the
GenBank databases by using the BLAST (Johnson et al, 2008b). The sequences were
assigned to taxonomic classification using the Ribosomal Database Project II (RDPII)
classifier with a confidence threshold of 90% (Wang et al, 2007). Multiple sequence
alignment of nearly full length 16S rRNA sequences obtained from clonal libraries was
done by Clustal X (Larkin et al, 2007) and NAST alignment (DeSantis et al, 2006).
Sequences aligned by Clustal X were edited manually using seaview program (Gouy et
al, 2010) to check for any ambiguity in the aligned sequences. All sequences were
checked for possible chimeric artifacts using the Bellerophon (DeSantis et al, 2006),
mallard (Ashelford et al, 2006) and chimera slayer programs (Schloss et al, 2009).
Significant difference in the composition of control, 10 ppb and 250 ppb As(III) exposed
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clone libraries was determined using LIBSHUFF program of Mothur software (Schloss et
al, 2009). Comparison between libraries at the taxonomic level was also done by
libcompare tool from RDP II database (Cole et al, 2009).
2.9 Phylogenetic analysis and diversity estimation
The distance matrix of nearly full length 16S sequences was prepared with
DNADIST program from PHYLIP package (Felsenstein, 1989) based on Jukes-Cantor
model (a substitution model based on the assumption that the rate of transition and
transversion is same) (Jukes & Cantor, 1969). A neighbor-joining tree was generated
using MEGA 4.0 software (Tamura et al, 2007) and the evolutionary distances were
computed using Jukes-Cantor model. Based on distance matrix generated with Phylip
package, clones with 97% (species level), 95% (genus level) and 90% (family level)
sequence similarity were grouped into the same phylotype/operational taxonomic units
(OTUs) using Mothur program (Schloss et al, 2009). Good’s coverage (C) of the clone
libraries was calculated by the formula:
C = (1− n/N)*100,

------------------------------------------ (2.10.1)

Where n= no. of sequences that are found only once in a library and
N= Total number of sequences in a library (Good, 1953).
Microbial richness and diversity in each of the clone library and the combined
datasets was estimated by rarefaction curve, Chao I estimator, Shannon and Simpson
diversity index using the Mothur program (Schloss et al, 2009). Rarefaction curve is
based on species richness (total no. of species in a sample) and gives information about
sampling efforts in a clone library and can be used to compare species richness among
different clonal libraries for a given level of sampling effort. Rarefaction curve represents
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the average number of OTUs/species observed when n clone are sequenced from the
same library (Gotelli & Colwell, 2001). Steep slope of the rarefaction curve indicates that
a large fraction of the species diversity remains to be discovered whereas flattening of the
curve towards end of the sampling indicates that enough clones have been sequenced and
additional sequencing will only yield fewer new OTUs. Chao I is a measure of species
richness and is based on the concept that the number of rare species in a clone library are
the best indicator of diversity. Chao I is calculated by the formula:
S = Sobs + (a2/2b),

------------------------------------------------------- (2.10.2)

Where Sobs = number of OTUs observed,
a = number of OTUs observed only once,
b = number of OTUs observed only twice and
S = estimated number of OTUs in a clone library (Chao, 1984).
Microbial diversity in a clone library is measured by taking into account two main
factors: richness and abundance. Shannon and Simpson diversity index are the two most
commonly used measures of diversity but differ due to the weightage given by the two
methods to species richness and abundance in the mathematical calculations. Simpson
diversity index gives more weightage to abundance whereas Shannon diversity index
gives equal weight to richness and abundance. Simpson diversity index is calculated by
the formula:
D= 1 – Ʃ(ni/N)2,

---------------------------------------------------- (2.10.3)

Where ni = proportion of OTU i relative to the total number of OTUs (N).
D ranges from 0 to 1 and decreases with increasing diversity (Simpson, 1949).
Shannon diversity index is calculated by the formula:
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H = −Ʃ pi ln pi,

---------------------------------------------------- (2.10.4)

Where pi = proportion of sequences found in the ith OTU.
H ranges from 1.5 to 5 and increases with increasing richness and evenness (Weaver &
Shannon, 1949).
Data deposition
The bacterial 16S rRNA gene sequences obtained in this study are deposited in
Genbank database with accession numbers HQ681318 - HQ681412 (2 week control),
JN012608 - JN012688 (2 week 10 ppb), HQ681413 - HQ681511 (2 week 250 ppb),
JN012882 - JN012991 (5 week control), JN012689 - JN012791 (5 week 10 ppb),
JN012792 - JN012881 (5 week 250 ppb), JN001204 - JN001304 (10 week control),
JN012992 - JN013087 (10 week 10 ppb) and JN013088 - JN013183 (10 week 250 ppb).
2.10 RNA extraction and cDNA preparation
For each time (2, 5 and 10 weeks) and dose combination (0, 10 and 250 ppb) set
of four mice were euthanized. The colon was removed and stored in 1 ml of RNA later
solution (Qiagen Inc., Valencia, CA, USA) at 4oC for 1 day and then transferred to −20oC
until used. For extraction of total RNA the sample was removed from RNA later solution
right before processing. Total RNA was extracted from 250 mg of colon sample using
trizol (Invitrogen, Carlsbad, CA, USA) according to manufacturer’s instruction with
some modifications. Each colon sample was homogenized using an electrical hand held
homogenizer in the presence of 250 µl of trizol. After homogenization, additional 1.25 ml
of trizol was added and the samples were vortexed for 2-3 minutes to achieve uniform
suspension. The samples were centrifuged at 12,000 x g for 10 minutes and the
supernatant was transferred to new 2.0 ml centrifuge tube. Chloroform (0.3 ml) was
52

added to the supernatant and the tubes were shaken vigorously. The samples were
incubated at room temperature for 2-3 minutes followed by centrifugation at 12,000 x g
for 15 min at 4oC. Upper aqueous phase that contains the RNA was transferred to a new
2.0 ml centrifuge tube. RNA was precipitated by adding 675 µl isopropanol and few
grains of glycogen. The tubes were incubated at room temperature for 10 minutes and
subsequently centrifuged at 10,000 x g. The supernatant was removed and the RNA pellet
was washed with 1 ml of 75% ethanol prepared from RNase free water and centrifuged at
7,500 x g for 5 minutes. The RNA pellet was dried in air and then resuspended in 35 µl of
RNase free water. Extracted RNA was quantified by reading the absorbance at 260 and
280 nm using Perkin Elmer UV/Vis spectrophotometer lambda 2S (260/280 nm, 40 µg
RNA = O.D. of 1). To remove any residual DNA in the extracted RNA, 15 µg of RNA
was treated with 6 Units of DNase I (Qiagen Inc. Valencia, CA, USA) in a total volume
of 20 µl and incubated at 37oC for 20 minutes. DNase activity was stopped by adding 2
µl of 25 mM EDTA to a total volume of 20 µl and incubating at 65oC for 10 minutes.
Equal amounts of DNase treated RNA (~ 4µg) was used as starting material for
the conversion to cDNA. Superscript III first strand synthesis super mix (Invitrogen,
Carlsbad, CA, USA) was used for obtaining cDNA following the manufacturer’s
instructions. To ~ 4 µg of DNase treated RNA, 50 ng of random hexamer, 1 µl of 10 mM
dNTP mix and RNase free water was added to a total volume of 10 µl. Annealing of the
random hexamers to the RNA was facilitated by incubating the reaction at 65 oC for 5
minutes. cDNA synthesis mix containing reverse transcriptase (10 µl) was added to the
reaction and the tubes were incubated at room temperature for 10 minutes, at 50 oC for 50
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minutes and finally at 85 oC for 5 minutes to stop the reaction. To verify the absence of
DNA, RNA samples without reverse transcriptase (-RT) were used as negative controls.
2.11 Primer design and optimization
Primers for amplification of target genes (arsA, arsB and nrfA) and internal
control/reference genes (rpoB) from Bacteroidetes thetaiotamicron were designed using
the primer3 program (Table 2.1) (Rozen & Skaletsky, 2000). The sequences for these
genes were obtained from the DOE Joint Genome Institute (http://img.jgi.doe.gov/). The
specificity of each primer pair was tested by amplifying the gene from microbial
community DNA from murine colon and confirmed by: (i) visualizing the expected
product size on 1.8% agarose gel and (ii) sequencing the amplified product and
performing a BLAST search. Optimal concentration of the primer pairs was determined
by comparing the Ct and relative fluorescence (Rn) values of both forward and reverse
primers at 4 different concentrations: 2.5, 5.0, 7.5 and 10 pmol/µl. The primer
concentration that resulted in low Ct and high Rn value was used for relative
quantification. Efficiency of each primer pair was tested by preparing a 10 fold dilution
series of the template and amplifying the template with its specific primer pair. The cycle
threshold (Ct) value for each dilution was determined by real time PCR system and
plotted against log template dilution. The slope of the line was determined and PCR
efficiency of the primer pair was determined by the formula:
m = − (1/log E)

--------------------------------------------------------- (2.12.1)

where m is slope and E is efficiency.
The efficiency of the internal control gene and target genes were within 10% of
each other. Expression of target genes and internal control genes in colon cDNA samples
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was tested by regular PCR and visualizing the PCR product on a 1.8% agarose gel.
Specificity of the primer pair was again checked by sequencing the amplified product.
Relative quantification of expression levels of target genes among different samples was
done by comparative Ct method (∆∆Ct) on step one real time PCR system.
2.12 Relative quantification by Comparative Ct
Real-time PCR reactions were prepared in 96 well, thin walled microplates and
carried out on step one real time PCR system (Applied Biosystems, Foster City, CA,
USA). The reaction mixture consisted of 7.5 µl of power SYBR green PCR master mix
(Applied Biosystems, Foster City, CA, USA), 5 pmol each of forward and reverse primer,
3 µl of cDNA and sterile water to a final volume of 15 µl. Each reaction was performed
in triplicate under thermocycling conditions consisting of initial step at 95 oC for 5
minutes followed by 50 cycles of 95oC for 15 sec, 57oC for 25 sec and 72oC for 30 sec
with data collection point. To check for the specificity of each reaction a final melt curve
analysis was performed at the end of the amplification cycles with fluorescence data
collected at 0.3oC intervals between 60 and 100oC. The negative controls included the no
template (water) and samples without any reverse transcriptase added. The Ct values of
target genes (arsA, arsB and nrfA) were normalized to internal control gene rpoB (∆Ct)
and were subsequently normalized to the control (0 ppb) mouse sample (∆∆Ct). The
∆∆Ct values were then transformed to 2−∆∆Ct which was used for statistical analysis. The
value of 2−∆∆Ct was obtained from the software provided with the step one real time PCR
system (Applied Biosystems, Foster City, CA, USA).
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2.13 Statistical analysis of real time data
Dose dependent changes in arsA, arsB and nrfA expression in mouse colon were
compared by one way analysis of variance (ANOVA) followed by Tukey’s correction.
The statistical analysis was performed using Graphpad Prism 5.0 software (Graphpad,
SanDiego, CA, USA).
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Gene
16S23S
rRNA

16S
rRNA

arsA

arsB

nrfA

rpoB

Primer

Sequence (5’ to 3’ end)

ITSF
ITSReub
1406F
23Sr
HDA1*
HDA2

GTCGTAACAAGGTAGCCGTA
GCCAAGGCATCCACC
TGYACACACCGCCCGT
GGGTTBCCCCATTCRG
ACTCCTACGGGAGGCAGCAGT
GTATTACCGCGGCTGCTGGCAC

Tm
(oC)
54.1
53.8
59.1
53.6
62.6
63.1

8F
1492R

AGAGTTTGATCCTGGCTCAG
GGTTACCTTGTTACGACTT

52
47

BTarsAF1089
TGACCCGGCAAATCACCTGAACTA
BTarsAR- GTTTCGGCAGCTTTGCTACGAACT
1211
BTarsBF684
GGTTGGCGGATTGCTATTAACGCT
BTarsBR- GCCCAACCGTAGGCAACAAAGAAT
827
BTnrfAF376
TCACTTCGTACCGGTTCTCC
BTnrfARTCGGATTCACGATTTCATCA
538
BTrpoBF477
CAAATTTCACGCCCAAAGTT
BTrpoBRAGGTCGTCACGGTAACAAGG
661

Reference
Cardinale et al,
2004
Fisher &
Triplett, 1999
Walter et al,
2001
Edwards et al,
1989
Stackebrandt &
Liesack, 1993

60.4
60.1

This study

59.9
60.2

This study

56.4
51.6

This study

52.2
56.9

This study

Table 2.1: List of primers used in this study. * indicates addition of GC clamp
(CGCCCG GGGCGCGCCCCGGGCGGGGCGGGGGCACGGGGGG) towards 5’ end
for DGGE. F and R stand for forward and reverse primer respectively.
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Chapter 3 : RESULTS
3.1 Estimation of bacterial community profile by RISA
The spacer regions between the 16S and 23S rRNA genes were amplified from 2,
5 and 10 week mouse colon community DNA to rapidly compare the bacterial profile of
control and As(III) exposed mouse colon. PCR products thus obtained were separated on
a 5% polyacrylamide gel on the basis of their size. The product size from spacer region
amplification ranged from 300 bps to > 1500 bps. In addition to the spacer region, the
primers used for RISA study also amplify approximately 120 bps from the 16S and 23S
rRNA genes (Cardinale et al, 2004). Therefore the product range from 300 to 1500 bps
on the polyacrylamide gel corresponds to an intergenic region ranging from 150 to 1350
bps. Variations in RISA profiles in the form of absence/presence of bands and band
intensity were observed in As(III) treated groups and control mice groups and also
between individuals of the same group. However, these alterations in band pattern and
intensity were more consistent between the groups rather than within the same group.
Due to a high number of bands and low resolution of these bands on the gel, dendrogram
analysis of RISA profiles was done to confirm that the variations observed in band
patterns and intensity were linked to arsenic exposure and not a result of inherent
variation between the individual mice (Figure 3.1).
Dendrogram analysis of RISA gels showed separate clustering of control and 250
ppb As(III) exposed groups after 2, 5 and 10 weeks of arsenite exposure. However,
samples from 10 ppb As(III) exposed groups either clustered with both control and 250
ppb exposed samples (as in case of 2 and 5 week samples) or formed a cluster with 250

58

ppb group as in 10 weeks of As(III) exposed mice (Figure 3.1). At each time point (2, 5
and 10 week) three separate clusters were formed in each of the dendrograms.
The mice from the 2 weeks of 250 ppb of As(III) exposed group formed a
separate cluster with a similarity of 50% between the individuals and showed only 36%
similarity with the rest of the control and 10 ppb group. However one mouse from the 10
ppb group clustered with 250 ppb group. This was expected from the 10 ppb group as
they are in transition phase from normal control group to a group that has been affected
by arsenic exposure.
In the 5 week RISA dendrogram, the three clusters within the dendrogram were
separately predominated by the three groups (control, 10 ppb and 250 ppb). However
some level of mixed clustering was observed between the groups. Four out of five mice
from the 250 ppb As(III) exposed group clustered together and showed > 50% similarity
whereas the fifth mouse clustered with the 10 ppb As(III) exposed mice.
The dendrogram from the 10 week RISA showed separate clusters for control and
10 ppb group and a third cluster with all the mice from 250 ppb exposed group and two
mice from 10 ppb exposed group. The control group shared > 40% similarity to each
other but only 20% similarity with the 10 and 250 ppb groups.
These results suggest that changes in microbial profile as determined by RISA in
response to 250 ppb of As(III) are dramatic after exposures for 2 weeks and continue till
10 weeks of 250 ppb exposure. Microbial changes in response to 10 ppb of As(III)
exposure although started appearing at week two but became distinct and consistent only
after 10 weeks of As(III) exposure.
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A. 2 week

B. 5 week

60

C. 10 week

Figure 3.1: RISA gels and dendrogram analysis of negative image of RISA fingerprints
generated from 16S-23S intergenic region of control (C1-C5), 10 ppb (E1-E5) and 250
ppb (M1-M5) arsenic exposed mice at A) 2 week, B) 5 week, and C) 10 week. L= 100 bp
DNA ladder. Numbers on left side of the DNA ladder represent size of the marker band
in base pairs. Scale bar on dendrograms represents similarity index values.
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3.2 Bacterial community composition of mouse colon as determined by ARISA
The spacer region between the 16S and 23S rRNA genes was amplified from 2, 5
and 10 week mouse colon community DNA. The PCR products thus obtained were
separated on a genetic analyzer to obtain a community profile for each colon sample. A
representative ARISA electrophoregram showing bacterial peaks obtained from mouse
colon is depicted in Figure 3.2 .
Regardless of time and dose exposures, ARISA electrophoregrams of the mouse
colon showed a total of 117 OTUs (peaks) with fragment size ranging from 287 bps to
1155 bps representing intergenic spacer region of approximately 37 bps to 905 bps. The
majority of the peaks ranged from 500 – 800 bps in size. Peaks shorter than 287 bps were
observed in a small number of samples. These peaks were attributed to nucleotides,
primers, primer dimers and chimeras and were excluded from further analyses. The
reproducibility of ARISA profiles was high among the replicates of the same sample. In
general, peaks with high fluorescence intensity were present constantly across all PCR
replicates of a sample, however, a very small number of less intense peaks (< 50
fluorescence units) varied in between the replicates. To overcome this variability and to
reduce the background noise, peaks less than 50 fluorescence units were not included in
the analyses. For all time points, a number of peaks were identified that were present only
in control samples and not in experimental mice and vice versa. In addition some of the
peaks that were present in all three dose groups differed in intensity between the three
sets of mice groups (0, 10 ppb and 250 ppb). Figure 3.3 shows heat maps (based on
relative peak height) obtained from ARISA profiles of colon samples.
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Figure 3.2: A typical bacterial community ARISA electropherogram obtained from
mouse colon. X axis at the top shows size of the intergenic region in bps and Y axis
corresponds to fluorescence intensity. (A) Full view of ARISA profile obtained from
mouse colon. Orange lines are internal size standard peaks and blue lines are intergenic
region peaks (B) Zoomed view of ARISA profile ranging from 640 to 710 bps. H= Peak
height, A= Peak area (shown with filled blue) and S=Peak size. Values for H, A and S are
shown at the bottom of each peak.
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Figure 3.3: Heat map showing ARISA peaks obtained from the colon of control (C1C5), 10 ppb (E1-E5) and 250 ppb (M1-M5) arsenite exposed mice at (A) 2 weeks (B) 5
weeks and (C) 10 weeks. Numbers towards the right of the image are equivalent to the
length of 16S- 23S ribosomal intergenic region amplified by primers 1406F and 23Sr.
Black indicates absence of peak and red indicates presence of peak. The color intensity
indicates differences in the relative fluorescence intensity of the peak.
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ARISA diversity
Not considering dose as a factor, the total number of peaks/OTUs detected in 2, 5
and 10 week colon samples were 66, 70 and 50 respectively. Approximately 22 peaks
were common between 2, 5 and 10 week samples. The number of OTUs shared between
different time points varied, with maximum number of OTUs (34 OTUs) shared by 10
and 5 week samples and least OTUs were shared between 10 and 2 week ARISA profile
(25 OTUs). Two and 5 week samples shared 32 OTUs (Figure 3.4). For all time points,
no significant differences were observed between control and As(III) exposed groups
with respect to the total number of peaks generated by ARISA. The number of OTUs
ranged from 43, 50, 36 in control samples, 41, 45, 39 in 10 ppb samples and 50, 44, 35 in
250 ppb As(III) exposed group in 2, 5 and 10 week samples respectively. These results
indicate that As(III) treatment did not have any detectable effect on peak diversity. In
addition, the results from ARISA profiles also indicate that arsenic exposure affects
certain bacterial communities in the colon. Disappearance of some peaks and appearance
of others in the As(III) exposed group along with variation in the intensity of peaks
indicates that arsenic exposure disturbs the microbial balance in the mouse colon (Figure
3.3).
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Figure 3.4: Venn diagram showing number of peaks/OTUs shared between ARISA
profiles of 2, 5 and 10 week mouse colon samples irrespective of the As(III) exposure
dose.
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Principle Component Analysis (PCA)
The tables containing the information about the peaks present in all samples and
their fluorescent intensity in terms of height and area were used for matrix generation. In
this matrix the height and area for each peak was relativized by dividing the fluorescence
of an individual peak by total fluorescent intensity of the sample to which that particular
peak belongs. Also each data set was averaged across its replicates. The matrices obtained
for presence/absence of peaks, relative peak height and relative peak area from each time
point were used separately for PCA. PCA ordination plots with all three variables
presence/absence of peaks (binary), relative peak height and area showed clear separation
of control and 250 ppb As(III) treated samples at all three time points. However for the
10 ppb dosage level, separation of control and 10 ppb samples was clear in case of 10
week samples but not for 2 and 5 week samples (Figure 3.5). The peaks that contributed
to the Principle Component 1(PC1) and PC2 above the mean % contribution of 1.51, 1.43
and 2.0 for 2, 5 and 10 weeks respectively are shown in Table 3.1. The peaks contributing
significantly to PC1 and PC2 were almost identical when peak height and peak area
matrices were used for PCA. However the peaks contributing to PC1 and PC2 differed in
number as well as size from the above in the case of the binary matrix. Irrespective of the
type of matrix used for PCA analysis, the overall relatedness of all the samples was
similar in all the ordination plots (Figure 3.5).
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I. 2 week

68

II. 5 week

69

III. 10 week

Figure 3.5: PCA plots generated from ARISA profiles of bacterial communities from (I)
2, (II) 5 and (III) 10week samples. Control (black squares), 10ppb (grey squares) and
250ppb (open squares). Percents shown along the axis represent the proportion of
variation by that axis. PCA plots based on (A) relative peak height, (B) relative peak area
and (C) presence/absence of peak (binary). Circles represent the groups that cluster
together.
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Peaks (bps) contributing to PC1 and PC2

2
week

5
week

10
week

Height

504, 546, 583, 588, 613, 678, 682, 710, 713

Binary

379, 421, 427, 438, 445, 457, 463, 479, 483, 509, 546, 562, 588, 590,
603, 613, 634, 645, 652, 660, 674, 678, 682, 713, 744, 767, 783, 810,
838

Area

504, 546, 583, 588, 645, 678, 682, 710, 713

Height

505, 509, 547, 574, 590, 624, 647, 654, 674, 679, 684

Binary

366, 379, 505, 509, 511, 519, 547, 574, 582, 608, 613, 633, 654, 661,
674, 679, 684, 691, 711, 787, 812, 852, 918, 958

Area

505, 509, 547, 574, 590, 624, 647, 654, 674, 679, 684

Height

508, 547, 574, 609, 623, 627, 633, 647, 674, 679, 684, 692

Binary

366, 401, 418, 436, 443, 464, 562, 574, 623, 627, 633, 640, 647, 653,
661, 674, 692, 702, 730, 765, 778, 813, 855, 925

Area

508, 547, 574, 609, 623, 627, 633, 647, 674, 679, 684, 692

Table 3.1: Peaks contributing above the mean % contribution values for PC1 and PC2 of
2, 5 and 10 week PCA plots based on relative peak height, presence or absence of peaks
(binary) and relative peak area.
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3.3 Microbial community as determined by DGGE
A small segment from the V3 region of the 16S rDNA was amplified from 2, 5
and 10 week mice colon bacterial community DNA. The expected product size after PCR
amplification was ~ 177 bp. PCR products thus obtained were separated on the basis of
their GC content on a 40 − 60% DGGE gel where the low GC fragments moved towards
the bottom of the gel. Alterations in DGGE profiles in the form of band intensity and
presence and absence of bands were observed when As(III) treated mice were compared
to control mice. These variations were observed between the individuals from the same
group as well. The differences in community composition were more pronounced for low
GC bacteria, with a visible shift in low % Mole GC fragments at all three time points.
However, careful observation of the band patterns indicated differences among high %
Mole GC species too at the different dose exposure levels. These changes were more
consistent and dramatic between the three groups with mice exposed to 250 ppb showing
more variation as opposed to 10 ppb exposed mice when compared with control group
(Figure 3.6). Similar to RISA, the total number of bands did not vary significantly
between control and arsenic exposed groups. This suggested that arsenic exposure did not
have any visible effect on microbial diversity of the murine colon. Although separated on
different gels, a shift in banding pattern was observed in between the control groups at
different time points indicating that microbial community of mouse is changing with
time.
Similar to RISA gels, dendrogram analysis of DGGE gels indicated that even at 2
weeks, the 250 ppb exposed mice clustered into separate clades (Figure 3.6). Although
visible differences in band patterns were found between control and 10 ppb As(III)
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exposed groups at 2, 5 and 10 weeks but dendrogram analysis showed clustering of 10
ppb group with control groups. These results indicate that variations observed in 10 ppb
group are so subtle that it is difficult to link these changes to As(III) exposure alone.
Dendrogram analysis of DGGE microbial profiles for 2 week control and As(III) treated
groups resulted in three main groups. Mice exposed to 250 ppb of As(III) clustered
together whereas control and 10 ppb groups showed mixed clustering and formed other
two groups. Mice exposed to 250 ppb of As(III) showed 55% similarity in band pattern to
the other two groups whereas in between the 250 ppb As(III) group the similarity values
ranged from 76 – 60%. Similarly, dendrogram analysis of 5 and 10 week DGGE gels
resulted in three different clusters. Mice exposed to 250 ppb of As(III) formed separate
cluster whereas control and 10 ppb groups formed mixed clustering.
Results from this study suggest that the observed differences between the three
dose groups (0, 10 and 250 ppb) are more pronounced than the differences observed
between the individuals of the same group. DGGE and dendrogram analysis clearly
demonstrated that As(III) exposure affected the microbial community of mouse colon.
The As(III) induced effect at 250 ppb exposure levels began at 2 weeks and continued
until 10 weeks. Despite visible changes in the band pattern of As(III) 10 ppb group from
the control group, the As(III) 10 ppb group did not form separate cluster from the control
group at all three time points.
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A. 2 week

B. 5 week

74

C. 10 week

Figure 3.6: DGGE and dendrogram analysis of negative image of DGGE fingerprints
generated from 16S rDNA PCR of control (C1-C5), 10 ppb (E1-E5) and 250 ppb (M1M5) arsenic exposed mice at A) 2 week, B) 5 week, and C) 10 week. Scale bar on
dendrograms represents similarity index values.
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3.4 Firmicutes and Bacteroidetes are the major phyla in mouse colon
For studying the microbial community structure of mice colon, bacterial clone
libraries generated from nearly full length 16S rRNA gene for each dose and time
combination were sequenced using the Sanger method. A total of 947 good quality
sequences were obtained, of which 123 sequences were found to be chimeras and
removed from the analysis. Table 3.2 shows the number of clones sequenced and the
number of good quality and non-chimeric sequences obtained from each library.
Based on RDP II database results, the mice colon microbial community contained
sequences from 5 bacterial phyla. Regardless of time and dose of As(III) exposure,
majority of the sequences belonged to the Bacteroidetes (37% of the total sequenced
population) and Firmicutes (60% of all sequences). Sequences from Deferribacteres,
Verrucomicrobia and Proteobacteria were observed in very low number, which was not
surprising given the fact that these phyla are only a minor component of the anaerobic gut
microbial community. Furthermore, only a few sequences (< 1%) were identified as
uncultured bacterial clone but showed identity with 16S sequences obtained from other
mammalian GI tract microbes. At the genus level, 12 different genera including
Barnesiella, Bacteroides, Ruminococcus, Oscillibacter, Anaerotruncus, Butyricicoccus,
Roseburia, Dorea, Robinsoniella, Lactobacillus, Akkermansia and Mucispirillum were
identified in the mice colon representing only 34.6% of the total sequenced population.
The sequences that were not classified at the genus level were classified to the next
higher level in the order of family, order, class, phylum or unclassified bacteria.
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2week
Control
2week
10ppb
2week
250ppb
5week
Control
5week
10ppb
5week
250ppb
10week
Control
10week
10ppb
10week
250ppb
Total

Total no. of
Clones
sequenced

Bad quality
sequence*

No. of putative
chimeric
sequences

No. of sequences
used for analysis

96

9

20

67

120

24

15

81

120

22

18

80

120

4

6

110

120

3

14

103

120

12

18

90

120

11

8

101

120

15

9

96

120

9

15

96

1056

109

123

824

Table 3.2: Sequencing information for the bacterial clone libraries obtained from colon
samples. * indicates sequences with ambiguous bases (N).
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Bacteroidaceae and Porphyromonadaceae were the only families observed in
phylum Bacteroidetes along with a few sequences that were identified as unclassified
Bacteroidales. Similarly, Lachnospiraceae was the most abundant family in phylum
Firmicutes followed by Ruminococcaceae, Lactobacillaceae, Peptostreptococcaceae and
Peptococcaceae. However unclassified Clostridiales (23.5%) formed a major part of the
Firmicutes population. Deferribacteres and Verrucomicrobia were exclusively formed of
a single genus namely Mucispirillum and Akkermansia, respectively.
When arsenite exposure was not considered as a factor, Firmicutes population
decreased with time from 2 to 10 week clone libraries. Within Firmicutes, family
Ruminococcaceae increased with time whereas Lachnospiraceae populations decreased
from 2 to 10 week clone libraries. Bacteroidetes population showed an increase with time
and a similar trend was observed for phylum Deferribacteres and Verrucomicrobia.
Within the Bacteroidetes, populations belonging to the family Porphyromonadaceae
increased with time from 2 to 10 week libraries whereas an opposite trend was observed
for the family Bacteroideaceae. Table 3.3 shows the classification of the sequences
obtained from these clone libraries to various levels of taxonomic hierarchy.
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Taxonomic group

2 week

5 week

10 week

Over all

Bacteroidetes (P)

18.4%

41.6%

46.7%

37%

Bacteroidia (C)

18.4%

41.6%

46.7%

37%

Bacteroidales (O)

18.4%

41.6%

46.7%

37%

Unclassified Bacteroidales (O)

N

0.3%

2.7%

1%

Bacteroidaceae (F)

4.8%

4.9%

2.7%

4%

Bacteroides (G)

4.8%

4.9%

2.7%

4%

Porphyromonadaceae (F)

13.6%

36.3%

41%

32%

Unclassified Porphyromonadaceae (F)

3.9%

7.26%

12.3%

8.1%

Barnesiella (G)

9.6%

29%

28.6%

23.5%

Firmicutes (P)

78.9%

56.4%

49.8%

60%

Unclassified Firmicutes (P)

N

1%

0.3%

0.9%

Clostridia (C)

75.9%

55.1%

46.7%

57.9%

Clostridiales (O)

75.9%

55.1%

46.7%

57.9%

Unclassified Clostridiales (O)

34.2%

24.1%

14.7%

23.5%

Ruminococcaceae (F)

8.34%

11.9%

14.3%

11.8%

Unclassified Ruminococcaceae (F)

5.26%

8.58%

11.6%

8.73%

Butyricicoccus (G)

N

1%

N

0.4%

Oscillibacter (G)

1.7%

1.65%

2.7%

2%

Ruminococcus (G)

0.4%

0.3%

N

0.2%

Anaerotruncus (G)

0.9%

0.3%

N

0.4%

Lachnospiraceae (F)

33.3%

18.8%

17.4%

22.3%

Unclassified Lachnospiraceae (F)

32%

18.8%

16.4%

21.6%

Roseburia (G)

0.4%

N

1%

0.5%

Dorea (G)

0.4%

N

N

0.1%

Robinsoniella (G)

0.4%

N

N

0.1%

Unclassified Peptostreptococcaceae (F)

N

N

0.3%

0.1%

Unclassified Peptococcaceae (F)

N

0.3%

N

0.1%
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Taxonomic group

2 week

5 week

10 week

Over all

Bacilli (C)

3%

0.3%

2.7%

1.9%

Lactobacillales (O)

3%

0.3%

2.7%

1.9%

Lactobacillaceae (F)

2.6%

0.3%

2.7%

1.8%

Lactobacillus (G)

2.6%

0.3%

2.4%

1.7%

Unclassified Lactobacillaceae (F)

N

N

0.3%

0.1%

Unclassified Lactobacillales (O)

0.4%

N

N

0.1%

Deferribacteres (P)

N

0.3%

1.3%

0.6%

Deferribacteres (C)

N

0.3%

1.3%

0.6%

Deferribacterales (O)

N

0.3%

1.3%

0.6%

Deferribacteraceae (F)

N

0.3%

1.3%

0.6%

Mucispirillum (G)

N

0.3%

1.3%

0.6%

Verrucomicrobia (P)

0.4%

0.6%

1.7%

0.9%

Verrucomicrobiae (C)

0.4%

0.6%

1.7%

0.9%

Verrucomicrobiales (O)

0.4%

0.6%

1.7%

0.9%

Verrucomicrobiaceae (F)

0.4%

0.6%

1.7%

0.9%

Akkermansia (G)

0.4%

0.6%

1.7%

0.9%

Proteobacteria (P)

0.4%

N

N

0.1%

Deltaproteobacteria (C)

0.4%

N

N

0.1%

Desulfovibrionales (O)

0.4%

N

N

0.1%

Unclassified Desulfovibrioniaceae (F)

0.4%

N

N

0.1%

Unclassified bacteria

1.7%

1%

0.3%

0.9%

Table 3.3: Percent distribution of bacterial 16S clone libraries obtained from mouse
colon to bacterial taxonomy. N = not found, P = phylum (highlighted), C = class, O =
order, F = family and G = genus.

80

3.5 As exposure is associated with increased Bacteroidetes
Despite interindividual variations, arsenite exposures clearly affected the
microbial community of mouse colon. Compared with the control group, for all time
points 10 ppb and 250 ppb As(III) exposed groups had an increase in the relative
abundance of Bacteroidetes and proportionally fewer Firmicutes at the phylum level of
taxonomy. Even at the class level, more Bacteroidia and fewer Clostridia were observed
in As(III) exposed groups (Figure 3.7). However based on RDP II library comparison
results, this change was significant (p<0.01) only for the 250 ppb groups at 2, 5 and 10
week interval whereas for the 10 ppb As(III) exposed groups the change was significant
only at 10 week interval. Within Bacteroidia, the number of sequences classified under
the family Porphyromonadaceae increased in response to As(III) exposure whereas no
such trend was observed for Bacteroidaceae (Figure 3.8). With respect to phylum
Firmicutes, sequences classified under family Lachnospiraceae and Ruminococcaceae
decreased after two and five weeks of 250 ppb of As(III) exposure. In the case of 10
weeks of 10 and 250 ppb of As(III) exposure, only the sequences identified as
Ruminococcaceae decreased significantly after As(III) exposure whereas no trend was
observed for Lachnospiraceae. Bacilli were generally abundant in the As(III) exposed
groups when compared to the control groups. Since many sequences from Firmicutes
could not be classified beyond the family level it is difficult to determine whether arsenic
treatment is affecting a single or more than one genus from these families. Paired
comparison of the control and As(III) treated libraries using libshuff analysis yielded a
value of <0.0001 which is less than a p value of 0.01 after Bonferroni correction,
indicating that the libraries are significantly different from each other (Table 3.4).
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Figure 3.7: Class level taxonomic distribution of clones obtained from clone libraries.
Stacked bar graphs show relative % distribution of sequenced clones to different
taxonomic classes. * indicates significantly different from control and 10 ppb for that
particular class (p<0.01) where ** represents significantly different from control group
only (p<0.01)
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Figure 3.8: Family level taxonomic distribution of clones obtained from clone libraries.
Stacked bar graphs show relative % distribution of sequenced clones to different
taxonomic families.
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2 wk
control
<0.0001

2 wk
10ppb

2 wk
250ppb

<0.0001

<0.0001

5 wk
Control

<0.0001

<0.0001

<0.0001

5 wk
10ppb

<0.0001

<0.0001

<0.0001

<0.0001

5 wk
250ppb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

10 wk
Control

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

10 wk
10ppb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

10 wk
250ppb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

0.0002*

<0.0001

2 wk
10ppb

2 wk
250ppb

5 wk
control

5 wk
10ppb

5 wk
250ppb

10 wk
control

10 wk
10ppb

<0.0001

Table 3.4: Paired comparison of clone libraries by libshuff. The 2 libraries were
considered significantly different if their p value generated by libshuff is lower than the
corrected p value after Bonferroni correction. After Bonferroni correction the corrected p
values of 0.00014 and 0.0007 are equivalent to the normal p values of 0.01 and 0.05. *
indicates that the libraries are significantly different at p = 0.05 whereas all other libraries
are significantly different at p = 0.01.
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3.6 Microbial diversity estimation
In order to assess the diversity of bacteria present in the mice colons, 16S rRNA
gene sequences obtained by sequencing were clustered into groups. Based on distance
matrix, clones with 97% (species level), 95% (genus level) and 90% (family level)
sequence identity were grouped into the same phylotype/operational taxonomic units
(OTUs). The number of OTUs with only 1 sequence at a distance of 0.03, 0.05 and 0.1
were 236, 163 and 59 respectively. Regardless of As(III) exposure, a total of 313 unique
phylotypes were identified including 159, 105 and 108 phylotypes from 2, 5 and 10 week
clone libraries respectively at the distance level of 0.03. However at the genus level (95%
sequence identity) only 136, 87 and 86 OTUs were found in 2, 5 and 10 week mice colon
contributing to a total of 241 OTUs in mice colons. The number of OTUs determined in
2, 5 and 10 week clone libraries at family level were 74, 51 and 47 respectively, totaling
towards 114 OTUs in mice colon. These results indicate that the diversity of mouse colon
microbiota decreased after 2 weeks. Also, the number of OTUs shared between different
libraries varied, with the maximum number of OTUs shared by 10 and 5 week clone
libraries or 2 and 5 week clone libraries and least OTUs were shared between 10 and 2
week clone libraries. This pattern of shared OTUs was consistent for all distances. These
results indicate that the microbial community from 5 week samples is intermediate in
type and diversity to that of 2 and 10 week microbial populations. Figure 3.9 shows the
number of OTUs shared between 2, 5 and 10 week clone libraries at a distance of 0.03,
0.05 and 0.1.
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Figure 3.9: Venn diagrams showing the number of OTUs shared between 2, 5 and 10
week 16S rRNA clone libraries irrespective of As(III) exposure dose at a distance of (A)
0.03 (B) 0.05 and (C) 0.10.
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Effect of arsenite on microbial diversity of the murine colon
Microbial diversity, richness and coverage were calculated for the combined data
set as well as for all the sample subsets based on time (2, 5 and 10 week) and dose
combinations (0, 10 and 250 ppb) (Table 3.5,Table 3.6). Arsenite exposure did not affect
the overall richness of murine colon microbiota at the genus and family level as indicated
by more or less the same number of observed OTUs in control and 250 ppb exposed
groups. The number of observed OTUs was a little higher for 10 ppb at 0.05 and 0.1
distance levels in all the libraries except for the 5 week 10 ppb group where the number
of observed OTUs were equal to the 5 week 250 ppb group.
Overall the Good’s coverage was 93% for the combined libraries at a distance of
0.1 indicating that sequencing 100 additional clones will yield only seven new OTUs.
When each library was considered individually, >83% coverage was observed for 5 and
10 week clone libraries at a distance of 0.10 but the coverage was lower (66 – 73%) for 2
week clone libraries. However the Good’s coverage was generally low at the genus level
for all the libraries except for 5 and 10 week control where 80 and 88% coverage was
observed respectively.
To estimate the richness of the clone libraries, rarefaction curves were plotted
(Figure 3.10). For the combined dataset at 0.03 and 0.05 distance levels the rarefaction
curve did not reach saturation towards the end of the sampling. However at a distance of
0.1 the curve almost reached plateau towards the end of sampling for the combined
dataset as well as for all individual types of clone libraries (Figure 3.10). Both rarefaction
curves and Good’s coverage estimates indicated that the majority of bacteria at the family
level of taxonomy have been captured in the current sequencing efforts. However new
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phylotypes would be detected with continued sampling from these colon samples at the
genus and species level.
Similar to rarefaction curves, estimations of species richness by Chao’s estimator
predicted that sequencing more clones can reveal more unique sequences (Table 3.5,
Table 3.6). Estimated numbers of OTUs as determined by Chao were relatively close to
the observed numbers at higher distance level (0.1) whereas the difference between
estimated and observed OTUs increased at a lower distance level. The percentage of
observed/estimated OTUs was between 33−76% at cluster distance of 0.1 whereas this
percentage was reduced to 14−69% at the genus level.
Bacterial diversity at the family and genus level as measured by Shannon and
Simpson index was least for 250 ppb group and highest for control group when time was
not considered as a factor (Table 3.5, Table 3.6). The highest diversity was observed for
the 2 week libraries and least for the 5 week when As(III) exposure was not included as a
factor. Within the individual library data sets, bacterial diversity was highest for 2 week
control and lowest for 5 week 250 group. These results differed from the microbial
richness wherein observed species richness as determined by rarefaction curve was
highest in the 2 week 10 ppb group and lowest in 10 week control group. The Shannon
index is prone to error and bias when the sampling is incomplete (Magurran, 1988).
Therefore during any discrepancy between the Shannon and Simpson diversity indices
more weight was given to the trends observed by the latter. Overall the results from
microbial diversity estimations suggest that more sequencing efforts will generate more
unique microbial species that in combination could have a profound effect on mouse
health and disease.
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2 wk
Control
2 wk
10ppb
2 wk
250ppb
2wk
All
5 wk
Control
5 wk
10ppb
5 wk
250ppb
5 wk
All
10 wk
Control
10 wk
10ppb
10 wk
250ppb
10 wk
All
All
Control
All
10ppb
All
250ppb
All

Observed
OTUs

Chao
Estimator of
species
richness

Good’s
Coverage
(C) (%)

Simpson
Diversity
Index (D)

Shannon
Diversity
Index (H)

51

352

36

0.012212

3.797245

59

227

39.5

0.014815

3.889397

50

180

50

0.039873

3.539687

136

533.5

53.5

0.013139

4.555065

36

64.875

80

0.105755

2.806833

42

88.42857

75

0.059585

3.20864

37

112.6

69

0.209488

2.574984

87

185.076923

83

0.080104

3.270088

29

42.2

88

0.077426

2.878059

42

108.4286

68

0.133991

2.90301

39

85.42857

73

0.093202

2.986581

86

164

82

0.053626

3.597955

96

243.5

78

0.046256

3.804828

119

467

68.5

0.051152

3.974711

97

275.75

75

0.06679

3.648178

241

696.275862

80

0.040893

4.328786

Table 3.5: Indices of richness, diversity and library coverage obtained for 16S clonal
libraries at a distance of 0.05. D decreases with increasing diversity while H increases
with increasing diversity.
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2 wk
Control
2 wk
10ppb
2 wk
250ppb
2wk
All
5 wk
Control
5 wk
10ppb
5 wk
250ppb
5 wk
All
10 wk
Control
10 wk
10ppb
10 wk
250ppb
10 wk
All
All
Control
All
10ppb
All
250ppb
All

Observed
OTUs

Chao
Estimator of
species
richness

Good’s
Coverage
(C) (%)

Simpson
Diversity
Index

Shannon
Diversity
Index

32

95.25

66

0.069652

2.987348

34

80.2

73

0.074383

3.012234

31

94.25

71

0.089241

2.790469

74

144.714286

80

0.066504

3.454768

25

40.6

88

0.137114

2.423934

23

56

88

0.110603

2.508098

23

42.5

85.5

0.249438

2.145428

51

113.142857

90

0.116058

2.767992

22

29

92

0.106337

2.546807

27

47

83

0.218421

2.286577

22

29.2

91

0.149123

2.371783

47

66.090909

93

0.09568

2.898701

55

86.90909

90

0.076669

3.091312

66

156.3

85

0.102407

3.025548

54

103.6

88

0.110427

2.8729

114

214.647059

93

0.079961

3.293593

Table 3.6: Indices of richness, diversity and library coverage obtained for 16S clonal
libraries at a distance of 0.10. D decreases with increasing diversity while H increases
with increasing diversity.
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A.

B.

Figure 3.10: Rarefaction curves obtained from 16S rDNA clone libraries. (A)
Rarefaction curves obtained from combined dataset at a distance of 0.03, 0.05 and 0.10.
(B) Rarefaction curves obtained from 3 time points (2, 5 and 10 weeks) and 3 doses (0,
10 and 250 ppb) at a distance of 0.10.
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3.7 Phylogenetic tree
To determine the phylogenetic relationship between the OTUs obtained from 16S
rDNA clone libraries of the murine colon a neighbor joining phylogenetic tree of the
representative OTU sequences (at 90% sequence similarity) from control, 10 ppb and 250
ppb group irrespective of the time point was constructed (Figure 3.11). A total of 174
clones were represented on the neighbor-joining tree. The phylogenetic tree indicated that
for most of the OTUs identified from the control group, nearly identical OTUs were
found in As(III) groups too. As expected, Clostridia formed the largest clade in the
phylogenetic tree consisting of OTUs from all three libraries. However the number of
sequences within certain phylotypes of Clostridia clade varied between the three groups.
Similar to Clostridia, clades within Bacteroidia consisted of OTUs from all three libraries
but the number of sequences within certain phylotypes were drastically different between
the control and As(III) exposed libraries. For example one of the OTU in Bacterodia had
133 sequences from the As(III) groups but only 18 sequences from the control group.
Bacilli formed a small clade in the phylogenetic tree and was exclusively formed by
OTUs obtained from As(III) exposed groups.
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Figure 3.11: Neighbor joining tree showing the positions of 16S rDNA phylotypes
obtained from mouse colon. Clones obtained from control mice are shown on red
terminal branches, clones from 10 ppb exposed mice are shown on green branches and
those obtained from 250 ppb As(III) exposed mice are shown on blue branches. Boot
strap values obtained from 1000 replications and above 50% are shown at the nodes.
Scale bar represents genetic distance based on 10 substitutions per 100 nucleotides. The
number after ―│‖ at the end of each of the clone name indicates the number of sequences
that were found under the same representative OTU.
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3.8 Distribution of ars operon
Distribution and occurrence of ars operons were determined bioinformatically in
partially or completely sequenced microorganisms from the DOE Joint Genome Institute
portal (http://img.jgi.doe.gov/). This was done to determine whether the mechanism for
arsenic resistance and detoxification occurs in microbes that typically reside in the gut
environment. The search was restricted to the microbial taxa that were identified from the
sequencing data of the mouse colon from section 3.4. Due to the high ambiguity in gene
annotation the search for ars operon in these genomes was done by three methods: COG
(Cluster of Orthologous Groups) search, protein BLAST using ArsB sequence from B.
thetaiotamicron and keyword search. The keywords used for the search for ars operon in
different bacterial species include ars, arsenate reductase and arsenical pump.
In total, 182 different bacterial species and strains were found on JGI website that
fall under the taxonomic classification found in the mouse colon. Of these, only 52
species had the whole genome sequenced. A total of 49 Bacteroidia, 39 Clostridia, 74
Bacilli, 14 Deltaproteobacteria, 4 Verrucomicrobia and 2 Deferribacters species were
searched for the presence of ars operon in their genome. The ars operon was defined as
sequences that occur as cluster of at least two ars genes and are separated by not more
than 200 bps. Based on this definition, only 18% of the total observed bacteria were
found to have ars operon. Table 3.7 lists the taxonomic classification used for search of
ars operon and microbes that were found to have an ars operon along with the
arrangement of ars genes within the operon.
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Species (Genome status)
ars operon arrangement*
P= Bacteroidetes, C= Bacteroidia, F= Bacteroidiaceae
Bacteroides dorei 5_1_36/D4(D)
RBCxxxxxR
B. thetaiotamicron VPI-5482(F)
BCADxxxR, BADxxxR
B. fragilis 3_1_12(D)
RBCxxxxxR
B. eggerthii DSM 20697(D)
BCADx
B. intestinalis 341 DSM 17393(D)
BCADxxxR, BADxxxR
B. sp.1_1_16 (D)
BADxxxR
B. sp. 2_1_33B (D)
BCADxxxR
B. sp. 4_3_47FAA (D)
BCADxxxR
B. stercoris ATCC 43183(D)
BCADxxxRx
B. vulgatus ATCC8482 (F)
BCADxxxR
B. vulgatus PC510 (D)
BCADxxxR
P= Firmicutes, C= Bacilli, F= Lactobacillaceae
Lactobacillus antri DSM 16041 (D)
CBR
L. fermentum IFO 3956 (F)
CBR
L. johnsonii NCC 533 (F)
CBR
L. reuteri CF48-3A (D)
BRCCBR, CBR
L. reuteri SD2112 (D)
BRCCBR, CBR
L. plantarum WCFS1(F)
xDxBADR
P= Firmicutes, C= Clostridia, F= Lachnospiraceae
Oribacterium sinus F0268 (D)
BAR
P= Firmicutes, C= Clostridia, F= Ruminococcaceae
Ruminococcus sp. 5_1_39BFAA(D)
CBxxxxxR
Ethanoligenens harbinense YUAN-3T (D)
BxxR
P= Firmicutes, C= Clostridia, F= Peptococcaceae
Desulfitobacterium hafniense Y51 (F)
BRCxR, CABR, CBR
D. hafniense DCB-2 (F)
BRC
Desulfotomaculum reducens MI-1 (F)
BR
Pelotomaculum thermopropionicum (F)
BR
Thermincola sp. JR (F)
BR
P= Deferribacteres, C= Deferribacteres, F= Deferribacteraceae
Deferribacter desulfuricans SSM1(F)
BCR
Denitrovibrio acetiphilus N2460 (F)
CB
P= Verrucomicrobia, C= Verrucomicrobea, F= Verrucomicrobiaceae
Verrucomicrobium spinosum DSM4136 (D)
CBxRxxxRx
Verrucomicrobiae bacterium DG1235 (D)
RBCAD
P= Proteobacteria, C= Deltaproteobacteria, F= Desulfovibrionaceae
Desulfovibrio sp. 3_1_syn3 (D)
BR
D. aespoeensis Aspo-2 (D)
BR
D. desulfuricans G20 (F)
CCB
D. magneticus RS-1 (F)
BR
D. salexigens DSM 2638 (F)
BR
Reference sequences (used for phylogenetic tree)
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Species (Genome status)
ars operon arrangement*
P= Bacteroidetes, C= Bacteroidia, F= Bacteroidiaceae
P. melaninogenica ATCC25845 (F)
BCADxxxR
P. bergensis DSM 17361 (D)
BCAR
P= Firmicutes, C= Clostridia, F= Clostridiaceae
Clostridium kluyveri DSM 555 (F)
CBR
Cl. beijerinckii NCIMB 8052 (F)
BCADR
Cl. Phytofermentans ISDg (F)
CDBAR
P= Firmicutes, C= Bacilli, F= Staphylococcaceae
Staphylococcus aureus RF122 (F)
CBR
P= Proteobacteria, C= Gammaproteobacteria, F= Enterobacteraceae
Escherichia Coli FVEC 1412 (D)
CBADR
P= Proteobacteria, C= Gammaproteobacteria, F= Pseudomonadaceae
Pseudomonas fluorescens PF-5 (F)
HCBR
P= Firmicutes, C= Bacilli, F= Bacillaceae
Bacillus subtilis subtilis 168 (F)
CBxR
Table 3.7: Arrangement of ars operon in various bacterial species. For genome status F
and D in parentheses indicates that the genome is completely sequenced (F) or in draft
stage of sequencing (D). * The ars genes are written in the order they are found in the
genome. ―x‖ represents genes encoding proteins of unknown function.
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Within the ars operon, arsB and arsR genes were found in almost all the bacteria
whereas arsA occurred in 40% of the bacteria. arsA was mainly distributed in
Bacteroidetes phylum mostly in association with arsD. The majority of the Firmicutes
had arsCBR or arsBR gene composition. Some of the species were found to have two ars
operons. The arrangement of genes constituting the ars operon varied from species to
species. Based on current estimates, ars operon is present in far more Bacteroidetes
species than Firmicutes indicating that the expression of ars operon could be the reason
behind selection for Bacteroidetes populations in As(III) exposed samples. In some of the
species, the ars operon had genes for transposition and/or integration in its vicinity
leading to speculation that ars gene might be transposed to other species.
To determine the evolutionary relatedness of the ars operon in these microbes
neighbor joining (NJ) phylogenetic trees were constructed separately for ArsA and ArsB
protein sequences (Figure 3.12, Figure 3.13). In the NJ trees the ArsA and ArsB
sequences formed three clusters. In both the trees Bacteroidetes were confined to a single
cluster. All ArsA sequences from Firmicutes clustered together whereas some of the
ArsB sequences formed clusters with Bacteroidia. Within Firmicutes, ArsB sequences
from Lactobacillus species formed a separate sub cluster but were separated from other
Bacilli. The ArsB sequences from Verrucomicrobiae, Delta proteobacteria and
Deferribacteres grouped together. Desulfitobacterium hafniense consists of three ArsB
sequences and each one of them was confined to separate sub cluster.
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Figure 3.12: A Neighbor joining tree of ArsA protein sequences. Boot strap values
obtained from 1000 replications are shown at the nodes. Scale bar represents evolutionary
distance based on number of substitutions per site. The Genbank accession number for
each sequence is given before the species name.
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Figure 3.13: A Neighbor joining tree of ArsB protein sequences. Boot strap values
obtained from 1000 replications are shown at the nodes. Scale bar represents evolutionary
distance based on number of substitutions per site. The Genbank accession number for
each sequence is given before the species name.
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3.9 Effect of As(III) on microbial physiology of the host
Selection of model organism
In order to understand the in vivo effect of As(III) on gut microbiota physiology,
ars and nrf operon genes were selected for comparing their expression at the mRNA level
between control, 10 and 250 ppb As(III) exposed mice. Since enough variability exists
between various species in the gene sequences from the two operons, a model organism
was needed to accomplish the above aim. The selection of the model organism was based
on the criteria that the selected organism should possess one or both of the operons (ars
or nrf operon) being studied, should belong to the taxonomic group of significance in the
gut and should be present in the mouse colon in detectable limits as determined by
general PCR. Based on these criteria, seven microorganisms namely Bacteroides
thetaiotamicron, Bacteroides intestinalis, Prevotella melaninogenica, Lactobacillus
planatarum, Dorea formicigenerans, Clostridium phytofermentans and Oribacterium
sinus were selected for further study. To screen for the presence of these species in the
mouse colon microbial community, species specific primers were designed (Appendix 5).
Table 3.8 shows the genes for which the species specific primers were designed and the
results obtained with these primers after amplification by general PCR. The results
indicated that B. thetaiotamicron was the microorganism that fulfilled all the above
criteria. Thus, for the expression studies by real time qPCR, primers for reference gene
(rpoB) and target genes (arsA, arsB, arsC and nrfA) were designed based on the sequence
of these genes from B. thetaiotamicron.
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Organism

Phyla

arsA

rpoB

nrfA

Bacteroides thetaiotamicron

Bacteroidetes

+

+

+

Bacteroides intestinalis

Bacteroidetes

−

+

−

Prevotella melaninogenica

Bacteroidetes

−

−

Ab

Oribacterium sinus

Firmicutes

−

+/−

Ab

Lactobacillus planatarum

Firmicutes

− (6)

NA

NA

Clostridium phytofermentans

Firmicutes

−(4)

NA

NA

Dorea formicigenerans

Firmicutes

Ab

+/−

−

Table 3.8: Genes used to determine the presence of specific microorganisms in the
mouse colon microbiota. The symbols indicate amplification (+), no amplification (-),
amplification in a few samples (+/−), gene sequence was not found in the genome (Ab)
and no primers were designed (NA). The number in parentheses shown above indicates
the number of primer pairs tested. For others only one primer pair was tested.
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Specificity of the primers designed for expression studies
Due to non-availability of the pure culture, genomic DNA from mouse colon was
used to test the specificity of each of the primer pair designed for amplifying reference
gene (rpoB) and target genes (arsA, arsB, arsC and nrfA). A total of 30 different primer
pairs were tested in three different reaction conditions for amplifying the arsC gene from
microbial community DNA of the mouse colon. However no amplification was achieved
with any of the primer pairs tested. These results indicate that either the arsC gene is
present at a very low abundance in colon microbiota or the PCR conditions or the primers
used were not suitable for the amplification of arsC gene from colon microbiota.
Figure 3.14 shows representative agarose gels with 185, 121, 144 and 163 bp PCR
products obtained from mouse colon microbial community DNA with rpoB, arsA, arsB
and nrfA primer pairs respectively. The PCR products thus obtained were free of any
secondary products, as indicated by the formation of a single band of desired length on a
regular agarose gel. The absence of any visible band in the negative control (water)
indicated that the primers do not form dimers under the PCR conditions tested. To further
confirm the specificity of the primers used, the PCR product obtained from each primer
pair was used for direct sequencing. The results from NCBI BLAST search confirmed
that the amplified product corresponds to the rpoB, arsA, arsB and nrfA genes of B.
thetaiotamicron.
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Figure 3.14: Representative 1.8% agarose gels showing amplification of reference [(A)
rpoB] and target genes [(B) nrfA (C) arsA and (D) arsB] from mouse colon microbial
community DNA. L = 100 bp DNA ladder, -ve = negative control.
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As mentioned in table 3.7, B. thetaiotamicron had 2 ars operons with gene
configurations BCADxxxR and BADxxxR respectively. Table 3.9 shows the nucleotide
identity of the genes that constitute the two ars operons from B. thetaiotamicron.
Although arsA and arsB genes were not 100% identical at the primer binding sites, the
primers designed specifically for amplifying part of arsA and arsB gene from operon 1
(BCADxxxR ) of B. thetaiotamicron, amplified the arsA and arsB regions from operon 2
(BADxxxR) as confirmed by direct sequencing of the PCR product. These results
indicated that the operon 2 (without arsC gene) from B. thetaiotamicron or from a related
strain was present in more copies in the mouse colon as compared to operon 1.

Nucleotide similarity

arsA

arsB

arsD

arsR

86%

84%

87%

88%

Table 3.9: Nucleotide identity between the ars genes from the two ars operons of B.
thetaiotamicron.
Accuracy of primer pairs for real time PCR
In order to obtain reliable results from comparative Ct method (∆∆Ct) the
efficiency of reference gene and the target gene should be within 10% range. The
efficiency of these genes was calculated by preparing a dilution series of the PCR product
obtained from the general PCR performed on microbial community DNA extracted from
mouse colon. Figure 3.15 shows the melt curve and the standard curve obtained for each
of the primer pairs. The efficiency for rpoB, nrfA, arsA and arsB primer pairs was 99%,
96%, 99% and 90% respectively. A single Tm peak was observed in the melt curve for
each of the primer pair indicating that the primers were suitable for real time PCR.
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A. rpoB

B. nrfA
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C. arsA

D. arsB

Figure 3.15: Melt curve and standard curve obtained for (A) rpoB (B) nrfA (C) arsA and
(D) arsB gene.

107

Relative quantification of arsA and arsB expression in mouse colon
The mRNA expression levels of arsA and arsB genes between control, 10 ppb and
250 ppb mouse colon samples were compared by comparative Ct method (2−∆∆Ct ) of real
time RT-qPCR. The arsA and arsB genes at 2 week time point yielded Ct values above
35 indicating that the genes were expressed at very low levels and could not be compared
by comparative Ct method. However for 5 and 10 week mouse colon samples, the Ct
values for arsA gene were lower than 35, indicating that the gene copy number of arsA is
higher in 5 and 10 week colon samples. Figure 3.16 shows the dose dependent response
of arsA expression in the 5 and 10 week mouse colon samples after As(III) exposure.
These results indicate that As(III) exposure at a concentration of 10 and 250 ppb does not
affect the expression of arsA in gut microbes.
With respect to the arsB gene, Ct values varied from sample to sample. For most
of the 5 week samples at least one of the replicates of each sample yielded melt curve
with desired Tm of 760C and a single peak, whereas for the 10 week colon samples
multiple Tm peaks were observed with most of the samples indicating that the arsB gene
was not expressed at levels to be compared by real time qPCR. Figure 3.17 shows the
dose dependent response of arsB expression in 5 week mouse colon samples after As(III)
exposure. No evidence for changes in expression of the arsB gene was observed in the 5
week samples in response to As(III) exposure. Together the results from expression
studies of arsA and arsB genes indicated that As(III) exposure at a concentration of 10
and 250 ppb via drinking water does not alter the expression of ars operon in mouse gut
microbes up to 10 weeks.
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Figure 3.16: Relative expression levels of arsA gene in control, 10 ppb and 250 ppb
mouse colons at (A) 5 week and (B) 10 week. Error bars indicate standard deviation.
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Figure 3.17: Relative expression levels of arsB gene in control, 10 ppb and 250 ppb
mouse colons at 5 week time point. Error bars indicate standard deviation.
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As(III) induced dose dependent alterations in nrfA expression
To determine the effect of As(III) exposure on physiology of the colon microbes,
the mRNA expression levels of nrfA gene were compared between control, 10 ppb and
250 ppb mouse colon samples by comparative Ct method (2−∆∆Ct ). Figure 3.18 shows the
time and dose dependent response of nrfA expression in 5 and 10 week mouse colon
samples after As(III) exposure. These results indicated that As(III) exposure at a
concentration of 250 ppb induced significant increase in the expression of nrfA in gut
microbes. For the 10 ppb As(III) exposure dose, significant increase in the expression of
nrfA was observed only after 10 weeks of As(III) exposure. Altered expression of the
nrfA gene in time and dose dependent manner in response to As(III) exposure
demonstrated that As(III) exposure impacts the physiology of the microbes residing in the
mouse colon.
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Figure 3.18: Relative expression levels of nrfA gene in control, 10 ppb and 250 ppb
mouse colons at (A) 5 week and (B) 10 week time point. Error bars indicate standard
deviation. ** indicates p < 0.01 and *** indicates p < 0.001 after Tukey’s post-hoc test.
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Chapter 4 : DISCUSSION
4.1 Molecular techniques as a tool for studying colon microbiota
In recent years, the use of culture independent techniques have grown at a fast
pace and have extended our knowledge about the diversity and composition of the
mammalian microbiota. This development has overcome the disadvantages associated
with the traditional time consuming and labor intensive cultivation based approaches
wherein the difficulty lies in differentiating related species/strains as well as in culturing
anaerobic gut microbes under laboratory conditions (Duncan et al, 2007). Numerous
studies have used 16S rRNA gene based sequencing (pyrosequencing, near full length
16S rDNA sequencing) and fingerprinting techniques (DGGE, RFLP) to study the gut
microbiota (Zoetendal et al, 2002; Nava et al, 2011; Eckburg et al, 2005; Osborn et al,
2000). In addition some of the studies have used the variability in the spacer region
between 16S and 23S rRNA gene (RISA, ARISA) of different bacterial species for
comparative studies related to gut microbiota (Scanlan et al, 2008; Spencer et al, 2011).
However the dynamic and complex nature of the mammalian microbiota along with the
microbial variation between individuals pose a challenge in these studies as each of these
technique comes with its own advantages and limitations (Sekirov et al, 2010). 16S
rDNA clone libraries based results give high taxonomic resolution but is very time
consuming and expensive approach. Pyrosequencing on the other hand is convenient and
cost effective approach in case of multiple samples but provides shorter reads of <400 bp,
thus giving only class or family level taxonomic resolution (Liu et al, 2008). DGGE and
RFLP are rapid methods for comparing bacterial profiles from different groups but
provide low taxonomic resolution due to smaller product size. With DGGE it is difficult
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to achieve reproducible gels and the technique itself is associated with inherent biases
since different bacterial species that have same GC content migrate to the same position
in the gel (Muyzer & Smalla, 1998). Both RISA and ARISA are highly reproducible and
less time consuming approaches. These provide low taxonomic resolution mainly
because the intergenic region database is not extensively available, especially for gut
microbes where majority of the bacteria have not been sequenced yet (Kovacs et al,
2010). ARISA, although more expensive than RISA, is advantageous as the resolution of
PCR products on the capillary is very high and it provides an accurate estimation of
intergenic length. However in both cases, the technique is biased as a single species can
have several intergenic regions with each one differing in length. Additionally a number
of bacteria have been identified where 16S and 23S rRNA genes are not organized in
operons but are separated from each other with > 3000 bp distance between them. This
size between 16S and 23S rRNA genes is far greater than the normal size separated on a
gel or a capillary (Kovacs et al, 2010). All of the fingerprinting techniques suffer from
the limitation of being unable to detect species that are present at a very low abundance
(<1%) in a mixed community. Fluorescent in situ hybridization (FISH) and RT-qPCR are
two other 16S rRNA gene based techniques that are used to identify and compare
bacterial communities in the gut (Kalliomäki et al, 2008; Penders et al, 2007). For both of
these techniques either species specific or group specific probes/primers need to be
designed, thus limiting the identification of novel species. Depending upon the conditions
used for hybridization and PCR, these probes/primers can bind to other closely related
species producing biased results (Sekirov et al, 2010).
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The primary goal of this study was to compare the bacterial profile of control and
As(III) exposed murine colon and to identify the taxonomic groups that are mainly
affected by arsenic exposure. In order to achieve this goal and to overcome the
constraints associated with cultivation independent techniques, 4 different molecular
approaches (DGGE, RISA, ARISA, clone library) based on principles of inter species
differences of GC content, variable length of 16S and 23S intergenic regions among
different bacterial species and variability within the conserved 16S rRNA gene were used
in this study to determine the effect of As(III) on colon microbiota.
4.2 Biases associated with method of DNA extraction
Besides individual limitations, all molecular techniques are prone to biases
associated with methods of DNA extraction and PCR. The silica and guanidinium
thiocynate method as well as QIAamp DNA stool mini kit from Qiagen Inc. were used in
this study for extracting microbial community genomic DNA from mouse colon. Both the
methods have been used previously in numerous studies to extract microbial DNA from
the stool samples of various species (Larsen et al, 2010; Boom et al, 1990; Barnard et al,
2011). Of these two methods, the silica method is inexpensive but time consuming
procedure. The silica slurry used for isolating DNA requires a two day preparation time
and requires preparation of buffers that are not regularly used in other procedures.
Moreover when the same amount of DNA was used for PCR, some of the samples did
not show any or minimal amplification indicating that PCR inhibitors were left in the
final extracted genomic DNA (Figure A.1). QIAamp DNA stool mini kit protocol on the
other hand gave more or less consistent yields of genomic DNA as well as PCR products
for all the samples when equal amounts of starting materials were used. However in both
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the methods, variations in the amount of DNA extracted due to incomplete
homogenization of the sample cannot be ruled out. Also the 260:280 ratios for the
extracted nucleic acid were better with QIAamp DNA stool mini kit protocol. Due to
inconsistencies associated with silica protocol, only results obtained with QIAamp DNA
stool mini kit from study 2 and part of study 1 are discussed below.
4.3 Microbial composition of the murine colon
Most of the studies related to the microbial communities in the colon of the host
have used stool samples as their study source. However, within the gut the composition
of microbial communities differs longitudinally between ascending and descending colon
as well as radially between mucosal and luminal region (Frank et al, 2007; Zoetendal et
al, 2002). To overcome these differences and to ensure that the bacterial community
directly associated with the gut lining is accounted for, both the ascending and
descending colon was used in this study to determine the in vivo impact of As(III) on
colon microbiota.
In the present study, comparison of RISA and ARISA profiles obtained from
microbial community DNA of murine colon were used to track the effect of As(III)
exposure on murine colon microbiota. The number of detectable bands obtained from
RISA profiles of an individual mouse colon ranged from 16 – 30 and the similarity value
between individuals of the same group ranged from 40 – 85%. The similarity index was
relatively low considering that the mice were genetically identical and housed under same
conditions. An attempt was made to sequence some of the dominant phylotypes obtained
from RISA both by making a clone library and by excising specific bands from the gel.
Reamplification of excised bands generally yielded multiple bands. This was attributed to
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low resolution of RISA products on the polyacrylamide gel. Of the 21 sequences obtained
from RISA clone libraries, 18 sequences showed similarity with Lactobacillus (Appendix
6). The product length of the 18 sequences varied from 290 bps to 504 bps indicating that
the spacer regions of Lactobacillus species and strains are distributed over a broad range.
These results also showed bias towards preferential insertion of smaller products into the
cloning vector. These results indicate that the inexpensive and rapid RISA approach is
more suitable for comparative studies rather than the studies that require taxonomic
identification of bacterial communities present in the host.
ARISA profiles from individual colon samples yielded only 15 − 35 peaks
whereas about 113 peaks were obtained collectively from all the samples. The number of
bands and peaks obtained from RISA and ARISA profiles were far less than the number
of species typically found in a host indicating that the techniques were not suitable for
diversity estimations. The ordination plots obtained after statistical analysis of ARISA
data differed between peak height, area and presence/absence and so does the peaks that
contributed to the variation in these plots. Similar differences have been observed
between the three types of ordination plots in other studies too, wherein it was
recommended that ordination plots obtained from relative peak height are best suited for
ordination based analysis of microbial community (Culman et al, 2008).
Results from DGGE showed that the number of bands ranged from 20 − 40 in any
individual mouse. Significant variation was observed between individuals of the same
group with similarity index values ranging from 55 – 90% which was considerably low
for the lower range. However other DGGE based studies on gut microbiota of mouse
have showed comparable similarity index values (McCracken et al, 2001). Similar to
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RISA and ARISA profiles, the number of bands obtained from DGGE fingerprints were
far less than the number of species typically found in a host. These observations indicate
that the DGGE based approach is more suitable for comparative studies that involve
detecting shifts in microbial populations rather than diversity estimation studies. Excising
specific bands from the DGGE gel and sequencing them or preparing a clone library from
the same PCR products can give information about the type of bacteria present in the
sample. However the PCR products resolved on DGGE gel in this study were ~177 bps in
length and ≥50% of the obtained sequences were not classified to any phylum at 90%
confidence threshold. When the classification was repeated at low confidence threshold
of 50 – 60% most of the unclassified bacteria resolved into the phylum level of
taxonomy. Moreover, the classification of these sequences to lower taxonomic levels was
highly ambiguous. A similar pattern was observed with clone libraries obtained from the
PCR products used for DGGE analysis (Figure A.5). These results showed that sequences
obtained from DGGE are best classified at the phylum level of taxonomy or at the class
level. Within each phylum the % GC ratio of species varies significantly. Thus sequences
from Bacteroidetes and Firmicutes, the two predominant phyla found in mouse colon,
were observed throughout the length of DGGE gel (Table A.1). Additionally no chimeric
sequences were detected in a total of 418 sequences obtained from DGGE gel or DGGEPCR product clone library. This was in concordance to the fact that it is difficult to detect
chimeras within smaller sequences (Haas et al, 2011). A typical near full length 16S
clone library generally yields 5−30% sequences that are chimeric (Ashelford et al, 2005).
Inability to detect chimeras in a DGGE sequence library indicates a potential bias
associated with this approach. Despite these limitations, DGGE is a relatively
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inexpensive method for detecting shifts in microbial populations under different
conditions.
The results from near full length 16S sequence analysis as well as the DGGEPCR product based library showed Bacteroidetes and Firmicutes as the predominant
phyla in the murine colon accounting for >90% of the total sequenced population. This is
in concordance with pyrosequencing based studies obtained from the colon and cecal
samples of the same strain of mice (Nava et al, 2011; Ley et al, 2005; Hoffmann et al,
2009). However those studies also found Actinobacteria, TM7, Acidobacteria,
Tenericutes and Cyanobacteria in the murine colon and cecal regions comprising less
than 1% of the total sequenced population. At the family level, 10 families were
identified in this study with near full length 16S clone library based approach (Figure
3.8). However sequences belonging to Prevotellaceae, Rikenellaceae, Clostridiaceae and
other rare families that have been observed in murine colon by other research groups
were found only in the clone libraries obtained from DGGE-PCR products (Figure A.6).
These differences in the identification of rare phyla and assignment of sequences to lower
taxonomic levels could reflect bias associated with inadequate sampling, criteria used for
the classification of sequences, the length of 16S region amplified and most importantly
the different primer sets used in the DGGE-PCR clone library, pyrosequencing and near
full length 16S based sequencing approaches. At the genus level ~65% of the sequences
were not assigned to any genus level, a trend found by other researchers too indicating
that the lower GI tract of mammals is largely colonized by uncultivated and
uncharacterized bacteria (Ley et al, 2005). These results emphasize the need to cultivate
and study the microbes that colonize the gut environment.
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4.4 Microbial community of the host changes with time
An important observation found in this study was the gradual change in host
microbiota with time (Figure 3.7). This observation was consistent with previous studies
that have shown the microbial community of the host to be dynamic and changing with
time (Tiihonen et al, 2010). However those time dependent studies estimated the
microbial difference between infants, adult and elderly humans which is different from
this study wherein differences in colon microbiota were observed within intervals of few
weeks in adult mice. Other time dependent studies that had observed the effect of diet,
antibiotic or any other factor on host microbiota have used only a 0 time point reference
as the control (Dethlefsen et al, 2008; Ley et al, 2006). Only one study with four week
old mice was found to reveal the differences in the microbial composition of the luminal
and mucosal portions of caecum, proximal and distal colon within a five day interval
(Hoffmann et al, 2009). No distinct pattern was observed regarding the relative
proportions of Bacteroidetes and Fimicutes in the above study. However the data
presented in the current study indicates a gradual increase in the ratio of Bacteroidetes
and Firmicutes over time. The reason for this shift in microbial communities over such a
short time span could be related to the developmental changes occurring in the mouse
within this time frame. Thus the above observation underscores the importance of using
separate control for each of the time points in microbiota related time course experiments.
4.5 Effect of arsenic on microbial composition of the murine colon
Exposure to arsenic via drinking water is a global health problem. The effect of
acute and chronic exposures of arsenic on human health differs significantly. Acute
exposure to arsenic at high doses generally leads to GI hemorrhage, multiple organ
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damage and death (Armstrong et al, 1984). On the other hand, chronic exposures at
environmentally relevant doses alter cell signaling pathways leading to cancers of various
organs, cardiovascular disease and diabetes (WHO, 2001; Hughes, 2002). Therefore in
this study the in vivo effect of As(III) on colon microbiota was determined after adding
sodium arsenite to drinking water at concentrations that are commonly found in the
environment. The results from this study reveal that As(III) in drinking water affects the
microbial composition of the gut. The differences between the control and As(III)
exposed mouse colon microbiota were more significant than the differences that could
have been due to variability within each group. Results from all the molecular approaches
used in this study showed shifts in host microbial populations after two weeks of 250 ppb
of As(III) exposure and ten weeks of 10 ppb of As(III) exposure. Banding patterns and
dendrogram analysis of RISA and DGGE gels showed that the molecular similarity
between the 2, 5 and 10 week 250 ppb exposed mice is greater than the similarity
between any of the 250 ppb mice to any of the control group mice from the same time
point. This type of intra group similarity was observed for 10 ppb As(III) exposed mice
only after 10 weeks of As(III) exposure. PCA plots obtained from ARISA showed
scattering of control and to a certain extent of the 10 ppb groups (except in 10 week
samples) across the plot whereas the 250 ppb groups tended to form clusters. The results
obtained from the 16S clone libraries were analyzed at various levels of taxonomical
hierarchy to identify the taxa that differed significantly between control and As(III)
exposed groups. An increase in Bacteroidetes and a proportionate decrease in Firmicutes
were observed with increasing dose of arsenic exposure versus control groups. As
expected the taxonomic composition of the 10 ppb group was intermediate to the control
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and the 250 ppb group but like the 250 ppb group, the average Bacteroidetes population
was also more in the 10 ppb group as compared to the control group. The stacked bar
graph obtained for relative taxonomic distribution of near full length 16S as well as
DGGE-PCR product based clone libraries showed that the 10 week 250 ppb exposed
group is more similar to the 10 week control as opposed to the 2 and 5 week 250 ppb
group, which differed significantly from their respective control groups. Also the level of
significant differences between the control and 250 ppb group of 10 week changed when
different confidence thresholds were used for classification. However, the significant
difference remained the same at all confidence thresholds for all the other libraries used
for comparison. The reason for such observation is unknown. The phylogenetic analysis
showed that the changes observed between control and As(III) groups were attributed to
class Bacteroidia and Clostridia and families Porphyromonadaceae, Lachnospiraceae and
Ruminococcaceae. At the genus level over 19% of the increase in Bacteroidetes in As(III)
exposed groups was associated with Barnesiella. In addition, an increase in Bacilli and
Lactobacillus was found in the As(III) exposed group. Since many sequences remain
unclassified at the order level it is not possible to conclude whether As(III) affects
different genera and families within a phyla differently, causing one subgroup to increase
while causing other to decrease. The results presented in this study reveal that, due to
inter individual variations in microbial community structure, it is necessary to use a
combination of molecular and statistical approaches to demonstrate the effect of any
variable on the microbial community of the host.
Human and mouse show considerable similarity in their distal gut microbiota at
the higher levels of bacterial taxonomy (Ley et al, 2005). Several recent studies have used
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murine models to reveal a relation between diseased and altered gut microbial
communities (Bibiloni et al, 2005; Turnbaugh et al, 2006). Some of these studies as in the
case of obesity showed similar results when repeated on human subjects (Ley et al, 2006;
Turnbaugh et al, 2006). Thus it is plausible that the results from this work may be
extended to humans.
4.6 Effect of arsenic on microbial diversity
The results from DGGE and RISA showed no significant difference in the total
number of bands obtained from control and As(III) exposed groups. Similarly ARISA
profiles and 16S clone libraries did not showed any difference in microbial richness
between control and As(III) exposed groups. For DGGE-PCR product based clone
libraries, the 250 ppb As(III) group was more diverse in the 5 week and less diverse in
the 10 week libraries when compared to the control groups. However, the diversity index
data from the near full length 16S based clone libraries showed low diversity in the 250
ppb As(III) groups when compared to control for 2, 5 and 10 week time points at genetic
distances of 0.05 and 0.1. These differences in the diversity estimations of 5 week
samples between 16S and DGGE based clone libraries could be related to the differences
in DNA extraction procedures used for obtaining the microbial community DNA. In the
10 ppb group from 2, 5 and 10 week samples the diversity was always more than the 250
ppb group but no particular trend was observed with respect to the control group from the
same time point. Although no firm conclusion about the effect of As(III) on the
microbial diversity of the mouse colon can be made from this study, nevertheless, the
reduced diversity in the 250 ppb group that is predominated by Bacteroidetes might be
related to the fact that Bacteroidetes is a far less diverse phylum when compared to the
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Firmicutes. Reduced diversity in the colon may result in a decreased number of microbe
associated metabolic pathways in the colon that might affect the physiological processes
of the host.
On the basis of diversity estimations and taxonomic classification, it can be
concluded that in this study although the rare bacteria might not have been sampled
efficiently, the effect of arsenic on predominant groups has been resolved.
4.7 Selective effect of arsenite on host microbiota: a direct effect
Bioinformatics analysis of distribution and occurrence of the ars operon in gut
microbes showed that far more Bacteroidetes harbor this arsenic resistant mechanism as
compared to the Firmicutes (Table 3.7). Grouping of ArsA and ArsB sequences from
Bacteroidetes in the same cluster of the phylogenetic tree indicated common origin of
these operons. However, the two proteins showed little similarity with any of the
reference ArsA and ArsB sequences, which was surprising considering that most of the
Bacteroidetes species had the E.coli type five gene ars operon configuration consisting of
arsA, arsB, arsC, arsD and arsR genes. Most of the Firmicutes were devoid of arsA gene
but their ArsB protein sequence clustered with B. subtilis indicating that these Firmicutes
possess an Acr3 type As(III) transporter system.
Primers designed specifically for amplifying part of arsA and arsB DNA and
cDNA from operon 1 of B. thetaiotamicron, in return amplified the regions from operon
2 as confirmed by sequencing. The reason for amplification of arsA and arsB cDNA from
operon 2 could be related to the fact that in species that have more than one ars operon,
the operon that lacks arsC gene is expressed at high levels in the presence of arsenite.
However the amplification of 2nd operon with genomic DNA indicates that the sequence
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for 2nd operon is present in more copies in the colon microbial community DNA.
Presence of multiple copies of 2nd operon in community DNA could relate to either intra
or inter genomic mobilization of the ars operon under selective effect of As(III) exposure
or gene duplication or binding of primers to ars operon of other closely related
Bacteroides species. Bacteroidetes populations have been documented to possess well
developed mechanisms for transposition of antibiotic resistant genes to other species
(Salyers et al, 2004). Occurrence of the ars operon on plasmids and the presence of
transposition related genes in the vicinity of the ars operon of certain species coupled
with the results above indicate that the ars operon can undergo horizontal transfer under
As(III) pressure and needs further investigation.
No change in expression of arsA and arsB was observed in response to 10 and
250 ppb of As(III) exposure under in vivo conditions of the colon. The reason could be
that neither As(III) nor its metabolic forms are present in enough quantities in the colon
so as to induce the expression of these genes. Studies with Shewanella sp strain ANA 3
have demonstrated that the expression of ars operon requires ≤ 100 µM concentrations of
As(III) in culture media and only 1.5 fold increase in expression was observed with 10
fold increase in As(III) in the media (Saltikov et al, 2005a). These values for induction
and fold increase in ars expression varies from species to species with a 14 - 39 fold
change in the expression of ars operon genes observed in the presence of equal amounts
of As(III) with different C. jejuni strains (Wang et al, 2009). However, the culture
conditions used in those studies were very different from the current study where the fold
change in arsA and arsB expression was determined under in vivo conditions with 10 and
250 ppb of As(III) in drinking water. Although levels of arsenic tested in this study did
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not appear to induce any expression of ars genes in colon bacteria, the basal level of
expression of these genes in colon bacteria might still provide selective advantage to the
Bacteroidetes populations that harbor arsenic resistance genes as opposed to majority of
the Firmicutes generally found in the colon that do not possess ars operon.
Arsenic compounds have been used since ages as antimicrobial agents at high
doses (Leonard, 1991). Arsenite levels in the range of 4 – 64 µg/ml of culture media have
been found to be inhibitory to C. jejuni strains that possess ars operon ((Wang et al,
2009). However the effect of ppb levels of As(III) on microbes that do not possess
mechanism for arsenic resistance is not known. Another reason for the decrease in
Firmicutes population in As(III) exposed murine colon could be to due antimicrobial
action by other gut residents that bloomed in the colon in response to As(III) exposure.
For example Lactobacillus converts sugars to lactic acid resulting in the acidification of
the colon environment (Corr et al, 2009). An increase in Lactobacillus in response to
As(III) exposure can suppress the growth of other gut microbes by reducing pH. However
further work is needed to determine the role of microbe-microbe interaction in
development of As(III) associated microbiota.
This part of the study underscores the importance of measuring levels of arsenic
and its metabolites in the colon as most of the ingested arsenic happens to be absorbed in
the small intestine and any remaining amounts of arsenic or its metabolites may or may
not have any direct effect on the viability of gut microbes per se.
4.8 Effect of arsenic on the microbial physiology of the host
Increased levels of nitrite, as an indicator used for estimating NO levels in the
host, have been observed in mouse liver after As(III) exposure at low doses
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(Barchowsky, unpublished data). Additionally, increased levels of nitrogen species such
as peroxynitrite have been reported in mouse liver in response to the generation of
superoxide anion from As(III) stimulated NADPH oxidase (Straub et al, 2008). Increased
NO levels can affect the gut lining, cause inflammation and can have a bactericidal effect
on gut bacteria (Endo et al, 2010; Kim et al, 2008; Sobko et al, 2006). An increase in NO
levels in the host may result in selective increase of microbes that possess genes to
combat high levels of NO. E.coli has been shown to combat NO toxicity by inducing the
expression of nrfA (Poock et al, 2002). In this study, time and dose dependent increase in
nrfA expression was observed in the mouse colon microbes after As(III) exposure under
in vivo conditions. The increased expression of nrfA in colon microbes along with
selective colonization of the colon by microbes that possess this gene may alter important
metabolic pathways in the host that could result in development of pathogenic conditions
in the host colon. The effect of As(III) on NO levels of the colon epithelia and microbial
generation of NO is not known currently. However, based on the results above, increased
NO level in the host in response to As(III) exposure seemed like a plausible explanation
for the observed increase in the expression of nrfA in As(III) exposed mouse colon.
4.9 Arsenic induced changes in the host: An indirect effect on gut microbiota
Although evidence for angiogenesis and vascular remodeling in mouse liver
indicated by defenestration of liver sinusoidal epithelial layer were seen by two weeks
after exposure to 10 ppb of arsenite (Straub et al, 2008), the changes in the microbial
flora of the murine colon started appearing at two weeks but these changes were not
significant until ten weeks of arsenite exposure. These observations suggest that the
effect of As(III) on gut community occurs in response to systemic changes of the host
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and are not due to the direct exposure to arsenic itself. The interaction between colon
epithelium and its microbiota is very complex with microbes present in the mucus layer
of the epithelial lining playing a role in the regulation of epithelial cell regeneration and
mucus layer production by goblet cells present in the epithelia. The outer mucus layer of
the epithelia is the site where bacterial colonization occurs whereas the inner mucus layer
acts as a shield and prevents microbial invasion into the host blood stream (Cherbuy et al,
2010; Johansson et al, 2011). Like respiratory epithelia, colon epithelia may secrete
innate immune protein like PLUNC that can regulate epithelial hydration as well as
biofilm formation (Gakhar et al, 2010). Thus the colon epithelial environment influences
the colonization of commensal bacteria by immune regulation and by providing access to
complex carbohydrates in the mucus layer. In situ observations using transmission
electron microscopy revealed that the small 0.25 μm coccoids (e.g. Ruminococcus)
disappeared by the 5 week time point in mice treated with 250 ppb of As(III) (Stolz,
unpublished data). This population also disappeared from the As(III) exposed 16S rRNA
based clone libraries. Dietary factors such as Vitamin A deficiency affect the
proliferation rate and differentiation of epithelial cells in the intestine (Uni et al, 2000). It
has been well established that arsenic at low levels alter signal transduction pathways
involved in cell cycle regulation and differentiation and proteins involved in immune
response and inflammation (Kozul et al, 2009b; Druwe & Vaillancourt, 2010). Although
the effect of arsenic on gut epithelium is not known, the above evidence suggest that
As(III) exposure can affect the colon epithelium differentiation, regeneration and
function making it less favorable habitat for certain bacterial populations. In this way,
As(III) associated changes in the gut microbiota can be more likely linked to arsenic
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induced changes in the host and gut environment rather than the direct impact of toxic
arsenic on gut community.
4.10 Implications of Arsenic induced changes in colon microbiota on host health
Gut microbes play a key role in various important processes in humans including
nutrient processing, energy harvesting, immune system regulation and brain development
(Hooper et al, 2002; Macpherson & Harris, 2004; Turnbaugh et al, 2006; Heijtz et al,
2011). In this study an increase in Bacteroides and lesser proportions of Firmicutes were
observed in colon of As(III) exposed mice. Similar trends involving an increased ratio of
Bacteroidetes to Firmicutes have also been associated with type I and type II diabetes
(Giongo et al, 2011; Larsen et al, 2010) and an opposite trend was observed in obesity
(Ley et al, 2006). Higher levels of Bacilli and Lactobacillus observed in this study were
also observed in type 2 diabetic human adults (Larsen et al, 2010). Bacteroidetes are
gram negative bacteria with LPS in their outer membrane which is an important virulence
factor and may cause inflammation (Allcock et al, 2001). Additionally Bacteroidetes
produce small chain fatty acids as end products of their metabolic pathways that have
important neurological effect on rat brain (MacFabe et al, 2007). Moreover arsenic
exposure in the environmental settings has been associated with neurological defects,
type II diabetes and reduced innate immunity ((Bardullas et al, 2009; Kozul et al, 2009a;
Navas-Acien et al, 2008)). Together they suggest that arsenic induced changes in
microbial community composition may induce further changes in mouse physiology such
as nutrient uptake, fat distribution, weight loss, diabetes and innate immune responses.
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Chapter 5 : SUMMARY AND FUTURE DIRECTIONS
The overall hypothesis of this project was that the chronic exposure to
environmentally relevant concentrations of As(III) will have direct impact on the
composition and physiology of the gut microbiota. By using a combination of molecular
approaches this study has shown that As(III) has time and dose dependent selective effect
on the murine colon microbiota. These changes in the mouse colon microbiota started
appearing at 2 weeks of 250 ppb of As(III) exposure and continued in 10 weeks. For 10
ppb of As(III) exposure levels these changes became significant only after 10 weeks of
As(III) exposure. Results from the 16S clone libraries showed an increase in
Bacteroidetes and a proportionate decrease in Firmicutes in 10 and 250 ppb As(III)
exposed groups versus control groups. Additionally, time and dose dependent changes in
the physiology of gut microbes was observed in the form of increased expression of nrfA
from Bacteroides in response to As(III) exposure. However no effect of As(III) exposure
was observed on the same organism with respect to the expression of genes involved in
arsenic resistance and detoxification (arsA and arsB). Since evidence for As(III) induced
changes in mouse liver were seen by two weeks after exposure to 10 ppb of As(III)
(Straub et al, 2008), it was concluded that the observed changes in the colon microbiota
occurred more likely in response to As(III) induced changes in mouse physiology rather
than the direct impact of As(III) on gut microbes.
The data presented in this work is novel in the sense that it a first step towards
understanding the in situ effect of chronic exposure to environmentally relevant
concentrations of As(III) via drinking water on the colon microbiota. This study also
130

sheds light on the possible impact of arsenic on the physiology of microbes residing in
the gut by using B. thetaiotamicron as the model organism and is the first study to show
that arsenic resistant genes are expressed in colon microbes under normal conditions of
the gut. However further work needs to be done to address specific questions such as the
impact of As(III) associated altered microbiota on the host health and host-microbial
interactions. The significance of this study is that it provides framework to study the
effect of other environmental contaminants on the GI tract. In any case, further arsenic
toxicological studies should include GI microbes as a possible affected organ or as an
organ that may play a role in arsenic associated disease progression.
Since enough similarity exists in the colon microbiota of mouse and humans, the
findings of this study can be investigated on human subjects. The results presented in this
study do not in any way prove that the microbiota of As(III) exposed mice is unhealthy,
yet this type of changed microbiota can have health effects in addition to those directly
related to arsenic exposure such as weight loss, diabetes, colon cancer and other GI tract
related problems. Metabolomics or proteomics approaches might help in deciphering the
effect of changed microbiota on host health and will be able to resolve the pathways by
which As(III) associated changes in colon microbiota may or may not affect the health
status of its host.
Reversal studies involving removal of As(III) after few weeks of exposure and
subsequent microbial studies will help in demonstrating whether As(III) associated
changes in the microbial community of the host is reversible or not and to what extent. If
the effect of As(III) is not reversible, then it should be analyzed whether introduction of
prebiotics/probiotics aids in reestablishment of the normal microflora. Another question
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worth investigating would be whether reestablishment of normal microflora reverts any
of the host physiological conditions caused due to As(III) exposure. These studies will
help to establish the link between As(III) associated microbiota and host physiology.
Studies demonstrating the effect of chronic exposures of As(III) at low doses on the
epithelial lining of the GI tract will help in understanding the mechanisms for selective
effect of As(III) on gut microbiota. This study will help in enhancing the current view of
the interactions that happen between the GI tract and its microbiota.
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APPENDICES
A.1 Materials and methods and results from Study 1
Materials and methods: Similar to section 2.1 to 2.9 except for the following:
Mice Exposure: Sodium arsenite at a concentration of 0 and 250 ppb in drinking water
was fed to groups of six mice for a period of 2, 5 and 10 weeks. However, only three
mice were exposed to As(III) for 10 week 0 ppb and 250 ppb group to obtain colon
samples.
DNA extraction: Microbial community DNA extraction from the colon of 2 and 5 week
samples was done by silica and guanidinium thiocynate (GuSCN) method as described by
Boom et al, 1990. Silica suspension was prepared by adding DI water to 6 g of SiO2
(spectrum cat.no.S1388) to a total volume of 50 ml and was sedimented for 24 hrs at unit
gravity. Forty three ml of the supernatant was removed from the silica gradient and the
volume was again raised to 50 ml with DI water. The silica mix was again allowed to
settle for 5 hrs at unit gravity. Forty four ml of the supernatant was removed from the
silica gradient and 60 µl of 32% HCl was added and mixed by vortexing. The silica
suspension thus obtained was aliquoted in 1.5ml eppendorf tubes and autoclaved. Nine
hundred μl of lysis buffer L6 [24 g GuSCN, 20 ml of 0.1 M tris HCl (pH 6.4), 4.4 ml 0.2
M EDTA (pH 8.0) and 0.5 ml Triton X] was added to 40 μl of silica suspension.
Homogenized mouse colon sample was added to the above mix and vortexed for 5
seconds. The tubes were incubated at room temperature for 10 minutes, vortexed and
centrifuged at 12,000 x g for 15 seconds. The supernatant was removed and the pellet was
washed twice with 1 ml of washing buffer L2 [24 g GuSCN in 20 ml of 0.1 M tris HCl
176

(pH 6.4)] followed by washing with 1 ml of 70% ethanol and 1 ml acetone. The pellet
was dried after the washings and then resuspended in 50 μl of TE buffer (10 mM tris HCl
and 1 mM EDTA pH 8.0) by incubating at 560C for 10 minutes in a water bath. Any
leftover debris was removed by centrifuging at 12,000 x g for 2 minutes and the
supernatant containing the nucleic acid was transferred to a sterile eppendorf tube and
quantified. DNA extraction from 10 week samples was done by QIAamp DNA stool mini
kit as described in section 2.2.
Reamplification of bands obtained from DGGE gels
Specific bands were excised from the DGGE gels by using a razor blade
and were kept in 10 μl of sterile water at 4oC overnight and later transferred to −20oC
until further use. The excised bands were reamplified using primers HDA1 (without GC
clamp) and HDA2 (Table 2.1) (Walter et al, 2001). The reaction mixture consisted of 10
μl of water eluted from DGGE bands, 4 μl of 5X buffer, 10 pmol each of forward and
reverse primers, 0.4 μl dNTPs from a 200 μM stock, 0.5U of GoTaq DNA polymerase
(Promega, Madison, WI, USA) and sterile water to a total volume of 20 μl. The reaction
mixture was denatured at 94oC for 5 minutes, followed by 30 cycles of denaturation at
94oC for 30 sec, annealing at 50oC for 30 sec, extension at 72oC for 30 sec and a final
extension at 72oC for 5 min. After PCR, the amplification was confirmed by visualizing
the products on a 1.8% agarose gel after EtBr staining.
Cloning and sequencing of reamplified bands and DGGE-PCR products
The reamplified PCR products and DGGE-PCR products were ligated into the
pCR2.1®-TOPO vector following the manufacturer’s instructions (Invitrogen TOPO TA
cloning kit, Invitrogen, Carlsbad, CA, USA). The ligation, transformation and plasmid
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DNA extraction steps were done as mentioned in section 2.7. Sequencing was done using
M13 forward and reverse primers provided with the Invitrogen TOPO TA cloning kit.
The reaction mixture for sequencing consisted of 300 ng plasmid DNA, 3.2 pmol primer,
4 µl BigDye solution, 2 µl 5X sequencing buffer and sterile water to a total volume of 20
µl. The reaction conditions involved initial denaturation at 96oC for 1 min, 40 cycles of
denaturation at 96oC for 30 sec, annealing at 50oC for 5 sec and extension at 60oC for 4
min followed by a final hold at 4oC. The completed reaction was then purified using
Centricep column refilled with 800 µl Sephadex G-50, dried in speed vac and
resuspended in 10 µl of deionized formamide and sequenced using a 3100-Avant
Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Data deposition: The bacterial 16S rRNA gene sequences obtained from study 1 are
deposited in Genbank database with accession numbers HQ681318-HQ681412 (10 week
control), HQ681413 - HQ681511 (10 week 250 ppb), HQ681512 - HQ681605 (5 week
250 ppb) and HQ681606 - HQ681697 (5 week Control).
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Results:
DNA extraction: Representative 0.8% agarose gels showing the quality of genomic DNA
extracted from mouse colon using silica and guanidinium thiocynate method and
QIAamp DNA stool mini kit are presented in Figure A.1. The 260:280 ratio for the
extracted nucleic acids obtained with silica and guanidinium thiocynate method was
generally ≤1.4 whereas with QIAamp DNA stool mini kit the 260:280 ratio varied
between 1.6-1.8.
A.

B.

Figure A.1: Representative 0.8% agarose gels showing high MW genomic DNA
obtained from mouse colons by using (A) Silica and guanidinium thiocynate method and
(B) QIAamp DNA stool mini kit. L= 100 bp DNA ladder, M= 1Kb DNA ladder.
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RISA: The spacer region between the 16S and 23S rRNA gene was amplified from 2, 5
and 10 week mouse colon community DNA. PCR products thus obtained were separated
on a 5% polyacrylamide gel. Similar to study 2, the product size for the spacer region
ranged from 300 bps to >1500 bps. Alterations in the RISA profiles of As(III) treated
mice were observed when compared to the control mice in the form of absence/presence
of bands and their intensity. These alterations between the control and 250 ppb As(III)
exposed groups were more consistent and dramatic in 10 week samples than 2 and 5
week samples (Figure A.2). Dendrogram analysis of the 10 week RISA gel showed
separate clustering of the control and 250 ppb As(III) exposed groups. However, mixed
clustering of the control and 250 ppb As(III) exposed groups was observed for 2 and 5
week samples (Figure A.2).

A. 2 week
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B. 5 week

C. 10 week

Figure A.2: RISA gels and dendrogram analysis of negative image of RISA fingerprints
generated from 16S-23S intergenic region of control (blue) and 250 ppb (red) arsenic
exposed mice at A) 2 week, B) 5 week, and C) 10 week. L= 100 bp DNA ladder.
Numbers on left side of the DNA ladder represent size of the marker band in base pairs.
Scale bar on dendrograms represents similarity index values.
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ARISA: ARISA was performed on 2, 5 and 10 samples using 5’end labeled 1406F and
23Sr primers. The peaks obtained from ARISA electrophoregrams were analyzed in the
same way as mentioned in section 3.2. The peak sizes obtained from ARISA profiles of
this study ranged from 277 bps to 1155 bps representing intergenic spacer region of 27
bps to 905 bps. The matrices obtained for presence/absence of peaks, relative peak height
and area were used for Principle Component Analysis (PCA). PCA ordination plots
obtained from all three matrices showed clear separation of control and 250 ppb As(III)
exposed samples in case of 10 week samples but not for the 2 and 5 week samples
(Figure A.3). An exception to this observation was separate clustering of the control
samples from the 250 ppb As(III) exposed samples in the 2 week binary matrix. However
similar clustering pattern was not found in the other two matrices (height and area) from
the 2 week samples.
2 week
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5 week

10 week

Figure A.3: PCA plots generated from ARISA profiles of bacterial communities from
control (black squares) and 250 ppb As(III) exposed colons (open squares) of (I) 2, (II) 5
and (III) 10 week samples. The percentages shown along the axis represent the proportion
of variation by that axis. PCA plots based on (A) presence/absence of peak (binary), (B)
relative peak height and (C) relative peak area. Circles represent the groups that cluster
together.
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DGGE: A 177 bp long segment of the 16S rRNA gene was amplified from 2, 5 and 10
week mice colon community DNA. PCR products thus obtained were separated on a 4060% DGGE gel and specific bands were excised and sequenced bidirectionally.
Alterations in DGGE profiles of mice treated with 250 ppb of As(III) were observed
when compared to the control mice. However, these changes were more consistent and
dramatic in 10 week samples as compared to 2 and 5 week samples (Figure A.4).
Dendrogram analysis of the DGGE gel showed clustering of control and 250 ppb As(III)
exposed groups in two different clades in 10 week samples. Two and 5 week samples
showed mixed clustering of the control and 250 ppb As(III) exposed groups (Figure A.4).
Table A.1 shows the taxonomic classification of the sequences obtained from the DGGE
gels of 2, 5 and 10 week colon samples.
A. 2 week
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B. 5 week

C. 10 week

Figure A.4: DGGE and dendrogram analysis of negative image of DGGE fingerprints
generated from 16S rDNA PCR of control (blue) and 250 ppb (red) As(III) exposed mice
at A) 2 week, B) 5 week, and C) 10 week. Numbers on right side of each lane represent
the sequenced band number. Scale bar on dendrograms represents similarity index values.
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Taxonomic
classification
Unclassified bacteria
Unclassified
Firmicutes
Unclassified
Bacteroidetes
Unclassified
Clostridia
Unclassified
Clostridiales

Time
point
5 week
10 week
2 week
10 week

dgge14C1, dgge13C3, dgge5C3, dgge5C4
dgge19A9, dgge19B5
3C3
dgge19B4, dgge17B1, dgge17B8

2 week

11B1

5 week

dgge14A1

5 week

dgge6A1

2 week
Unclassified
Lachnospiraceae

Unclassified
Porphyromonadaceae
Unclassified
Prevotellaceae
Unclassified
Rikenellaceae
Unclassified
Ruminococcaceae
Lachnospiraceae

5 week

Prevotellaceae
Rikenellaceae

11A4, 11A5, 11B4, 11B2, 4B1, 3A3, 4A1, 3C2,
3C5, 4B4
dgge13B1, dgge13A3, dgge14A2, dgge6B3,
dgge6B2, dgge6B5, dgge6B4, dgge5B1

10 week

dgge19C2, dgge19C12, dgge19C5, dgge19B3,
dgge19A8, dgge17A4, dgge17B6, dgge17C6,
dgge17B7, dgge17B5, dgge17A1

2 week

12C3, 11C1, 11C2, 3A2, 3C1, 4B3, 4B6

10 week

dgge17C11, dgge17B10, dgge17A2, dgge17C12,
dgge17C13, dgge17B2, dgge17C5, dgge17A3

10 week

dgge17C4

2 week

12A2

10 week

dgge19A5, dgge19B7, dgge19C4

2 week

4B2, 12A2.1

5 week

dgge5C1, dgge6A3, dgge6B1, dgge6A2, dgge6A5,
dgge5C5, dgge13A1

10 week
2 week
Porphyromonadaceae

Band name

10 week
2 week
10 week
2 week
10 week

dgge17C8, dgge17B4, dgge19C13, dgge19C1
12C1, 12B1, 11A1
dgge17C14, dgge17C7, dgge17A7, dgge19A2,
dgge19C6, dgge19C1
3A1
dgge17B9, dgge17C10, dgge17A5, dgge17A8
11A3, 12C2, 12B2, 11B3, 4A2, 4A4, 4A3, 4A5,
4B5
dgge19C3
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Taxonomic
classification
Ruminococcaceae
Anaeroplasmataceae

Time
point
5 week
10 week
5 week
2 week
5 week

Bacteroidaceae
10 week

Deferribacteraceae
Lactobacillaceae

Band name
dgge13A2
dgge19B6, dgge17B3, dgge17A6, dgge19B2
dgge14C3
11A2, 3C4
dgge5C2, dgge14C2, dgge14A3
dgge19C7, dgge17C2, dgge19A1,dgge17C9,
dgge19C10,dgge17C3, dgge19C8, dgge19C9
dgge19A3, dgge19A4, dgge19A6, dgge19A7

5 week
10 week
2 week
5 week

dgge6A4, dgge13B2
dgge17C1, dgge19B1
12A
dgge13C2, dgge13C1, dgge6B6

Table A.1: Taxonomic classification of the bands sequenced from 2, 5 and 10 week
DGGE gels. Each sequenced band is assigned to the lowest taxonomic level achieved at
50% confidence threshold. The time point refers to the DGGE gel from which the bands
were sequenced. Nomenclature of the bands is such that it can be associated with the
band numbers on the DGGE gels shown in figure A.3. For example, dgge13C2 from 5
week time point in the last row of the above table refers to band labeled as 2 from 13C
lane of 5 week DGGE gel.

187

Clone library: A total of 194 clones from 10 week colon samples were analyzed, 32 from
DGGE bands of control mice, 29 from DGGE bands of As(III) treated mice, 62 from
control and 70 from 250 ppb of As(III) treated DGGE-PCR product clone library. In case
of 5 week colon samples, 186 clones were analyzed, 17 from DGGE bands of control mice,
14 from DGGE bands of As(III) treated mice, 75 from 16S rDNA control clone library and
80 from 250 ppb of As(III) DGGE-PCR product clone library. The majority of the cloned

sequences were assigned to the phylum Bacteroidetes and Firmicutes. Very few
sequences belonging to the phylum Deferribacteres, Verrucomicrobia, Proteobacteria and
Tenericutes were obtained. Most of the sequences classified under Firmicutes phylum
were members of the class Clostridia and family Lachnospiraceae. Ruminococcaceae,
Lactobacillaceae, Clostridiaceae and Erysipelotricheaceae were other families observed
under the phylum Firmicutes. Within phylum Bacteroidetes, Bacteroidia was the
predominant class constituted by families Bacteroidaceae, Prevotellaceae, Rikenellaceae
and Porphyromonadaceae. Only one sequence was observed from the class
Sphingobacteria, a Bacteroidetes. Furthermore, a number of clones were identified as
uncultured bacterial clone when the sequences were classified at 90% confidence
threshold. However the number of unclassified bacteria dropped immensely when
classification was performed at 50% confidence threshold (Figure A.5).
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Figure A.5: Class level taxonomic classification of sequences obtained from DGGEPCR product clone library. Left side classification was obtained at confidence threshold
of 50% while right side taxonomic classification was obtained at a confidence threshold
of 90%. * indicates significantly different from the control group for the same class
(p<0.01).
Comparison of the control and 250 ppb libraries at 50% confidence threshold by
using RDP II library compare tool showed that the two libraries differ with respect to the
number of sequences that belong to phylum Bacteroidetes at both 5 and 10 weeks. At the
same time, the control and 250 ppb libraries were different for Firmicutes only at the 5
week time point. Significant increase in Bacteroidaceae was observed after 250 ppb of
As(III) exposure at 5 and 10 week intervals. In the 10 weeks samples, presence of
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Prevotellaceae in the control clone library along with significant increase in
Bacteroidaceae and decrease in Porphyromonadaceae after arsenic treatment kept the
Bacteroidetes population constant in both control and 250 ppb of As(III) exposed
libraries. Additionally sequences belonging to the Rikenellaceae family were observed
only in the 5 and 10 week 250 ppb As(III) exposed clone libraries. The number of
sequences belonging to class Clostridia and family Lachnospiraceae decreased
significantly in 5 week samples after 250 ppb of As(III) exposure but did not had any
effect at 10 weeks. Since most of the sequences that belong to family Lachnospiraceae
could not be classified any further it was difficult to detect whether arsenic treatment was
affecting a single or more than one genus from this family.
Paired comparison of 5 and 10 week control and As(III) treated libraries using
Libshuff yielded a p-value <0.001, indicating that the two libraries are significantly
different from each other. Regardless of the As(III) exposure it was found that the
microbial community of mouse changed over time. The ratio of Firmicutes to
Bacteroidetes decreased with time from 5 to 10 week in DGGE-PCR products clone
libraries (Figure A.5, A.6).
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Figure A.6: Family level taxonomic classification of sequences obtained from DGGEPCR product clone library at confidence threshold of 50%. * indicates significant
difference between the control and 250 ppb As(III) exposed group for the same family
(p<0.01).
Microbial diversity: Based on distance matrix, sequences obtained from the 5 and 10
week DGGE gels and DGGE PCR product based clone library were grouped into the
same phylotype when they were 97%, 95% or 90% identical. For the combined dataset,
the number of OTUs with only one sequence at a distance of 0.03, 0.05 and 0.1 were 71,
45 and 23 respectively. Regardless of As(III) exposure, a total of 121 unique phylotypes
were identified including 72 and 71 phylotypes from 5 and 10 week clone libraries
respectively at the distance level of 0.03. The number of unique phylotypes observed in
the DGGE based clone libraries decreased with an increase in distance. However no
significant difference in the number of observed OTUs was found in response to the
As(III) exposure or time. Figure A.7 shows the number of OTUs shared between the
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control and 250 ppb As(III) exposed clone libraries obtained from the 5 and 10 week
mouse colon samples at a distance of 0.05.

Figure A.7: Venn diagram showing the number of OTUs shared between control and 250
ppb As(III) treated DGGE-PCR product based clone libraries obtained from 5 and 10
week colon samples at a distance of 0.05. 250 ppb As(III) exposed groups are indicated
by experimental in the figure.
The values obtained from Good’s coverage indicate that sequencing additional
clones will add only a few OTUs at the family and genus level. For each individual
library, >80% coverage was observed at distances of 0.05 and 0.10. Table A.2 shows the
number of OTUs, estimated richness, Good’s coverage and diversity indices obtained
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from each library and from the combined data set. Overall the Good’s coverage was 88%
and 94% for the combined libraries at a distance of 0.05 and 0.1 respectively.
Rarefaction curves obtained for the combined dataset at 0.03 and 0.05 distance
levels did not reach saturation towards the end of the sampling. However for the 0.05
distance level, the curve rise was less steep towards the end of the sampling. At 0.1
distance level the curve almost reached plateau towards the end of sampling (Figure A.8).
Both rarefaction curves and Good’s coverage estimates indicated that the majority of
bacteria at the family level of taxonomy have been captured in the current sequencing
efforts. Similarly, estimation of species richness by Chao’s estimator predicted that
sequencing more clones could reveal more unique sequences in all the clone libraries
(Table A.2). The percentage of observed/estimated OTUs was almost similar for both the
family and genus level and ranged between 43−73%.
Within the individual library data sets, bacterial diversity at the family and genus
level as measured by Shannon and Simpson index was highest for the 10 week control
and lowest for the 5 week control group. These results differ slightly from the microbial
richness wherein observed number of OTUs as determined by rarefaction curve was
lowest in the 10 week 250 ppb As(III) exposed group. Overall, no effect of As(III)
exposure was observed on the microbial diversity of mouse colon at any time point with
any of the diversity estimations used in this study (Table A.2).
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Observed
OTUs
5wk
control
5wk
250 ppb

Chao Estimator
Good’s
of species
Coverage
richness
(C)
Distance 0.05

Shannon
Diversity
Index (H)

Simpson
Diversity
Index (D)

30

60.6

80%

2.733323

0.105829

33

57.42857

80%

2.971714

0.067948

53

111.6667

82%

3.063833

0.098925

38

63.5

81%

3.392611

0.030459

29

40

88%

3.009824

0.053597

10wkall

53

120.6667

85%

3.215441

0.051493

All

84

154.7143

88%

3.584084

0.049188

5wk all
10wk
control
10wk
250 ppb

Distance 0.01
5wk
control
5wk
250 ppb

18

29.25

89%

1.766123

0.325609

23

53.33333

85%

2.231012

0.180508

31

69.25

90%

2.153226

0.229468

26

48.75

85%

2.687578

0.096305

18

27.33333

92%

2.112844

0.184086

10wk

36

83.5

90%

2.655157

0.128946

All

52

77.3

94%

2.619702

0.169657

5wk all
10wk
control
10wk
250 ppb

Table A.2: Indices of richness, diversity and library coverage obtained for DGGE-PCR
product based clonal libraries at distances of 0.05 and 0.10.
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Figure A.8: Rarefaction curves obtained from all the sequences obtained from the
DGGE-PCR product based clone library at a distance of 0.03, 0.05 and 0.10.
Phylogenetic tree: A neighbor joining tree of the representative OTU sequences obtained
at a distance of 0.05 from the control and 250 ppb DGGE-PCR product based clone
libraries of 5 and 10 week mouse colon samples was constructed (Figure A.9). A total of
130 OTUs were represented on the neighbor-joining tree. The phylogenetic tree indicated
that most of the OTUs identified in the DGGE-PCR product based clone libraries are
present in the control as well as 250 ppb As(III) exposed groups. The Lachospiraceae
family formed the largest clade in the phylogenetic tree followed by Bacteroideaceae and
Porphyromonadaceae. The number of sequences within certain OTUs was drastically
different between the control and As(III) exposed libraries. For e.g. OTUs represented by
Rikenellaceae were exclusively obtained from 5 and 10 week 250 ppb of As(III) exposed
mouse colons.
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Figure A.9: Neighbor joining tree showing the positions of 16S rDNA phylotypes
obtained from the mouse colon. Clones obtained from control samples are shown as blue
circles and those obtained from 250 ppb As(III) exposed samples are shown as red
triangles. Boot strap values obtained from 1000 replications and above 50% are shown at
the nodes. Scale bar represents genetic distance based on 10 substitutions per 100
nucleotides. The number between ―│ │‖ indicates the number of sequences that were
found under the same representative OTU.

197

A.2 Protocol for 5% polyacrylamide gel
5X TBE buffer
54 g Tris base
27.5 g Boric acid
20 ml 0.5M EDTA pH (8.0)
Make up the volume to 1000 ml with nanopure water
40% Acrylamide/Bis
38.93 g acrylamide
1.07 g bis-acrylamide
Dissolve in 100 ml nanopure water
Filter and store in dark at 4oC
10% APS
Dissolve 1g APS in 10 ml nanopure water.
5% polyacrylamide gel
3 ml 5X TBE buffer
1.87 ml 40% Acrylamide/Bis
150 µl 10% APS
15 µl TEMED
Make up the volume to 15 ml with nanopure water
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A.3 Protocol for DGGE
50X TAE buffer
242 g Tris base
57.1 ml glacial acetic acid
100 ml 0.5M EDTA pH (8.0)
Make up the volume to 1000 ml with nanopure water
40% Acrylamide/Bis
38.93 g acrylamide
1.07 g bis-acrylamide
Dissolve in 100 ml nanopure water
Filter and store in dark at 4oC
10% APS
Dissolve 1g APS in 10 ml nanopure water.
0% Urea-formamide(UF) stock solution for 10% arylamide gels
12.5 ml 40% acrylamide
1 ml 50X TAE
Make up the volume to 50 ml with nanopure water
80% Urea-formamide stock solution for 10% arylamide gels
12.5 ml 40% acrylamide
1 ml 50X TAE
16 ml ultrapure formamide
16.8 g Urea
Make up the volume to 50 ml using pure water.
Working urea-formamide gradient solutions
40% UF: Mix 5 ml 0% UF stock solution and 5 ml 80% UF stock solution
60% UF: Mix 2.5 ml 0% UF stock solution and 7.5 ml 80% UF stock solution
Add 100 µl 10% APS and 10 µl TEMED to working gradient solutions immediately
before pouring the gel.
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A.4 LB media preparation
LB liquid broth (pH 7)
10 g tryptone
5 g yeast extract
10 g NaCl
Make up the volume to 1 L with nanopure water and autoclave.
LB Agarose plates
10 g tryptone
5 g yeast extract
10 g NaCl
15 g agar
Make up the volume to 1 L with nanopure water and autoclave.
Ampicillin selective media
Prepare stock solution (100 mg/ml) by dissolving 100 mg ampicillin in 1 ml of 50%
ethanol. Add 1000 µl of ampicillin stock solution to 1 L of LB media.
X- Gal
Add 40 mg of X-gal to 1ml of dimethylformamide. Use 40 µl of X-gal for each LB plate.
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A.5 Primers used in section 3.9
Gene

IMG Gene
Object
Identifier

rpoB

642809876

arsA

642811825

nrfA

642811669

Prevotella
melaninogenica

rpoB

645585915

arsA

645586155

Oribacterium
sinus

rpoB

644432171

arsA

644434364

Lactobacillus
planatarum

arsA

Clostridium
phytofermentans

arsA

Dorea
formicigenerans

rpoB

641806964

nirB

641808481

Organism

Bacteroides
intestinalis

637590361

641293247

Primer Sequence (5’ to 3’ end)
F2168-GGCGTCGTACAAACCAGAAT
R2368-CCACACGTTCGTTCAATACG
F59-AGGGCGGTGTAGGAAAAACT
R253-CTTGTTCCGGGTCGAGATTA
F1023-CAATGTGTACGAACGCCAAC
R1221-ATGGAAAGAACCACCGTGAG
F2269- AACGGTGAGTTGGCATTAGG
R2579-TCGCTTTCACCCTTAGGAGA
F121-GGCTTGGCAGATAATGGAAA
R298-TAACGCCTTCCCTGTATTCG
F627-TGTCTTTATTCGTGCGCTTG
R867-GTATCGTCCCACCTTGGCTA
F89-GTGCAACAGCAGTGGCTTTA
R371-AAGGCAGCAATCTCCACTGT
F274-AGTGTTGTTGGCCCTTATCG
R734-GGTGTTTTAAGCGTGCCATT
F715-AATGGCACGCTTAAAACACC
R1164-CAATACCTGCTGCTCGTCAA
F1063-ACCGTTCATCTAGCCACCAC
R1594- GTGTAGCCAGCATGCTTTGA
F274-AGTGTTGTTGGCCCTTATCG
R831- CGGCACTTCATACTGAGCAA
F274-AGTGTTGTTGGCCCTTATCG
R1164-CAATACCTGCTGCTCGTCAA
F715-AATGGCACGCTTAAAACACC
R1594- GTGTAGCCAGCATGCTTTGA
F254-AGGCTGCTGCTGAATATCGT
R1017-TTTTCCAACACCACCCTTTC
F254-AGGCTGCTGCTGAATATCGT
R1158-ATGCTCATCAATGTGGCTCA
F998-GAAAGGGTGGTGTTGGAAAA
R1320-GTTATCTGCACGCTCCACAA
F254-AGGCTGCTGCTGAATATCGT
R1320-GTTATCTGCACGCTCCACAA
F2765-AGATGTCACCGGGAGTGAAC
R3051-CGCACCATCAAATACAGGTG
F1026-AGATAACCGCCTGACTGGTG
R1210-CCGGTGTAAATCTGCAAGGT

Table- 0.3: The sequences for the above genes were retrieved from DOE Joint Genome
Institute portal (http://img.jgi.doe.gov/) and the primers were designed using primer 3
program.
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A.6 Sequences obtained from RISA clone library and their top BLAST result
>12A3 (472 bp)
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTATGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATACTATCTAGTTTT
CAAAGAACAAGTTTGATAACTAATGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCC
CGTATAATGGGCCTAAGGTGGACTCGAACCACCGACCTCACGCTTATCAGGC
GTGCGCTCTAACCAGCTGAGCTATAGGCCCATTTAGCTCTGAGAGTAGACCTC
TCAAAACTAAACAAAGTTTACGATAAAAGTGCAGGTTTCCGAAATTATCCTT
AGAAAGGAGGTGATCCAGCCGCAGGTTCTCCTACGGCTACCTTGTTACGACA
gb|AY526616.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete
sequence; and 23S ribosomal RNA gene, partial sequence Length=762
Score = 819 bits (443), Expect = 0.0, Identities = 463/472 (98%), Gaps = 4/472 (1%)
>12A4 (486 bp)
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGATAACTAACGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCC
CAAAATATTTATTTAATGGGCCTAAGTGGACTCGAACCACCGACCTCACGCTT
ATCAGGCGTGCGCTCTAACCAGCTGAGCTATAGGCCCAAAATAAGCAACCTT
GAGAAAAGTAAATCTCTCAAAACTAAACAAAGTTTACGATAAAAGTGCAGGT
TTCCAAATTATCCTTAGAAGGGGGGGATCCAGCCGCAGGTTCTCCTACGGCT
ACCTGGTTACGACA
gb|AY526614.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete
sequence; and 23S ribosomal RNA gene, partial sequence Length=776
Score = 822 bits (445), Expect = 0.0, Identities = 475/488 (97%), Gaps = 8/488 (2%)
>12A6 (395 bp)
GCCAAGGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACG
ATAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAA
CGCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGT
TTTCAAAGAACAAGTTTGATAACTATTGTTATCAATGGGAGCTTAACGGGATC
GAACCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAG
CCCCATGTTTTAAGAGTAAACCTCTCAAAACTAAACAAAGTTTACGATAAAA
AGTGCAGGTTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCCAGCCGCAGG
TTCTCCTACGGCTACCTTGTTACGACA
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gb|AY526613.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and
23S ribosomal RNA gene, partial sequence Length=682
Score = 669 bits (362), Expect = 0.0, Identities = 386/396 (97%), Gaps = 8/396 (2%)
>12A7 (542 bp)
GTCGTACAGGGTAGCCGTACCGGAAGGTGCGGCTGGAACACCTCCTTTCTGG
GAGCGCANAGTTCGTTATCAAGTTGACTCAGAGGTATTAGTTAACTTGTACTA
CGGTTGAATATGTATAAAATATAGATCTACCGGCAATAAAGTGTCGGCAAGA
GAGAAAAATGATGCTGAGGGAAACCAAGGCAAAGTTGACAGTCCTATAGCT
CAGTTGGTTAGAGCGCTACACTGATAATGTAGAGGTCGGCAGTTCANCTCTG
CCTGGGACTACAGAATCTCTGAGAGAGAATTTTGGGGGATTAGCTCAGCTGG
CTAGAGCATCTGCCTTGCACGCAGAGGGTCAACGGTTCGAATCCGTTATTCTC
CACAAAAAAGTTACCGAGACATCAGAAACGTAAAGTAACGACAAGATCTTTG
ACNTGATGGACAACGTAAATAAAGTAACCAGGAGCAAGCTGAANATTTATCA
ATCCGATTTACCCCTGTGGGTANCCGGAAATAAAAAAGTAAGCCAGGGGCAG
ACGGGTGGATGCCNTTGGNCA
gb|EU136697.1| Parabacteroides goldsteinii strain JCM13446 16S ribosomal RNA
gene, partial sequence Length=2002
Score = 889 bits (481), Expect = 0.0, Identities = 521/541 (96%), Gaps = 9/541 (2%)
>4A23 (291 bp)
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGAT
AAATGGTTATGAGTTTAGCGATCANACATTAAATGTTTTAACTCTTTAAAACG
CGGTGTTCTCGGTTATTTTAATTAACANAGAAATAAAAGATATTATCTAGTTT
TCAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGAT
AAAAGTGCNGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAG
GTTCTCCTACGGCTACCTTGTTACGACA
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 473 bits (256), Expect = 2e-130, Identities = 280/292 (96%), Gaps = 6/292
(2%)
>4A7 (292 bp)
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGATA
AAAGTGCAGGTTTCCGAAATTATCCTTAGAANGGAGGTGATCCAGCCGCAGG
TTCTCCTACGGGCTACCTTGTTACGACNA
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gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 492 bits (266), Expect = 6e-136, Identities = 283/291 (97%), Gaps = 4/291
(1%)
>4A17 (293 bp)
GCCAGGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGA
TAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAAC
GCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTT
TTCAAAGAACANGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGA
TAAAAGTGCAGGTTTCCGAAATCATCCTTAGAAAGGAGGTGATCCAGCCGCA
GGTTCTCCTACGGCTACCTTGTTACGACNA
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 486 bits (263), Expect = 3e-134, Identities = 282/291 (97%), Gaps = 3/291
(1%)
>4A18 (389 bp)
GCCAGGCATCCACCATGCGCCCTTAATANCTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCC
CATGTTTTAAGAGTAAACCTCTCAAAACTAAACCAAAGTTTACGATAAAAAG
NGCNGGTTTCCGNAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCGGTTCT
CCTACGGCTACCTTGTTACGAC
gb|AY526613.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and
23S ribosomal RNA gene, partial sequence Length=682
Score = 658 bits (356), Expect = 0.0, Identities = 381/393 (97%), Gaps = 7/393 (2%)
>4A3 (392 bp)
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGAT
AATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACG
CGGTGTTCTCGGTTATTTTAATTANCAAAGAAATAAAAGATATTATCTAGTTT
TCAAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGA
ACCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCC
CCATGTTTTAAGAGTAAACCTCTCAAAACTAAACAAAGTTTACGATAAAAAG
TGCNGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGGTTTCT
CCTANCGGCTACCTNGGTTACGAC
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gb|AY526613.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and
23S ribosomal RNA gene, partial sequence Length=682
Score = 656 bits (355), Expect = 0.0, Identities = 382/395 (97%), Gaps = 8/395 (2%)
>4A19 (291 bp)
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGAGAGTAGATCTCTCAAAACTAAACAAAGTTTACGATA
AANGTGCAGGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAG
GTCCTCCTACGGCTACCTTGTTACGACA
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 484 bits (262), Expect = 1e-133, Identities = 282/291 (97%), Gaps = 4/291
(1%)
>4A4 (~470 bp)
GCCAAGGCATCCACCATGCGCCCTTATAACTTAACCTATATTATCTTATGATA
TGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAACTCTTTAAAACGCGG
TGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATACTATCTAGTTTTCA
AAGAACAAGTTTGATAACTAATGTTATCAATGGAGCTTAACGGGATCGAACC
GTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCCCG
TATANTGGGCCTAAGTGNACTCCNAACCACCGACCTCACGCTTATCAGGCGT
GCGCTCTAACCAGCTGAGCTATAGGCCCATTTACTCCTGAGNGTAANCCNCN
CCAAACTAACCAANGTTANNATAANGGNGCGGGTTTCCGAAATTATCCTTAA
AAAGGNGGGTGANCCCCCCCCCGGTTNCCCTACGGGTACCTTGGTACNACA
gb|AY526616.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete
sequence; and 23S ribosomal RNA gene, partial sequence Length=762
Score = 649 bits (351), Expect = 0.0, Identities = 431/473 (91%), Gaps = 14/473 (3%
>4A12 (389 bp)
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGAT
NATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACG
CGGTGTTCTCGGTTATTTTAATTAACAAAGAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAGCCCC
ATGTTTTAAGAGTAACCCTCTCAAAACTAAACAAAGTTTACGATAAAAGGTG
CAGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGGGTTCTC
CTACGGCTACCTTGTTACGACA
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gb|AY526613.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and
23S ribosomal RNA gene, partial sequence Length=682
Score = 649 bits (351), Expect = 0.0, Identities = 380/393 (97%), Gaps = 8/393 (2%)
>4A20 (290 bp)
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGATA
AAAGTGCGGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGG
TTCTCCTACGGCTACCTTGTTACGACA
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 494 bits (267), Expect = 2e-136, Identities = 283/290 (98%), Gaps = 3/290
(1%)
>4A6 (289 bp)
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAACTCTTTAAAACGCG
GTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTTC
AAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGATAA
AAGNGCNGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGGT
TCTCCTACGGCTACCTTGTTACGACA
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 486 bits (263), Expect = 3e-134, Identities = 281/290 (97%), Gaps = 4/290
(1%)
>4A15 (292 bp)
GCCAGGCATCCACCATGGCGCCCTTNAATAACTTAACCTATATTATCTTACGA
TAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAAC
GCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTT
TTCAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGA
TAAAAGTGCAGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCA
GGGTTCTCCTACGGCTACCTTGTTACGAC
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 486 bits (263), Expect = 3e-134, Identities = 284/293 (97%), Gaps = 6/293
(2%)
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>4A5 (388 bp)
GCCAGGCATCCACCATGCGCCCTTATANCTTAACCTATATTATCTTACGATAA
TGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGCG
GTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTTC
AAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGAAC
CGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCCC
ATGTTTTAAGAGTAAACCTCTCAAAACTAAACANAGTTTACGATAANAAGTG
CAGGTTTCCGAAATTATCCTTAGAAAGGNGGTGATCCNGCCGCNGGTTCTCCT
ACGGCTACCTTNGTTACAAC
gb|AY526613.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and
23S ribosomal RNA gene, partial sequence Length=682
Score = 647 bits (350), Expect = 0.0, Identities = 375/389 (96%), Gaps = 6/389 (2%)
>4A21 (~482 bp)
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTAACGA
TAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAAC
GCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTT
TTCAAAGAACAAGTTTGATAACTAACGTTATCAATGGAGCTTAACGGGATCG
AACCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGC
CCCGTATANTGGGCCTAAGTGGACTCGAACCNCCGACCTCACGCTTATCNGG
CGTGCGCTCTAACCAGCTGAGCTATAGGNCCNTTTAGCTCTGAAGAGTAGAC
CTCTCAAAACTAAACANAGGTTTACGATAANNGTGGCNGGTTTCCCNAAATT
ATCCTTAGAAAGGGAGGNGATCCNNNCCCGNNGGTTCNCCCACGGGCTACNT
TGGTTCNAACG
gb|AY526616.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete
sequence; and 23S ribosomal RNA gene, partial sequence Length=762
Score = 693 bits (375), Expect = 0.0, Identities = 419/443 (95%), Gaps = 10/443 (2%)
>4A1 (~486 bp)
GCCAGGCATCCACCATGCGCCCTTATACTTAACCTATATTATCTTACGATAAT
GGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGCGG
TGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTTCA
AAGAACAAGCTTGATAACTAACGTTATCAATGGAGCTTAACGGGATCGAACC
GTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAANGCCCCA
AAATATTTATTTAANGGGGCCTAGGNGGACTCGAACCCCCGACCTCACGCTT
ATCNGGCGTGCGCTCTAACCAGNTGAGCTATNNGCCCAAATAAGCAACCTTN
GAANAAAAGTANANCTCTCAAACTAACAAAGTTTACGANNANGGTGCNGGN
TCCNAAATTACCCTTNGAANGAGGGGNTCCCNCCCCCNGGTNCNCNTACNGG
CTACCTTGGTANNAAC
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gb|AY526614.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete
sequence; and 23S ribosomal RNA gene, partial sequence Length=776
Score = 651 bits (352), Expect = 0.0, Identities = 436/485 (90%), Gaps = 16/485 (3%)
>4A2 (~290 bp)
GCCAAGGCATCCACCATGCGCCCTTAATACTTAACCTATATTATCTTACGATA
ATGGNNATGGAGTTTAGCGATCAAACNTTAAATGTTTTTAAACTCTTTGNNNC
GCGGTGTTCTCGGTTATTTTAATTAACAANGAATAAAAGATTTTATCTAGTTT
TTCAAGAACAAGTTTGAGAGTAGGCCTCTCAAACCTANGCAAAGTTTNCATG
AGGGGGNNGGGNTCCNAAATTATCCTTAAAAGGTAGGGGACCCANCCCCNA
GTTCCCCTNCGGNNACNTTNNAACNANA
gb|AY526615.1| Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA
gene, partial sequence Length=581
Score = 292 bits (158), Expect = 6e-76, Identities = 237/280 (85%), Gaps = 13/280
(5%)
>4A22 (Incomplete sequence)
GTCGTACAGGTAGCCGTATCGGAAGGTGCGGCTGGATCACCTCCTTTCTAGG
GAAAAAGTAGGGGTTGGATTACTGTCTAGTTGTCAAGGAGTCCGTGCGGCGG
AAGACATATAGGAACAGCTGCTGTGCTTGCACAGGCAGATGTGGATATATGG
ATTCCGGCATAAGGCNAATGACCGAGCGCGAGGTATTGCAAANCATTACCCG
AGAGTGCGGGGATTCGAGNCACGGGGCNGAGTAAATAAAANACNACNCAAN
NANANGNNTTCNCGNTGGCCAATGCCCCTTATGGGNACACCCCCCGTTTCNC
NTCCCAAACACGNNGGTTAANCCCGTANGCGGGCCGAA
gb|GU208684.1| Alicyclobacillus tolerans strain DSM 16297 16S-23S ribosomal RNA
intergenic spacer and 23S ribosomal RNA gene, partial sequence Length=366
Score = 99.0 bits (53), Expect = 2e-17 Identities = 65/70 (93%), Gaps = 4/70 (6%)
>4A13 (Incomplete sequence)
GGTCGTAACAAGGGTAGCCGTATCGGNAAGGTGCGGCTGGATCACCTCCTTT
CTAGGGAAGAAGAAGTAGGGTTGTATTGCTGTTTAAAAGTGAAGGATTCCGG
TGGTGATGCNCTTAGGGGANACACACGTACCCTTCCCGAACACGATCGTTAA
GACTTAAGCGGCCGATGGTACTATACTGGAGACGGTATGGGAGAGCAGGTGT
NGTGCCGGAACNTAAAAAACATTTAGAATTGCTGGTTTTACCNGGGATCAGA
GACNGGGACANAGATTCTTTGNATCTGATGGCTGATAAAGCCTNCACCCATG
GCATGTGAAAACTTGTCCGNANCCCAAAGAGGNCCCCCCGTACCTTTAAAAA
CCAAATATTGNANANTTCTTTTTTACCNGNTTTGCCANCGAAGATNCC
gb|CP001107.1| Eubacterium rectale ATCC 33656, Features in this part of subject
sequence: rRNA-16S ribosomal RNA rRNA-5S ribosomal RNA, complete genome
Length=3449685
Score = 163 bits (88), Expect = 8e-37 Identities = 183/227 (81%), Gaps = 19/227 (8%)
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A.7 Clustal alignment of ars genes from the two operons of B. thetaiotamicron
arsA
operon2
operon1

ATGAAAGCATTCAATTTATCCGATATAGAACTGACTAAATACCTGTTTTTTACAGGTAAA 60
ATGAAAGCATTTAATTTATCCGATATAGAACTAACAAAATACTTATTCTTCACAGGAAAA 60
*********** ******************** ** ****** * ** ** ***** ***

operon2
operon1

GGTGGAGTAGGAAAGACTTCTATTGCTTGTGCCACAGCAGTTGGTTTGGCTGATAAGGGA 120
GGTGGAGTAGGAAAAACCTCTATTGCTTGCGCTACGGCAGTGGGATTAGCTGATAAAGGG 120
************** ** *********** ** ** ***** ** ** ******** **

operon2
operon1

AAGAAAATACTTCTTATCAGTACAGATCCGGCTTCTAACTTACAAGATGTTTTCGATCAA 180
GAGAAAATTCTTCTTATCAGTACAGACCCGGCTTCTAACCTGCAAGATGTTTTCAATCAA 180
******* ***************** ************ * ************ *****

operon2
operon1

TCCTTAAACGGACACGGTACAGCTATTTCAGAAGTGCCGGGACTGACTGTTGTAAACCTT 240
ACCCTAAACGGACATGGTACAGCTATTTCAGAAGTACCGGGGCTGACGGTCGTAAACCTT 240
** ********** ******************** ***** ***** ** *********

operon2
operon1

GATCCTGAGCAGGCAGCAGCAGAATACAGAGAAAGTGTTATTGCACCTTTCAGGGGAAAA 300
GACCCTGAACAGGCAGCAGCAGAGTACAGGGAAAGTGTGATTGCACCTTTTAGAGGACAA 300
** ***** ************** ***** ******** *********** ** *** **

operon2
operon1

TTACCCGAAAGCGTTATTCAGAATATGGAAGAACAGCTTTCAGGTTCCTGCACAGTAGAA 360
TTACCTGAAAGCGTTATTCAAAATATGGAAGAACAACTTTCAGGCTCTTGTACGGTAGAA 360
***** ************** ************** ******** ** ** ** ******

operon2
operon1

ATCGCAGCTTTTAATGAGTTCTCGGACTTTATTACCGATGCTGATAAAGCAAAGGAGTAT 420
ATCGCTGCCTTTAATGAGTTTTCAGACTTTATCACCGATGCTGATAAAGCGAAGGAATAC 420
***** ** *********** ** ******** ***************** ***** **

operon2
operon1

GACCATATAATTTTTGATACAGCACCTACCGGACATACATTGCGAATGTTGCAGCTTCCA 480
GACCACATTATTTTTGATACAGCACCTACCGGACACACATTGCGAATGTTGCAGCTTCCA 480
***** ** ************************** ************************

operon2
operon1

TCTGCATGGAGTACATTTATTAGTGAAAGTACACATGGTGCATCCTGTTTAGGGCAGTTA 540
TCGGCATGGAGTACATTTATTAGTGAAAGTACACATGGCGCATCTTGTTTAGGACAATTA 540
** *********************************** ***** ******** ** ***

operon2
operon1

TCAGGCTTGGAGGAACGGAAAGGAATTTATAAACAGGCGGTAGAAACCCTATCTAATACA 600
TCAGGCTTGGAAGAAAGGAAAGGTATCTATAAACAGGCGGTTGATACATTGTCTGATACA 600
*********** *** ******* ** ************** ** ** * *** *****

operon2
operon1

AGCGCAACTCGGTTAGTACTGGTCAGTCGTCCTGAAATTTCTCCATTGAAAGAAGCTGCC 660
AGCGCAACCCGGTTAGTATTGGTAAGCCGTCCTGAAATAGCACCGTTGAAAGAAGCTGCC 660
******** ********* **** ** *********** * ** ***************

operon2
operon1

CGCTCTTCATCTGAATTACAGCTATTGGGAATTAAAAATCAGTTGTTGGTGATAAATGGT 720
CGTTCTTCGCATGAATTACAACTATTGGGAATTAAAAATCAGCTATTGGTGATAAATGGT 720
** *****
********* ********************* * ***************

operon2
operon1

ATTTTACAGCAACTGAATGAAGCGGATGATGTGTCACGACAACTGCATAACAGGCAGCAA 780
GTTTTACAGCAATTAGATGAAGCAGACAATGTTTCACAACAACTGTATAACAGGCAGCAA 780
*********** * ******* ** **** **** ******* **************

operon2
operon1

AAGGCATTACAGGGTATGCCTGCTGAACTATCTGAATATCCTATGTACAGCGTTCCTCTA 840
AAGGCGTTACAAAGTATGCCTATTGCATTATCTGAATATCCCATGTATAGCGTTCCTCTG 840
***** ***** ******** ** * ************* ***** ***********

operon2
operon1

CGTTCTTATAATTTATCTGATATAGCTAATATACGCCGTATGTTATACAGCGACAGCCTT 900
CGTTCTTACAATTTATCCAATATTGCCAATATCCGCCGTATGCTATACAGTGATAGTATT 900
******** ******** **** ** ***** ********* ******* ** ** **

operon2
operon1

GCGGATGATATTTGTTATCAGCCTGTAAGTGGTGCTAAAAGTATAGACGACTTGGTTAAT 960
ACGAATGAAATTCGTTATCAGCCGATAACTGATAGCAAAAGTATAGATGAATTGGTAAAT 960
** **** *** ********** *** ** *
*********** ** ***** ***
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operon2
operon1

GACCTCTATACTTCCGGTAAGCGGGTAGTGTTCACAATGGGAAAAGGCGGTGTAGGTAAA 1020
GACCTCTATACTTCCGGTAAACGAGTAGTGTTCACAATGGGAAAAGGTGGCGTAGGAAAA 1020
******************** ** *********************** ** ***** ***

operon2
operon1

ACTACCTTAGCAACAGAAATAGCTCTGAAATTAACAAAACTCGGTGCAAAGGTACATCTT 1080
ACGACCTTAGCCACAGAAATAGCCTTGAAATTAACAAAGCTCGGTGCAAAGGTTCATCTT 1080
** ******** *********** ************* ************** ******

operon2
operon1

ACCACCACTGATCCGGCAAACCATCTGAACTATGATCTCGCTATAAAGTCGGGTATTACA 1140
ACCACTACTGACCCGGCAAATCACCTGAACTATGATTTTGCCATCAAATCAGGTATTACG 1140
***** ***** ******** ** ************ * ** ** ** ** ********

operon2
operon1

GTAAGTCATATTGATGAAGCGGAAGTATTGGAAAACTACAAGAATGAAGTTCGTAGCAAA 1200
GTAAGCCATATAGACGAAGCGGAAGTGCTGGAAAAATACAAGAATGAAGTTCGTAGCAAA 1200
***** ***** ** *********** ******* ************************

operon2
operon1

GCGGCAGAAACCATGACTGCCGAAGATATGGAATATATTGAAGAAGATTTACGTTCGCCA 1260
GCTGCCGAAACCATGACTGCCGAAGATATGGAATATATAGAGGAAGATTTACGTTCACCA 1260
** ** ******************************** ** ************** ***

operon2
operon1

TGCACACAAGAAATCGCAGTTTTCAAGGCATTTGCCGAAATTGTAGATAAAGCGGACAAT 1320
TGTACGCAAGAAATCGCCGTATTTAAGGCTTTTGCTGAAATTGTAGATAAAGCGGAGAAT 1320
** ** *********** ** ** ***** ***** ******************** ***

operon2
operon1

GAAATTGTGGTGATTGATACTGCACCGACAGGTCATACATTGTTGCTTTTGGATGCTACC 1380
GAAATCGTAGTGATTGATACTGCACCAACAGGACATACTTTGTTGCTTTTGGATGCTACC 1380
***** ** ***************** ***** ***** *********************

operon2
operon1

CAAAGCTACCATAAAGAAGTAGAACGTACCCAAGGAGCAGTTACGGGAGCGGTAGCCAAT 1440
CAAAGCTATCACAAAGAAGTAGAACGTACACAGGGAGAAGTAACCGGAGCAGTAGCCAAT 1440
******** ** ***************** ** **** *** ** ***** *********

operon2
operon1

TTATTGCCCCGTTTGCGTAATCCAAAGGAAACGGAAGTCGTAATTGTTACCTTGCCTGAA 1500
TTATTACCCCGTTTACGCAATCCACAGGAAACGGAAGTAGTAATAGTCACTTTACCCGAA 1500
***** ******** ** ****** ************* ***** ** ** ** ** ***

operon2
operon1

GCGACACCTGTATTTGAAGCTGAACGCCTGCAAATGGATTTGCAACGCGCCGGAATTAAT 1560
GCAACACCTGTTTTTGAAGCAGAACGCCTACAAATGGATTTGCAGCGTGCCGGGATTAAC 1560
** ******** ******** ******** ************** ** ***** *****

operon2
operon1

AACAAATGGTGGGTAGTAAATGCCTGCCTGTCAATGACAAATACGGAAAATTCATTTTTG 1620
AACAAATGGTGGGTAGTAAATGCCTGTTTGTCATTGACAAATACAGCAAATTCATTTTTG 1620
************************** ***** ********** * *************

operon2
operon1

CAGGCGAAAGCACAAAATGAAGTAAATTGGATTAAGAAAGTAGAACAATTGTCAAAGGGT 1680
CAAGCAAAAGCGCAAAGTGAATTGACTTGGATTAAGAAAGTAGAAGAATTGTCAAAGGGC 1680
** ** ***** **** **** * * ******************* *************

operon2
operon1

AATGCTGCCTTGATTGGATGGAAAAATATATAG 1713
AATACTGCCCTGATTGAATGGAAAAACTTATAA 1713
*** ***** ****** ********* ****

arsB
operon2
operon1

ATGGAAAAATATATAGGAATTGGATTTTTTGAAAGATACCTGACTGTTTGGGTAACTTTG 60
ATGGAAAAGAAACAAGGAATTGGATTTTTTGAAAGATACCTGACTATTTGGGTAGCCTTG 60
******** *
******************************* ******** * ***

operon2
operon1

TGCATTGTTGCTGGTATTGCTATCGGACAATGGTTTCCGGCAATATCGCAAACATTGAGT 120
TGTATCGTTATCGGGATAGCCATCGGACAATATCTTCCGGCAATACCGCAAACATTGAGC 120
** ** ***
** ** ** **********
*********** *************

operon2
operon1

AAATTAGAATACGCCAATGTGTCTATACCTGTGGCTATCCTGATTTGGTTAATGATTTAC 180
AAATTTGAATATGCCAACGTGTCTATACCTGTGGCTATCCTGATTTGGTTAATGATATAT 180
***** ***** ***** ************************************** **
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operon2
operon1

CCCATGATGCTGAAAGTAGATTTTCAGAGTATTAAAAACGTTGGTAAGCGTCCGAAAGGA 240
CCCATGATGCTGAAAGTAGATTTTCAGAGCATCAAGAACGTAGGCAAACGTCCGAAAGGG 240
***************************** ** ** ***** ** ** ***********

operon2
operon1

ATTATCATCACTTGTATTACAAATTGGCTTATAAAGCCTTTTACAATGTTTGGAATAGCT 300
ATTGTCATTACTTGTGTGACGAACTGGGTAATAAAGCCATTCACCATGTTTGGAATAGCT 300
*** **** ****** * ** ** *** * ******** ** ** ***************

operon2
operon1

TATCTATTCTTCTACGTTGTTTTCAAGTCTCTAATATCTGCCGAATTGGCCGAAGAATAT 360
TATCTATTCTTCTACGTTATTTTCAAGTCATTAATCCCTGCCGGATTAGCCGAAGAATAT 360
****************** ********** **** ****** *** ************

operon2
operon1

TTAGCAGGGGCAGTCTTATTGGGTGCTGCACCTTGTACGGCAATGGTATTTGTATGGAGT 420
TTAGCTGGGGCAGTTCTGTTAGGTGCTGCACCCTGTACGGCGATGGTGTTTGTATGGAGT 420
***** ******** * ** *********** ******** ***** ************

operon2
operon1

TATCTGACCAAAGGGGATGCTGCCTATACATTGGTGCAGGTTGCAGTGAATGATTTAATC 480
CATTTAACCAAAGGGGATGCAGCTTACACATTGGTGCAAGTGGCAGTCAATGATTTAATA 480
** * ************** ** ** *********** ** ***** ***********

operon2
operon1

ATATTGGTTGCTTTCGCTCCTATTGTTGCTTTTTTATTGGGCGTAGGTGGCGTTACGATT 540
ATATTGGTTGCTTTCGCTCCTATCGTTGCGTTTTTGTTGGGTGTCGGTGGCGTTTCTATC 540
*********************** ***** ***** ***** ** ********* * **

operon2
operon1

CCGTGGGATACATTATTGCTTTCAGTTGTATTGTTTGTTGTCATTCCTCTTTCTGCCGGA 600
CCGTGGGACACGCTTATACTCTCGGTCGTACTGTTTGTTGTCATTCCACTTTCTGCCGGA 600
******** ** * * ** ** ** *** **************** ************

operon2
operon1

ATAATAACCCGCATACTGGTTATCCGGCGAAAAGGGATAGAATATTTTAATACTGTATTT 660
ATAGTAACCCGTGTAACGGTTATCCGGCGAAAAGGAATAGACTATTTCAATACCGTCTTT 660
*** ******* ** ****************** ***** ***** ***** ** ***

operon2
operon1

ATCCGTAAGTTTGATAATTATACGACTGGCGGGTTACTATTAACGCTTATCATTCTGTTT 720
GTCCGCAAGTTCGATAACTATACGGTTGGCGGATTGCTATTAACGCTTATCATCCTGTTT 720
**** ***** ***** ****** ****** ** ***************** ******

operon2
operon1

TCATTTCAAGGAGAAACCATATTGAACAATCCGTTGCACATCGTATTGATTGCCGTTCCG 780
TCGTTTCAGGGGGAAACGATACTGAACAATCCGTTACATATTGTCTTGATTGCCGTCCCG 780
** ***** ** ***** *** ************* ** ** ** *********** ***

operon2
operon1

CTTGTGTTGCAAACAGTTCTGATATTCTTTGTAGCCTATGGTTGGGCGAAATGGTGGAAA 840
CTTGTCCTGCAAACGGTTCTGATATTCTTTGTTGCCTACGGTTGGGCAAAGTGGTGGAAG 840
***** ******* ***************** ***** ******** ** ********

operon2
operon1

TTACCTCACAATATAGCTGCACCTGCCGGAATGATTGGTGCAAGCAATTTTTTTGAATTA 900
TTACCCCACAATGTCGCCGCACCTGCCGGAATGATTGGTGCGAGTAACTTCTTTGAGTTG 900
***** ****** * ** *********************** ** ** ** ***** **

operon2
operon1

TCGGTGGCTGTGGCTATATCGCTTTTCGGTTTGCAATCCGGTGCTGCATTGGCTACAGTG 960
GCGGTGGCGGTGGCTATTTCTCTTTTCGGCTTACAGTCCGGTGCTGCACTGGCTACCGTA 960
******* ******** ** ******** ** ** ************ ******* **

operon2
operon1

GTAGGGGTGTTGGTTGAAGTTCCGGTTATGCTGATGTTAGTGAGAGTTGCAAATAATACA 1020
GTAGGCGTATTGGTTGAAGTTCCAGTAATGCTTATGTTAGTAAAAATAGCCAATAATACA 1020
***** ** ************** ** ***** ******** * * * ** *********

operon2
operon1

TACAGGTGGTTTACAATAAAATCAAGTATGAGTAAATAG 1059
AGAAGTTGGTTTCC--TAAAGTAAAATAA---------- 1047
** ****** * **** * ** **

arsR
Operon1
Operon2

ATGGGTCACCCGGCACGAATGGCAATTCTTAGTTTCTTAGCTAAACAAGAAAGTTGTTTC
ATGGGACACCCGGCACGAATGGCTATTCTTAGTTTCTTGGCTAAACAGGAAAGTTGTTTC
***** ***************** ************** ******** ************

Operon1
Operon2

TTCGGAGATATTCACGAAGTACTACCCATTGCTAAAGCAACCGTTTCGCAGCATTTAAAA
TTCGGAGATATTCACGAAGAATTGCCTATTGCCAAAGCAACCGTTTCACAGCACTTGAAA
******************* * * ** ***** ************** ***** ** ***
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Operon1
Operon2

GAACTGAAAGATGCAGGGTTAATTCAGGGGGAAATAGAAACACCAAAAGTTCGGTATTGT
GAGCTGAAAGATGCAGGATTAATTCAGGGAGAAATAGAAACGCCCAAGGTGCGATATTGT
** ************** *********** *********** ** ** ** ** ******

Operon1
Operon2

ATCAACCGAGAGAATTGGGAACTTGCCCGTAAATTATTTGCTGCATTTTTGGGTGATTGT
ATTAATAAGGAAAATTGGGAACTTGCCCGCAAATTATTTGCTGCATTTTTGGGAGATTGT
** **
** ***************** *********************** ******

Operon1
Operon2

AAATGTACGGGTACATCGTGCTGTGGATAA
AAATGTACAGGAACATCGTGCTGTGGATAA
******** ** ******************

arsD
Operon1
Operon2

ATGAAAACAATAGAAATTTTTGACCCGGCAATGTGTTGCCCTACGGGTTTGTGTGGAACT
ATGAAAAAGATAGAAATTTTTGATCCGGCAATGTGTTGCCCTACGGGTTTGTGTGGAACA
******* ************** ***********************************

Operon1
Operon2

AATATTAATCCTGAATTAATGAGGATAGCCGTTGTTATCGAAACATTGAAAAGACAGGGT
AATATCAATCCTGAATTGATGAGGGTTGCAGTTGTTGTCGAAACATTGAAAAGACAGGGT
***** *********** ****** * ** ****** ***********************

Operon1
Operon2

GTTGTTGTTACCCGTCATAATTTGCGGGACGAACCGCAAGTTTATGTAAGTAACAAGACT
GTTATTGTTACCCGTCACAATTTACGGGATGAACCACAGGTGTATGTGAGCAATAAAACA
*** ************* ***** ***** ***** ** ** ***** ** ** ** **

Operon1
Operon2

GTAAACCAATATCTTCAAAAGAATGGTGCAGAAGCACTGCCTATTACTTTGGTGGATGGT
GTAAATGAATATCTTCAAAAGAATGGTGCAGAAGCTTTACCTATTACTTTAGTAGATGGT
***** **************************** * *********** ** ******

Operon1
Operon2

GAAATTGCAGTTTCTAAAGATTATCCCACAACTAAACAAATGAGTGAATGGACAGGAATT
GAAATTGCAGTTTCTAAAGTTTATCCTACCACTAAACAAATGAGTGAATGGACGGGAGTG
******************* ****** ** *********************** *** *

Operon1
Operon2

AATTTAGACTTGATGCCCGTTAAATAA
AATTTAGATTTAATGCCCGCTAAATAA
******** ** ******* *******
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